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SUMMARY
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"ii:
.The aims of this study were (i) to analyse an adhesin from C. albicans and (ii) to 
identify the epithelial cell molecule(s) to which the adhesin binds. Extracellular 
polymeric material (EP), composed mainly of mannoprotein, is thought to originate 
from the cell surface when yeasts are grown in medium containing a high concentration 
of galactose. Previous work has shown that this material contains a proteinaceous 
adhesin. More recently, a complete purification scheme for the yeast adhesin was 
devised (Tosh and Douglas, 1992) which made use of the findings from earlier studies 
on adhesion mechanisms. The purification protocol involves the stepwise treatment of 
EP with N-glycanase, papain, and dilute alkali followed by afRnity adsorption with the 
trisaccharide determinant of the H (type 2) blood group antigen on inert silica beads. 
Adhesin purified in this way is devoid of carbohydrate, can inhibit adhesion of yeasts to 
buccal epithelial cells (BEC) by up to 80%, and consists of one major component as 
determined by reverse-phase fast protein liquid chromatography (FPLC). Purified 
adhesin was prepared in this study and it was found to inhibit adhesion of C. albicans 
GDH 2346 cells to BEC by up to 74.81%.
EP was subjected to some of the treatments previously found to have an effect on 
its adhesion-inhibition activity, prior to analysis by reverse-phase high performance 
liquid chromatography (RP-HPLC). Each of the treatments produced some alteration in 
the HPLC profile of EP and the combined treatment of EP with all the above reagents 
(N-glycanase, papain, and dilute alkali) resulted in the production of a number of 
protein fragments. The fragments appeared to be more hydrophobic than the parent 
molecule.
The purified adhesin was analysed further. Amino acid analysis showed that it 
was mainly composed of the amino acids Thr, Pro, Ala, Ser, Val, Gly, Asx and Glx, 
which made up around 80% of the total amino acids. No Cys was detected and there 
was very little Met, Phe and Arg. This composition is remarkably similar to a large 
number of microbial adhesins which would appear to indicate a relationship between 
the amino acid composition of lectin-like proteins and their function as carbohydrate 
binding molecules. I
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In previous studies, the visualisation of EP and purified adhesin on SDS-PAGE 
proved difficult. However, in this study, an alternative approach to protein visualisation 
was employed. Purified adhesin was biotinylated prior to SDS-PAGE and Western blot 
analysis. The adhesin was then probed for using ^^^I-streptavidin and, after 
autoradiography, was seen as a strong band with a molecular mass of approximately
15.7 kDa. Its successful visualisation meant that partial amino acid sequencing could be 
attempted. The following sequence was obtained; Phe-Asp-Tyr-Glu-His-Val-Asp-X- 
Ala-Val. There was no complete match found in the protein database but the purified 
adhesin sequence contains an interesting motif, FDYE, that is found in a wide range of 
proteins from a variety of sources. The partial amino acid sequence obtained for the 
adhesin is most probably an internal sequence, produced as a result of enzymic cleavage 
by the action of papain.
The second aim of this study was to identify receptors for C  albicans on buccal 
epithelial cells. BEC glycolipids were prepared and a glycolipid chromatogram overlay 
system was employed. This system has been used to characterise a number of microbial 
adhesin-receptor relationships. Six strains in total were examined for their ability to 
bind to separated glycolipids. Five strains bound to glycolipids expressing H-blood 
group antigen as indicated by comparison with an identical chromatogram overlaid with 
biotinylated Ulex europaeus lectin. These strains also bound to an additional lipid from 
BEC which appeared to have a terminal N-acetyl-D-galactosamine residue, as 
determined by comparison with an identical chromatogram overlaid with N-acetyl-D-
■galactosamine-specific lectin from Helix pomatia. However, the yeast cells did not bind
.to control glycolipids with N-acetyl-D-galactosamine as a terminal sugar residue and so
.N-acetyl-D-galactosamine per se is unlikely to be the receptor. From the relative 
mobility of this Candida binding lipid and the control lipids, the yeast cells may be 
binding to blood-group A antigen, to which Ulex europaeus lectin cannot bind. This 
would suggest that fucose alone and not just the H antigen can act as a receptor for C. 
albicans. In a similar experiment, EP and purified adhesin from GDH 2346 were 
biotinylated and overlaid onto TLC plates of separated glycolipids and probed with ;
^^^I-streptavidin prior to autoradiography. EP and purified adhesin were found to bind
to H-blood group antigen but there was no binding to the additional lipid which was 
bound by the whole cells. The component on the Candida cell surface that binds to the 
additional receptor may not be released as part of EP or the ability of EP to bind to this 
antigen may be lost during the purification procedure. The binding of whole cells and 
EP from the sixth strain, GDH 2023, to glycolipids was also examined by the 
chromatogram overlay assay. Biotinylated whole cells, EP and biotinylated Griffonia 
simplicifolia lectin II (specific for N-acetyl-D-glucosamine) were overlaid onto TLC 
plates of separated lipids as previously described. By comparison of the resultant 
autoradiographs both EP and whole cells from this strain were seen to bind to 
glycolipids containing N-acetyl-D-glucosamine. These results support those of earlier 
investigators which suggested that strains GDH 2346, GRI 681, GRI 682, and MRL 
3153 all share a common adhesion mechanism involving L-fiicose-containing receptors 
but that strain GDH 2023 differs in that its adhesion mechanism involves GlcNAc- 
containing receptors. Use of the TLC overlay analysis system in the present study 
demonstrates unequivocally the identity of glycoconjugates as receptors and confirms 
that adhesin molecules on the yeast cell surface bind in a lectin-like manner to epithelial 
cell components containing L-fucose or GlcNAc. I
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1. THE GENUS CANDIDA
1.1 Historical Aspects
The earliest recorded descriptions of thrush as a clinical entity were made by 
Hippocrates in his "Epidemics" (circa 460-377 B.C.) when he described two cases of 
oral aphthae associated with underlying diseases (Adams, 1939). Conditions 
recognisable as oral and gastrointestinal candidosis were described by Rosen von 
Rosenstein (1771) in a paediatrics text.
The initial discovery of the organism causing thrush was not made until 1839 
when Langenbeck described a fungus in buccal aphthae in a case of typhus. A great 
deal of confusion surrounded the taxonomic study of the thrush fungus for a century 
following Langenbeck's description. Gruby placed the fungus in the genus 
Sporotriticum in 1842, while Robin, in 1853, named it Oidium albicans. This was the 
first use of the name albicans which is derived from the Latin for "whitening". 
Quinquaud proposed the name Syringospora robinii in 1868 while Reess, in 1877, 
named the fungus Saccharomyces albicans. Monilia albicans was the name proposed 
by Zopf, in 1890. This name was retained for a number of decades and gave rise to 
the term "moniliasis" for infections due to the thrush fungus.
The taxonomy of the fimgus was clarified by Berkhout in 1923 and she 
proposed the name Candida for the genus which was later adopted internationally.
Toga Candida is Latin for the white robe worn by "candidates" for the Senate. So in 
combination, Candida and albicans means "whitening white".
1.2 Ecological niche
Yeasts can be isolated from a wide variety of habitats including plants, insects 
and soil (Kreger van Rij, 1984). However, the yeast species acknowledged as 
principal agents of human candidosis have a comparatively restricted natural 
distribution, and have been discovered primarily in association with man and other
20
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warm-blooded animals (Odds, 1988). Candida species are also frequently found in 
the hospital environment: in foods, in the air, and on a variety of fomites (Barnett et 
al, 1983). They are commonly isolated from the mouth, gut and vagina of apparently 
healthy individuals. The majority of studies on yeast carriage have been conducted on 
subjects who are attending hospitals and clinics, and as Candida species are 
opportunistic pathogens, the results obtained may not reflect a truly normal 
population (Odds, 1988). Candida albicans is known to colonise humans more 
frequently than other Candida species. C glabrata and C. tropicalis can be found in 
the normal flora of the oral cavity, gastro-intestinal tract and vagina, but less 
frequently than C albicans. C.krusei, C. guilliermondii and C. parapsilosis are 
found more frequently as part of the skin flora. Colonisation rates increase 
dramatically for all species in patients receiving cytotoxic drugs that alter the 
gastrointestinal mucosa, and/or broad spectrum antibiotics (Odds, 1988).
2. BIOLOGY OF CANDIDA
2.1 Classification
Yeasts were defined by Lodder (1970) as fungi whose predominant 
morphological form is unicellular. This definition was refined by Kreger van Rij 
(1984) who described yeasts as unicellular fungi capable of reproducing by budding 
or fission.
The genus Candida as a whole comprises 196 species. Among these species,
C. albicans isolates are consistently the most virulent. C. tropicalis is also pathogenic 
but is quantitatively less so than C albicans. Less pathogenic are C. parapsilosis, C. 
pseudotropicalis, C. glabrata. C. kefyr, C. guilliermondii and C. krusei. Another two 
species, C. lusitaniae and C. viswanathii, are possibly to be regarded as pathogenic 
but only in the immunocompromised host (Odds, 1988). The species within the genus 
are separated primarily on the basis of their physiological properties. Each species has 
a characteristic pattern of assimilation reactions and relationships between species
21
may be inferred by comparisons of such patterns. C albicans can be easily and 
quickly identified by using either the germ tube test (Taschjian et a l, 1960) or the 
test for chlamydospore production (Benham, 1931; Kligman, 1950; Dawson, 1962).
2.2 Typing systems
Typing systems for the medically important fimgi have not received the same 
attention as the systems used for pathogenic and epidemiological studies with 
bacteria and viruses (Merz, 1990). However both genotypic and phenotypic 
approaches are now being employed and the latest methodologies offer good to 
excellent discrimination between different species within the genus Candida (Odds, 
1993). Typing systems based on genotypic differences have obvious advantages over 
phenotypic approaches, but problems of analysing the genetics of Candida species 
have been hampered by the absence of a sexual cycle and the lack of molecular tools 
(Merz, 1990).
Hasenclever and Mitchell (1961) were the first to demonstrate the existence of two 
antigenic types of C. albicans - serotypes A and B. The A serotype possesses the 
same group of antigens as serotype B, plus two extra antigens. The two types differ 
in their cell-wall structure. New approaches to biotyping include quantitation of 
relative growth in the presence of various inhibitors or substrates, typing of 
isoenzyme patterns (Lehmann et al, 1989), and assessment of colour and 
morphologies of colonies on medium containing tétrazolium salts (Odds, 1993). A 
number of other methods of biotyping have been described including 
chromatographic assessment of yeast cell fatty acids (Brondz et al, 1989) and whole 
cell protein electrophoresis (Vancanneyt et al, 1991).
Genotypic identification and characterisation of species and strains within the 
genus Candida is currently an area of active research. Individual strains of C. 
albicans may now be typed by use of DNA restriction fi'agments in Southern blots 
probed with species-specific mid-repeat-sequence oligonucleotides (Odds, 1993). 
Random amplified polymorphic DNA profiles can also be used for providing
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genotypic characters for taxonomic descriptions, for confirming the identities of 
stock isolates, for typing Candida species in epidemiological investigations, and for 
the rapid identification of pathogenic fimgi (Lehmann et al, 1992).
2.3 Genetics
Until relatively recently, the genetics of Candida species was little studied. 
However, in the last decade, progress has been rapid and a number of reviews on the 
subject have been published (Shepherd et al., 1985; Whelan, 1987; Kurtz et al, 
1988; Magee et al., 1988; Scherer and Magee, 1990; Ernst, 1990; and Lott et al, 
1992). Genetic analysis is complicated by the diploid nature of most of the species 
(not C. glabratd) and the absence of any known sexual cycle. The close similarity 
between C albicans and the more often studied Saccharomyces cerevisiae has been 
useful in the isolation of Candida genes and the development of the C. albicans 
transformation system (Odds, 1988). The genetics of C. albicans is becoming 
increasingly important in researching virulence determinants, phenotypic variants and 
drug resistance.
When C. albicans is isolated it is normally diploid and naturally heterozygous 
(Whelan et a l, 1980). An important implication of this elevated ploidy is that it 
provides a significantly greater potential for genetic diversity than would be found in 
a haploid strain.
Candida genes cloned via their counterparts in S. cerevisiae range from those 
coding for actin (Mason et al, 1987) and tubulin (Smith et al, 1988) to those for 
amino acid biosynthesis (Rosenbluh et al, 1985) and sugar utilisation (Magee et al, 
1988). Goshorn and Scherer (1989) were able to isolate several Candida biosynthetic 
genes by complementation. Mycophenolic acid-resistant auxotrophs were used to 
analyse prototrophic natural variants by spheroplast fusion. The fusion products were 
shown to be heterozygous for many of the parental chromosomes by molecular and 
genetic criteria. Rare fusion products expressed recessive parental markers. This 
approach will provide many new selectable markers for DNA transformation of
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Candida species and makes possible the isolation of genes affecting functions not 
found in S. cerevisiae (Scherer and Magee, 1990).
The genetic map of C. albicans has been derived from experiments with only 
a few strains and although particular linkages seem to be widely conserved (Poulter 
and Hanrahan, 1983) the variability of the electrophoretic karyotype suggests that 
considerable differences may exist between strains (Scherer and Magee, 1990).
Phenotypic variation or switching is a phenomenon in C albicans which 
involves a heritable change in colony morphology, cell shape or susceptibility to 
antifungal agents (Scherer and Magee, 1990). Slutsky et al (1985,1987), working on 
the white-opaque switching system, demonstrated the reversibility of the switching 
process and obtained data on the frequency of the changes. They found that the range 
of colony phenotypes was limited for any given switching system and provided
evidence for the role of ultraviolet radiation as a stimulator of the transition. There -
are potentially two genetic systems involved in any instance of phenotypic instability; 
the genes involved in the transition, and the genes involved in producing the alternate 
phenotype. This will complicate the study of the genetics of the switching ’mechanisms (Scherer and Magee, 1990). Phenotypic variations have been observed in
strains isolated from patients with active Candida infections (Soli et ah, 1987). The
possible role of these processes in pathogenesis is discussed later.
2.4 Morphogenesis
C. albicans can adopt different morphological forms: budding yeast cells or 
blastoconidia, pseudohyphae (elongated yeast cells which appear as filamentous cell 
chains) and true hyphae with septa. C. albicans can also form chlamydospores but 
only in vitro. These large, refractile, thick walled cells were proposed by Van der 
Walt (1967) as part of a sexual cycle of C. albicans but this theory is no longer 
credited (Odds, 1988).
The change from yeast to hyphal form is environmentally regulated and can be 
triggered in vitro in a number of ways including growth on nutrient poor plates, in
24
the presence of some amino acids (especially proline), at near neutral pH and above 
33OC. None of these triggers acts alone under all conditions (Odds, 1988).
Interest in the ability of C. albicans to change its shape comes partly from the 
obvious significance of any morphogenetic process to developmental biology but 
mainly from the presumption that hypha formation is a process of pathological 
significance. The evidence, to date, comparing the relative pathogenicity of yeast and 
hyphal forms of C  albicans is inconclusive. The mycelial form is invariably seen in 
smears or scrapings within hours of inoculation into experimental animals supporting 
the link of morphogenesis and pathogenesis (Gresham and Whittle, 1961; Louria and 
Brayton, 1964; Balish and Philips, 1966). However, in the majority of established 
candidosis lesions, the fungus almost always produces yeasts and hyphae which 
suggests that neither form is pathologically inferior. The presence of only C albicans 
yeast cells does not necessarily mean no infection, and similarly, the presence of 
hyphae in an individual smear or biopsy cannot be interpreted as of clinical 
significance (Odds, 1988). Other Candida species (and other fungi) can function as 
very effective pathogens without the ability to produce hyphae. There are reports of 
hyphal forms of C. albicans having an increased ability to adhere to human buccal 
epithelial cells (Kimura and Pearsall, 1978; Kimura and Pearsall, 1980). Sobel et al 
(1984) found that a variant strain of C. albicans, incapable of hyphal formation at 
37OC, was less likely to colonise the rat vagina than the wild-type strain. Rotrosen et 
al (1985) demonstrated the ability of hyphal C. albicans to adhere to vascular 
endothelial cells to a greater extent than the yeast form. Other reports suggest that in 
experimental disseminated candidosis, yeast-form inocula rather than hyphal-form 
inocula produce higher mortality rates (Evans, 1980; Mardon et al, 1975; Oblack et 
al 1978).
The evidence for resistance to phagocytosis and intracellular killing of yeast 
and hyphal forms is equally contradictory. Both morphological forms of the fungus 
seem to have the ability to initiate and to sustain pathological responses in
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mammalian hosts, but it is likely that one form may be better adapted than the other 
to survive in specific microniches in vivo (Odds, 1988).
3. CELL SURFACE OF CANDIDA ALBICANS
cell units and blastospores (Sentandreu et al, 1991). Chitin is thought to be localised
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3.1 Cell-wall Composition
The cell-wall of C. albicans is composed primarily of mannoprotein, glucan, 
and chitin. The carbohydrate components comprise approximately 90% of the cell- 
wall (w/w) but there are also small quantities of protein (3-6%, w/w) and lipid (2%,
w/w) (Shepherd and Gopal, 1991). On average, around two-thirds of the total 
carbohydrate is glucan and one third is mannan. Chitin is a minor constituent (0.6- 
2.7%) and its abundance in the wall varies with the growth form; mycelial walls 
contain roughly three times more chitin than yeast cell walls (Sentandreu et a l, 
1991).
3.2 Glucans
Beta-glucans are the main structural components of the C. albicam cell-wall. 
There are three types of beta-glucan; an alkali-soluble polymer, a branched acid- 
soluble glucan containing mainly pl-6-linked glucose and a highly branched insoluble 
form with variable amounts of pi-3 and pi-6 linkages, and branch points 
(Sentandreu et al, 1991). Studies using regenerating protoplasts have shown that 
radioactive glucose is incorporated into a p i,3-linked polymer (Gopal et al, 1984b). 
Also, membrane preparations from C albicans catalyse the synthesis of a linear 
polymer/w v/7ro (Orlean, 1982).
3.3 Chitin
Chitin is a linear polymer of pl-4-linked N-acetyl glucosamine monomers. It is an 
important component of the cell wall, particularly at the septum between both hyphal
in the lower layers of the cell wall but is also present at bud scars (Sentandreu et al, 
1991). It is found in yeast forms, germ tubes, and hyphae, although the proportion is 
higher in hyphae (Chattaway et al, 1968). Chitin and glucan provide rigidity and 
appear to be essential for cell division (Calderone and Braun, 1991). There is 
experimental evidence to suggest that glucans and chitin are covalently linked (Ruiz- 
Herrera a/., 1994)
3.4 Mannoprotein
Because of their significance as antigenic determinants in Candida species, cell- 
wall mannoprotein structures have been studied far more intensively than have glucan 
structures (Odds, 1988). The general structural features of C  albicans 
mannoproteins, as well as their biosynthesis and export, are thought to be similar to 
those of S. cerevisiae (Sentandreu et a l, 1991). Protein accounts for approximately 
10% of the total molecular weight of the S. cerevisiae mannoprotein molecule 
(Ballou, 1976). Mannoprotein is composed of mannose polysaccharides covalently 
linked to protein via serine, threonine and asparagine residues. Short polysaccharide 
chains are O-linked to the hydroxyl group of serine and threonine residues. Larger 
more complex polysaccharides are N-linked via two units of N-acetyl-D-glucosamine 
(N-acetylchitobiose) to asparagine residues on the protein (Calderone and Braun, 
1991). The N-linked polymers are long linear chains of mannose units joined through 
a  1-6 linkages to which either single mannose residues or polymers containing a 
variable number of mannose residues joined through a  1-2 and occasionally terminal 
al-3  linkages (Nelson, 1991). Both the N- and 0-glycosylation processes are 
initiated in the endoplasmic reticulum (Ruiz-Herrera and Sentandreu, 1975; Zueco et 
al, 1986).
There is some disagreement over the precise structures that function as specific 
immunodeterminants. Okubo et al (1979) showed that the most heavily 
phosphorylated mannose polymers are the most serologically active in terms of C 
albicans antigen factor 6, the component that distinguishes serotype A from serotype
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B. Although it has long been known that C. albicans mannans are more heavily 
phosphorylated than those of S. cerevisiae, the significance of phosphate groups in 
mannan immunodeterminants has received relatively little attention (Odds, 1988). 
Casanova and Chaffin (1991) examined the phosphate containing proteins of the C. 
albicans cell surface. They demonstrated that not all glycoprotein components 
contained detectable phosphate, and at least one 19-20 kDa protein may be 
phosphorylated in the absence of carbohydrate.
3.5 Cell-wall organisation
Ultrastructural studies of the C albicans cell wall have indicated a complex 
microarchitecture. The wall is of variable thickness and is composed of several layers 
that are revealed by differences in electron density (Calderone and Braun, 1991). The 
number of layers and their morphology are variable and may be related to the stage of 
growth, growth form, growth medium or fixation procedure (Poulain et al, 1978). 
The inner layer adjacent to the plasma membrane is formed by a microfibrillar glucan 
network filled with amorphous material (possibly mannoprotein) together with other 
glucan polymers. Chitin is located at bud scars and is also distributed throughout the 
cell wall, but mostly in the inner layers (Sentandreu et al, 1991). The overall 
structure of the wall and its chemical nature appear to be similar in both growth 
forms of the fungus. Hyphal walls do differ quantitatively from those of the yeast 
form; they are only about half as thick, they have three times the amount of chitin and 
they have a noticeably reduced amount of mannoprotein. The outer fibrillar layer is 
mannoprotein enriched, although mannoprotein is distributed throughout the cell 
wall. Synthesis of this fibrillar layer is promoted by growth in medium containing high 
concentrations of galactose (McCourtie and Douglas, 1984).
28
3.6 Plasma membrane
The plasma membrane of C. albicans is a typical eukaryotic phospholipid 
bilayer with frequent invaginations. The membrane is composed of large quantities of 
lipid and protein with some carbohydrate and little or no nucleic acid (Hubbard et al, 
1986). The levels of total lipids, sterols, and phospholipids are significantly higher in 
the mycelial form (log phase) of C. albicans than in the yeast form. Increased 
phospholipid levels in the mycelial form are due to higher levels of 
phosphatidylcholine, phosphatidylserine, and phosphatidylinositol. The changes in 
lipid composition are clearly demonstrated in altered thermotropic phase behaviour. 
Gel-to-liquid crystalline phase transitions are observed at 36 and iT C  for the lipids 
of the yeast and mycelial forms, respectively. These changes coincide with a higher 
uptake rate for L-proline and an increased sensitivity of the mycelial form for 
antifungal drugs (Goyal and Khuller, 1994). Study of the membrane is important as it 
is a prime target for attack by antifungal antibiotics. This will be expanded upon later.
3.7 Extracellular polymeric substances
Masler et al (1966) reported the excretion of polysaccharide-protein 
complexes from C albicans cells. These complexes were composed of 74-86% 
mannan, 21-31% glucose, 1-1.5% glucosamine and 11-14% protein, and were 
immunologically active. Mankowski (1968) reported that extracellular polymeric 
material was biologically active, having the ability to inhibit the growth of newborn 
mice and also kill them. Other biological activities attributed to this material include 
the release of histamine fi*om mast cells (Sikl et al, 1964), and reduction of the 
phagocytic ability of white cells (Trnovec et al, 1978). Extracellular polymeric 
material inhibits adhesion of yeasts to neutrophils (Diamond et a l, 1980) and buccal 
epithelial cells (McCourtie and Douglas, 1985). This EP is thought to originate from 
a fibrillar layer on the yeast surface and its ability to inhibit adhesion suggests that it 
contains an adhesin.
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hyperalimentation and extensive antibiotic treatment, it is possible that these other
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4. CANDIDOSIS
Candida species are strictly opportunistic pathogens that rarely or never cause
clinically important disease in a host with intact antimicrobial defences (Odds, 1988).
.Candidosis can occur in two forms: superficial and systemic candidosis. As the name 
implies, superficial candidosis means "on the surface" e.g. skin, nails and oral mucosa. 
Systemic infection can refer to disease as a result of entry of organisms into the 
bloodstream {Candida septicaemia) and it may involve several organs. Systemic 
disease can also appear as localised primary disease with only one organ affected.
.4.1 Factors influencing infections
Gentles and LaTouche (1969) listed 39 disorders, diseases, debilities and 
iatrogenic factors that predispose individuals to various forms of candidosis.
4.1.1 Dietary factors
There is evidence to suggest that a diet rich in carbohydrate may promote oral 
colonisation of Candida (Samaranayake, 1986). Sucrose oral rinses are known to 
aggravate palatal candidosis in denture stomatitis sufferers (Olsen and Birkland,
1976) Also, experiments on primates suggest an increase in oral yeast concentration
'when they are fed a high sugar diet by mouth. The oral yeast concentration fell when 
the primates were fed via an intragastric tube (Bowen, 1974; Bowen and Cornick,
1970). Vitamin and iron deficiencies may also be a factor in susceptibility to 
candidosis (Jorizzo, 1982; Samaranayake, 1986). I
4.1.2 Mechanical factors
Trauma, burns, local occlusions and maceration all predispose the host to 
candidosis. Since severely burned patients often receive intravenous
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predisposing factors, rather than the burn injury alone, increase their susceptibility 
(Gauto et al, 1977; MacMillan et a l, 1972; Richards et a l, 1972). Occlusions such 
as wound dressings, nappies and even a wristwatch have all been shown to cause skin 
lesions due to Candida (Maibach and Kligman, 1962).
4.1.3 Medical factors
A number of surgical techniques and drug therapies predispose to candidosis. 
Transplantation surgery, such as heart-lung, kidney, bone marrow and pancreas 
transplantation, often has systemic candidosis as a complication (Odds, 1988; Gentry 
and Price, 1991). Intravascular catheters, especially those used for parenteral 
nutrition also present a risk of systemic candidosis especially when such devices are 
left in situ for long periods (Band and Maki, 1979). It is probable that the Candida 
species that colonise these catheters come from both exogenous and endogenous 
sources. Indwelling urinary catheters and heart valve prostheses are also strongly 
associated with Candida infections (Odds, 1988).
Drugs that predispose individuals to candidosis include antibiotics, corticosteroids, 
oral contraceptives and agents that induce neutropenia (Winner and Hurley, 1964; 
Odds, 1988). Yeasts are able to multiply more readily in situations where commensal 
bacteria have been eliminated (Odds, 1988). Corticosteroids and drugs that induce 
neutropenia have pronounced immunosuppressive effects. Oral contraceptives have 
been implicated as a predisposing factor for vaginal candidosis. This area of research 
has become controversial but there are indications that the oestrogen component of 
the combined-type pill has the greatest effect on candidal carriage (Jackson and 
Spain, 1968).
4.1.4 Natural factors
There are a number of diseases and disorders that are associated with 
candidosis including diabetes mellitis, other endocrine disorders, infection, 
immunopathological disorders, cystic fibrosis and various forms of cancer (Gentles
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and La Touche, 1969). The mechanism by which diabetes increases host susceptibility 
to candidosis is not clear. It has been proposed that high tissue- and blood-glucose 
levels may favour the growth of Candida in diabetics. It has also been suggested that 
in diabetics, the conversion of glucose to sorbitol reduces the available concentration 
of NADPH and thus inhibits the oxidative killing mechanism of neutrophils (Wilson 
and Reeves, 1986).
Candidosis is also more common in infants, the elderly and in pregnancy 
(Odds, 1988). Infants undergoing treatment with antibiotics and intravenous 
catheterisation (especially premature babies) are clearly at risk from Candida 
infections (Winner and Hurley, 1964; Gentles and La Touche, 1969). Old age may 
not necessarily be a factor predisposing to candidosis in itself. However, other late 
onset disease and medical treatments used on the elderly may increase the risk of 
candidosis (Odds, 1988); for example, there is a clear association between oral 
candidosis and denture wearing.
Vaginal thrush is a common complaint and a number of factors are believed to 
favour its onset. Pregnancy is known to be associated with an increase in vaginal 
carriage of yeasts and there is a marked decrease in the proportion of women carriers 
post-partum (Singha and Balsdon, 1979). Hormonal changes may be an important 
factor during pregnancy (Mathur et al, 1978). Sobel (1985) listed a number of 
factors that may influence the incidence of vaginal thrush in pregnancy: vaginal pH, 
vaginal glycogen concentration, and receptor states of the vaginal epithelium. The pH 
value of the vagina varies, being highest in the upper part and during menstruation, 
with an average of pH 4.5 (Tindall, 1987). King et al (1980) reported much less 
adherence to C albicans yeast cells at pH 4 (close to vaginal pH in pregnancy) than 
at pH 7.3, However, other workers have found that vaginal pH is not related to 
candidal carriage in pregnant or non-pregnant women (Drake et a l, 1980).
Among the many types of cancer that are known to predispose to candidosis, 
leukaemia and lymphomas are by far the most commonly associated with serious 
Candida infections. Anti-cancer therapy tends to be vigorous and many treatments
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are known risk factors for candidosis e.g. cytotoxic and immunosuppressive drugs, 
and intravenous catheterisation.
4.2 Oral Candidosis
Candida species can cause a variety of diseases in the oral cavity of which 
thrush and denture stomatitis are most commonly seen. Candida can also cause oral 
leukoplakia and some other forms of oral pathology.
4.2.1 Oral Thrush - acute pseudomembranous candidosis
This disease is commonly seen in infancy, old age, and in the terminally ill 
(Finlay, 1986). It is also found in association with other disease states such as 
diabetes, cancer and AIDS. Oral thrush appears as white lesions on the buccal 
mucosae, tongue, throat, and gum linings. The lesions can form confluent plaques 
which give rise to the term "pseudomembranous". The C. albicans hyphae and yeast 
cells invade the tissue to the extent of the stratum corneum but do not penetrate 
beyond the stratum spinosum (Lehner, 1967). When the patches are scraped off they 
reveal a raw area of epithelium.
4.2.2 Denture stomatitis - chronic atrophic candidosis
This most common of Candida associated disease presents as chronic 
erythema and oedema of the portion of the palate that is in contact with dentures. 
The patient may experience slight soreness but it is frequently the associated angular 
cheilitis that is the presenting complaint. Angular cheilitis appears as encrusted 
erosive lesions at the corners of the mouth. Separate studies on the incidence of the 
disease have suggested that 24% (Nyquist, 1952), 50% (Jacobsen et a l, 1979) and 
60% (Budtz-Jorgensen et al, 1971) of denture wearers suffer from denture 
stomatitis. Yeasts are known to adhere well to the plastics used in dentures 
(McCourtie and Douglas, 1981; McCourtie et al, 1986). There tends to be no tissue 
invasion in relation to denture stomatitis (Odds, 1988).
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4.2.3 Candida leukoplakia - chronic hyperplastic candidosis
Oral leukoplakias occur when the surface of a chronically inflamed area 
becomes white and smooth. Candida leukoplakias occur most commonly on the 
cheeks and less commonly on the tongue. Smoking (and perhaps denture wearing) is 
associated with the disease (Odds, 1988). Tissue invasion, as in oral thrush, is limited 
to the upper epithelial layers (Mohamed, 1975). The condition may be related to iron 
and folate deficiencies (Jenkins et al, 1977; Mackie et al, 1978).
4.3 Vaginal thrush - vulvovaginal candidosis
Candida infections of the female genitalia are approximately ten times more 
common than infections of the penis (Odds, 1988). This is most likely due to the 
more favourable growth conditions to be found in the vagina. Vaginal secretions have 
been shown to promote the growth of C. albicans (Bisschop et a l, 1985). The 
secretions consist of tissue fluids, leukocyte and epithelial cell debris, electrolytes, 
proteins and lactic acid (McGroarty, 1993).
Acute pruritus and vaginal discharge are the usual presenting complaints. The 
classical sign of vaginal thrush is the presence of white plaques, analogous to those 
seen in oral thrush, on the vulvar, vaginal or cervical epithelium (Odds, 1988). 
However, these plaques are not always seen. It is more common to find intense 
erythema and oedema of the labia minora and lower third of the vagina with or 
without plaques and discharge (Monif, 1985). The disease is predominantly seen in 
women of child-bearing age and frequently in the absence of underlying factors that 
predispose to the illness. Two factors that are strongly associated with the onset of 
vaginal thrush are pregnancy and diabetes while other factors have not been shown 
convincingly to play any significant part (Ryley, 1986). The Candida species found in 
the vagina are believed to be derived mainly from the gastrointestinal tract; however, 
sexual transmission is a possible route (Thin et al, 1977). As in oral candidosis, the 
fungi do not seem to penetrate deeper than the stratum corneum (Odds, 1988). 
Chronic, recurrent, vulvovaginal candidosis applies to women who have had at least
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three or four clinically and mycologically proven episodes of vaginal candidosis 
within 12 months (Witkin et al, 1983; 1986). Recurrent thrush is a complex and 
possibly multi-factorial condition. One or more defects in leukocyte anti-Candida 
defences possibly allow a number of viable Candida cells to remain in the vagina, 
despite the action of antifungal agents, resulting in relapse (Odds, 1988),
4.4 Chronic mucocutaneous Candidosis (CMC)
Around 90% of cases of CMC have their onset within the first 20 years of life 
(Odds, 1988). In most cases, oral thrush is the earliest symptom. Angular cheilitis and 
lip fissures may develop and the oesophagus may occasionally be involved (Shepherd, 
1986). Skin lesions, when present, mainly appear on the face, ears, neck and 
shoulders. Many of the cases are related to endocrine disorders such as 
hypoparathyroidism, hypoadrenocorticism, and hypothyroidism. However, diabetes 
mellitis is only rarely seen related to CMC (Odds, 1988). Defects in immune function 
are also implicated as causes of this disease (Rosman, 1979). The fact that it is almost 
exclusively C albicans that accounts for CMC is probably significant. Even in 
extreme cases, the fungus appears unable to break superficial defences and initiate 
disseminated infection (Odds, 1988).
4.5 Systemic Candidosis
There has been a dramatic rise in the incidence of invasive Candida infections since 
the 1950s. This has been attributed to such factors as the increasing application of 
cytotoxic chemotherapy to the management of malignancies (Lew, 1989), the 
prevalence of infections due to HIV, and the widespread use of newer and more 
powerful antibacterial agents (Banerjee e ta l, 1991, Anaissie e ta l, 1989).
Systemic candidosis may arise as localised disease with only one organ affected or 
as Candida septicaemia in which several organs are affected. Virtually all visceral 
forms of Candida infection result from haematogenous spread of yeasts with the 
exception of the digestive, respiratory, and urogenital tracts whose epithelial surfaces
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may be directly invaded by exogenous yeasts (Odds, 1988). Fungal cells enter the 
bloodstream either by persorption from the gut or contamination via intravascular 
catheters (Salfelder et al, 1977). Wound infection may also play a role especially in 
burns patients (Spebar and Pruitt, 1981). The drugs available for the treatment of 
systemic candidosis carry the risk of host toxicity (amphotericin B), drug resistance 
(flucytosine) or low efficacy (azole antifungals) (Odds, 1988).
4.5.1 Candidosis of the gastrointestinal tract
The gastrointestinal tract can be infected by C albicans from its mucosal 
surfaces or via the bloodstream although the latter is considered rare (Trier and 
Bjorkman, 1984). Oesophageal candidosis is the most common form of gastro­
intestinal candidosis. Less commonly seen is gastric candidosis and rarer still is 
intestinal candidosis (Odds, 1988). Diagnosis requires biopsy showing candidal tissue 
invasion as commensal fimgi are commonly found with smears and cultures. The 
characteristic endoscopic appearance of oesophageal candidosis is of yellow-white 
plaques on an erythmatous background analogous to oral thrush lesions (Scott and 
Jenkins, 1982). Oesophageal candidosis is often seen in cancer patients (2.8-6.7%) 
and there is an even higher incidence among AIDS patients (9.4%) (Chandler, 1985). 
Gastric candidosis is usually the result of Candida invasion of existing gastric ulcers 
and operative wounds (MinoH et al, 1982). Intestinal candidosis is extremely rare 
and the literature on primary intestinal candidosis is small (Odds, 1988). Candida 
enteritis is probably rare but is likely to be more of a problem in infants (Kozinn and 
Taschdjian, 1962).
4.5.2. Candidosis of the respiratory tract
Candidosis in the lower respiratory tract is common in cases of disseminated 
candidosis where the fungus reaches the lungs via the bloodstream. Primary bronchial 
or pulmonary candidosis arising via the airways is probably very rare (Odds, 1988), 
Again, diagnosis requires histopathological evidence from biopsy due to the
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likelihood of commensal Candida isolation with sputum samples. There is a high risk 
of pulmonary candidosis among severely immunocompromised patients, especially 
those with haematological malignancies and neutropenia (Odds, 1988).
4.5.3 Candidosis of the urinary tract
Candiduria is commonly initiated by indwelling catheters and the removal of 
such devices is often sufficient to eliminate the problem (Schonebeck, 1972). Other 
predisposing factors include immunosuppression, diabetes, and urinary tract 
dysfunction (Fisher, 1993). Candidosis of the urinary bladder (Candida cystitis) is 
very unusual in patients below the age of 50 years and is often related to diabetes and 
catheterisation. Symptoms of this disease are similar to other forms of cystitis and 
treatment usually involves amphotericin B instillations (Paladino and Crass, 1982).
4.5.4 Renal candidosis
Diabetes tends to be the most common single factor seen in association with 
renal candidosis. The infection is often obstructive with fungal material collecting in 
the renal pelvis. Fever is seen in around one third of cases (Odds, 1988). The most 
likely route of infection is via the bloodstream. Ascending Candida urinary infections 
seems to be rare in humans and the fungus adheres poorly to bladder mucosa 
(Levison and Pitsakis, 1987).
4.5.5 Candida endocarditis
Although rare, Candida endocarditis has aroused considerable interest as it is 
extremely difficult to diagnose and treat (Odds, 1988). Its occurrence is related to the 
placement of central venous catheters with their tips close to or within the right 
atrium causing injury to the endocardium or vascular endothelium (Sanchez et a l,
1991). Platelets adhere to the exposed subendothelial tissue and cells attach to fibrin- 
platelet matrices or to fibronectin, a component which is exposed on traumatised 
heart valve tissue (Scheld et al, 1981; 1985). Fungi can also adhere to the plastics
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used in the catheters themselves (Klotz et al, 1985). The disease is also seen in 
intravenous drug abusers, patients undergoing hyperalimentation or as a complication 
of prolonged intravenous antibiotic administration (Scheld et a l, 1983). The 
untreated disease will eventually lead to heart failure but even if discovered the 
mortality rate is high with 24% survival with antifungal treatment alone and 73% 
survival with resection and antifungals (Odds, 1988).
4.5.6. Miscellaneous other forms of systemic candidosis
A number of other anatomical sites can be infected by Candida species. These 
include the central nervous system, bones and joints, liver, spleen and pancreas. The 
brain is often involved in cases of disseminated candidosis but only rarely is the 
central nervous system the principle or sole focus of the disease (Walsh et al, 1985), 
The disease can take two forms: meningitis and cerebral infections, usually in the 
form of brain abscesses.
Candida infections of the bones or joints can arise either by local inoculation 
(injury, surgery) or via the bloodstream. The disease can take the form of arthritis and 
osteomyelitis. Of infections arising from external sources, 40% are caused by C 
guilliermondii or C. parapsilosis, both of which are common skin commensals. The 
majority of haematogenous bone and joint candidoses are caused by C  albicans and 
C. tropicalis and half of such cases have a recent history of abdominal surgery or 
malignancy (Odds, 1988).
Candida infections of the liver, spleen and pancreas are often seen in disseminated 
candidosis but again are only rarely present as primary foci of infection. Focal 
infections at these sites are most commonly found in cases of acute leukaemia and the 
causative agent is usually C. albicans (Tashjian et al, 1984).
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5. ANTIFUNGAL AGENTS
Due to the eukaryotic nature of fungi, the number of suitable targets for 
therapeutic attack is limited (Lyman and Walsh, 1992). There are a number of 
antifungal agents that are active against Candida species and they fall into three 
broad types: the polyenes, the azoles and flucytosine.
5.1 Polyene antifungals
There are four polyene antifimgals that are routinely used in clinical practice: 
amphotericin B, candicidin, natamycin and nystatin. The polyenes are characterised 
by a macrolide ring that is closed by formation of an internal ester or lactone and 
contain a series of at least three conjugated double bonds (Hamilton-Miller, 1973). 
They are natural products of filamentous bacteria, usually Streptomyces species, and 
have their effects on eukaryotic cell membranes by altering their permeability. The 
membrane damaging action of polyenes is due to their high avidity for sterols 
especially ergosterol. Their selective toxicity for fungi occurs because fungal cell 
membranes contain ergosterol as the major sterol component whereas mammalian 
cell membranes contain cholesterol (Bolard, 1986).
Amphotericin B is the drug of choice for the treatment of systemic fungal 
infections (Midez et al, 1989). Oral administration of the drug is only used in cases 
of gastrointestinal candidosis as the compound is not absorbed significantly from the 
gut. If parenterally administered, amphotericin B seems to be widely distributed 
around the body (Sugar, 1986). Amphotericin B binds to ergosterol which alters 
membrane permeability, causing leakage of sodium, potassium and hydrogen ions and 
eventually leads to cell death (Palacios and Serrano, 1978). It also binds to other 
sterols, such as cholesterol, which accounts for much of its toxicity (Medoff and 
Kobayashi, 1988). There are a number of side-effects associated with amphotericin B 
such as kidney damage, accompanied by uraemia, which is especially dangerous in 
premature neonates. Regular blood tests for signs of kidney damage are 
recommended (Baley a/., 1984).
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Nystatin is used commonly in the treatment of oral and vaginal candidosis as 
well as in cases of oesophageal candidosis (Odds, 1988). It is not absorbed from the 
gastrointestinal tract. Its use is restricted to topical treatment only due to its toxicity 
and insolubility (Kerridge and Nicholas, 1986).
Candicidin is another polyene antifungal that is too toxic for systemic 
chemotherapy but is of great use in vaginal candidosis. (Odds, 1988). Less impressive 
as an antifungal agent is Natamycin which has been used in vaginal candidosis (Odds, 
1988).
5.2 Azole antifungals
A large number of azole antifungals have been developed for clinical use. The
three main classes are topically active imidazole derivatives, orally active N- 
. .substituted imidazoles, and triazole derivatives. They are synthetic compounds with 
one or more 5-membered rings, where each ring has 2 (imidazoles) or 3 (triazoles) 
nitrogen atoms. Topical imidazoles cause alterations in the sterol composition of 
Candida membranes by their action on cytochrome P-450, and at high concentrations 
they will exert direct effects on the yeast cell membrane (Vanden Bossche, 1985). 
Azoles are also thought to inhibit the ATPase of fungal cell membranes. This effect 
has been shown with miconazole and ketoconazole (Irani and Truong, 1986). 
Although resistance to azoles is becoming more common (especially with 
fluconazole), it seems relatively rare with toxicity being the major problem associated 
with their use (Odds, 1988; Lyman and Walsh, 1992).
Imidazoles are one of the two major classes of antiftmgal azole derivatives. Among 
this group are clotrimazole and miconazole. They are both relatively water insoluble 
and are poorly absorbed by the gastrointestinal tract. Their use is limited to topical 
application (Lyman and Walsh, 1992). Ketoconazole on the other hand is the first 
successful, orally absorbable, antifungal azole. It is insoluble at neutral pH but 
dissolves in the presence of stomach acid. It can then gain access to the blood stream 
via the stomach mucosa. The most frequent side-effects are gastrointestinal
Is
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(Dismukes et al., 1983) but some hepatotoxicity has been reported in 2-8% of 
patients (Lewis et al,, 1984).
The other major class of antifungal azole derivatives are the triazoles. The triazole 
ring is less nucleophilic and therefore more resistant to metabolic attack (Richardson 
et al,, 1990). In addition, the triazole ring may be more specific for fungal enzyme 
systems and have increased potency (Grant and Clissold, 1989).
Itraconazole is a water insoluble, lipophilic, triazole analogue that exhibits 
excellent activity against most human fungal pathogens. It is soluble in the gastric 
milieu, has a broader spectrum than ketoconazole, and is less toxic (Warnock, 1989). 
This drug appears to have low hepatotoxicity with the main side-effects being 
gastrointestinal disturbances, dizziness, headache, and leucopenia (Graybill, 1993).
Fluconazole is a water soluble, fluorine substituted, Z»/5-triazole antifungal agent 
available for oral or intravenous use in the treatment of a number of localised and 
disseminated mycoses. It has comparable activity to that of ketoconazole: inhibition 
of fungal C-14 demethylase. However, it is significantly less potent against 
mammalian enzymes and hence is more specific to fungal cytochrome P450-mediated 
reactions (Shaw etal,, 1987). It acts by inhibiting synthesis of ergosterol, an essential 
sterol in fungal cell membranes. The drug is rapidly absorbed after oral dosing, and 
penetrates well into body fluids and tissues, including cerebrospinal fluid. Extensive 
clinical trials (reviewed by Zervos and Meunier, 1993) demonstrate its clinical 
efficacy in candidosis, including oropharyngeal, oesophageal, and disseminated forms. 
Other potential uses include prophylaxis of fungal infection in immunocompromised 
cancer patients and single-dose therapy of vaginal candidiasis. Fluconazole is 
generally well tolerated and is only rarely associated with serious adverse effects or 
laboratory test abnormalities (Zervos and Meunier, 1993). Gastrointestinal disruption 
and elevated hepatic transaminase activity are rare complications (Saag and 
Dismukes, 1988).
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5.3 Flucytosine (5-fluorocytosine, 5-FC)
Flucytosine is a fluorinated pyrimidine with high activity against most 
Candida isolates in vitro (Odds, 1988), It was developed as a possible cancer therapy 
but was found to have no effect on tumour cells. However, it was found to have in 
vitro and in vivo antifungal activity (Berger and Duschinsky, 1962). It is absorbed 
well by the gut so it may be given orally to treat systemic yeast infections. 
Flucytosine is less toxic than amphotericin B but there is a problem of resistance to 
the drug (Kerridge and Nicholas, 1986). The most common side-effects (6% of 
patients) are gastrointestinal problems, but abnormal liver fonction (5% of patients) 
has also been reported (Benett, 1977). The most serious toxicity associated with this 
agent is dose dependent bone marrow suppression (Kaufman and Frame, 1977). 
Flucytosine has seen increasing usage as an adjunct to amphotericin B therapy. This 
combination was originally proposed due to the observation that amphotericin B 
potentiates the uptake of flucytosine by increasing fongal cell permeability (Medoff et 
al., 1972). Two mechanisms of action have been proposed for flucytosine. These are 
the disruption of DNA synthesis and alteration of the amino acid pool by inhibition of 
RNA synthesis. Cytosine permease actively transports flucytosine into the yeast cell 
where it is converted (by cytosine deaminase) to 5-fluorouracil, which replaces uracil 
in the pyrimidine pool and thus disrupts protein synthesis. In addition, 5-fluorouracil 
can then be converted through several steps to 5-fluorodeoxyuridine monophosphate, 
a competitive inhibitor of thymidylate synthetase, and thus arrests DNA synthesis 
(Diasio et al., 1978). Resistance to flucytosine can arise at three locations in the 
above pathway: cytosine permease, cytosine deaminase, and UMP-
pyrophosphorylase with the most common mutation occuring in the UMP- 
pyrophosphorylase (Whelan and Kerridge, 1984).
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5.4 Antifungal drug development
The discovery of antifungal agents that possess selective toxicity against the 
eukaryotic fungal cell remains an important scientific challenge. Ideally, a selectively 
toxic antifungal agent should be developed that interacts with a fungal target not 
found in other eukaryotic cells. New developments have included the modification of 
existing drug molecules to eliminate toxicity and improve activity, for instance, the 
development of the lipid formulations of the polyene antifimgal agent amphotericin B. 
New triazoles with broad-spectrum antifimgal activity, such as saperconazole, are 
also being assessed (Hay, 1994). The development of drugs that act as cell-wall 
biosynthesis inhibitors has been slower, although a number of molecules with activity 
against key enzymes have been found. The major targets are glucan synthesis, 
inhibited by the echinocandin lipopeptides and papulacahdins; chitin synthesis, 
inhibited by the polyoxins and nikkomycins; and mannan, to which the pradimicins 
selectively bind (Debono and Gordee, 1994). Chitin synthase inhibitors have been 
studied through chemical modification of the polyoxins and nikkomycins but are 
limited because of unfavourable pharmacokinetics.
6. PATHOGENICITY OF CANDIDA
6.1 Pathogenicity of different species of Candida
Among the many species of Candida, C. albicans isolates are consistently the 
most virulent; C. tropicalis is also pathogenic but is quantitatively less so than C. 
albicans (Odds, 1988). Less pathogenic are C. parapsilosis, C. glabrata. C. kejyr, C. 
guilliermondii and C. kruset Another two species, C. lusitaniae and C viswanathii, 
are possibly to be regarded as pathogenic but only in the immunocompromised host 
(Odds, 1988). Within the species C. albicans, it is possible that serotype B is less 
pathogenic than serotype A (Martin and Lamb, 1982; Auger, et a i, 1983). The above 
conclusions are drawn from both animal experiments and epidemiological studies.
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Species and strain differences in pathogenicity can be exploited as a basis for 
determining molecular virulence attributes in the pathogenesis of candidosis. 
However, difficulties in genetic manipulation of C. albicans have hampered direct 
analysis of genes that code for virulence determinants (Odds, 1988).
a
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6.2 Host defence mechanisms
There are a number of non-specific host defence mechanisms that act to 
prevent candidal invasion. The epithelial surfaces of the skin and mucous membranes 
are a physical barrier to the organism. The skin is not often colonised by C albicans.
Epithelial cell turnover is an important form of defence in the gastrointestinal tract as 
well as in the mouth and vagina (Smith, 1985). Saliva contains components that have 
antimicrobial effects such as lactoferrin and lysozyme It also has a mechanical 
function in washing and diluting. Pollock et al, (1984) have purified histidine-rich 
polypeptides from saliva and shown them to be potent inhibitors of C. albicans 
growth. Reduction in the flow of saliva or its constituents, whether due to disease or 
age of host, leads to increased levels of C. albicans in the oral cavity often resulting 
in overt oral candidosis (Hoffinan and Haidaris, 1993).
Polymorphonuclear leukocytes (PMNs) and macrophages can ingest and kill 
Candida species. This is a crucial mechanism in the defence of the host against 
invasive, deep-seated candidosis (Odds, 1988). Patients with reduced PMNs are more 
vulnerable to disseminated Candida infection (e.g. diabetics, patients with leukaemia 
or cancer, or those undergoing chemotherapy) than comparable patients with normal
PMN levels. Also, in patients with AIDS or CMC that have impaired lymphocyte
■immunity but whose phagocyte function is normal, visceral spread of Candida is 
highly unusual (Odds, 1988). Candida antigens can stimulate formation of antibodies 
in all immunoglobulin classes and are found commonly in the serum of healthy 
individuals (Cassone and Torosantucci, 1991). Candida preparations tested as 
vaccines have been shown to have a limited protective effect against intravenous
challenge with live C. albicans in mice and rabbits (Giger et a l, 1978; Hasenclever 
andMitchel, 1963, Bistoni etal,  1986).
C. albicans cell-wall polymers are released from the cell surface and can stimulate 
an immune response (Cassone and Torosantucci, 1991). The specific antigens of 
Candida are proteins and mannoproteins. Chitin and glucan are not considered to be 
antigenically important. Individuals that carry C albicans in the gastrointestinal tract 
will have a consistent level of anû-Candida antibody (mostly IgG and IgA). These 
individuals will show a positive skin test when challenged with cell-wall antigen 
(Odds, 1988).
6.3 Candida albicans virulence factors
A number of factors have been proposed that enhance the virulence of C. 
albicans. These include toxins, enzymes, dimorphism, phenotypic variation, and the 
ability to adhere to host surfaces.
6.3.1 Toxins
The action of C. albicans extracts as toxins has been studied extensively. For 
example, Cutler et a l (1972) compared fractions of C  albicans, prepared by 
mechanical and chemical methods, for toxicity in animals. They found that cell-wall 
glycoprotein was lethal to mice (provided they were pretreated with actinomycin D) 
and was also pyrogenic in rabbits. The potency of this material was much less than 
that of bacterial endotoxin. Iwata (1979) described a molecule called "canditoxin" 
which is an acidic intracellular protein. It produces anaphylactic shock in mice, is 
cytotoxic for mammalian cell lines in vitro and is heat labile. Antibodies to canditoxin 
were also found to be protective against C albicans challenge in mice. This molecule 
has only ever been isolated from one strain of C. albicans, from a patient with 
candidal meningitis. No other workers have managed to isolate a similar molecule in 
any strain. It is unlikely that a microbe in frequent commensal contact with man could
45
contain or secrete a potentially bioactive toxin and retain its status as an opportunistic 
pathogen (Odds, 1988).
6.3.2 Enzymes
C. albicans produces a number of enzymes that are thought to contribute to 
its virulence. One such enzyme, an aspartyl proteinase, degrades albumin, 
haemoglobin, immunoglobulin, epidermal keratin, collagen and extracellular matrix 
proteins (Payne and Ray, 1993). MacDonald and Odds (1983) examined differences 
in virulence for mice between a proteinase-secreting strain of C. albicans and a 
proteinase-deficient mutant. The mutant was considerably less lethal than the parent 
when inoculated intravenously into mice and lower counts of C. albicans were 
recovered from the organs of mice infected with the mutant.
Kwon Chung et al., (1985) produced genetic evidence for the role of extracellular 
proteinase in virulence of C. albicans. The relationship between extracellular 
proteinase and virulence for mice was studied by using a set of three isolates that 
included a proteinase-producing parent, a proteinase-deficient mutant derived by 
nitrous acid treatment of the parent, and a spontaneous revertant obtained by mouse 
passage of the mutant. The morphological markers and the carbon assimilation 
pattern were identical in these isolates. The parental isolate produced a high level of 
proteinase in vitro and caused foetal infection (100%) within 21 days. The mutant 
produced no detectable enzyme in vitro, and all mice survived until day 22. Only 
30% of the mice infected with the mutant died between days 23 and 30. The isolates 
recovered from the dead mice were found to be proteinase sufficient, indicating that 
the mice died after the organism in tissue had reverted. The reverted mutant 
produced proteinase in vitro at 44% the level of the parental isolate and induced fatal 
infection in 90% of the mice within 30 days. These findings indicate that proteinase 
activity is one of the virulence factors associated with C. albicans. The secreted 
aspartyl proteinases of C. albicans (products of the SAP genes) are thought to 
contribute to virulence through their effects on Candida adherence, invasion, and
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pathogenicity. (Magee et al., 1993). Tsushima et al., (1994) showed that C. albicans 
aspartyl proteinase cleaves and inactivates human epidermal cysteine proteinase 
inhibitor, cystatin A. Fusek et al, (1994) investigated the specificities of extracellular 
aspartyl proteinases from C. albicans, C. tropicalis, and C. parapsilosis. By using a 
library of synthetic substrates, and testing inhibition by pepstatin A, these workers 
demonstrated that the proteinases differed substantially in their specificities.
C. albicans also produces phospholipases which may act during infection. Barratt- 
Bee et al (1985) found a correlation between phospholipase activity, mouse lethality 
and adherence to buccal epithelial cells. More recently, Prakobphol et al. (1994) 
suggested that C tropicalis may adhere to lysophospholipids on host cells and that 
the adhesin involved may be a phospholipase. They demonstrated that adhesion to a 
lysophospholipid resulted in the formation of at least five breakdown products. These 
products suggested the presence of lysophospholipase-transacylase and 
lysophospholipase. The identity of the adhesin remains to be confirmed.
There are other enzymes produced by C albicans such as plasmocoagulase, 
haemolysin, and neuraminidase but their role in pathogenesis is not proven (Odds, 
1988).
6.3.3. Dimorphism
C. albicans is capable of growing as yeasts or as elongate hyphae. Hyphae 
can play a role in adherence and invasion of host surfaces. They also may have the 
ability to grow out of phagocytic cells, but there is no clear relationship between 
cellular morphology and pathogenic status of C. albicans (Odds, 1988). Kimura and 
Pearsall (1980) and King et a/. (1980) demonstrated that hyphal forms of the yeast 
were more adherent to epithelial cells than yeast forms. Hyphal forms have been 
shown to express different cell-surface components to yeast-form cells. For example, 
hyphal forms bind fibrinogen, laminin, and C3d (complement conversion product) 
while yeast forms do not (Bouali et al., 1986; Calderone et a l, 1988; Bouchara et 
a l, 1990).
47
In addition to hyphae, other morphological forms may be observed in growing 
cultures of C  albicans. Pseudohyphae are considered to be an aberrant form of 
division by budding. They appear as chains of elongated cells with constrictions. 
Chlamydospores may also be produced under certain growth conditions. These 
structures are large, thick-walled, ellipsoidal-shaped cells and may be seen in 
stationary phase cultures (Shannon, 1981).
6.3.4. Phenotypic variation
Many successful pathogenic organisms have developed the capacity to vary 
phenotype by spontaneously generating variants within infecting populations. This 
capacity enables the organism to evade the immune system of the host. Bacteria such 
as Salmonella typhimurium (Glasgow et al., 1989) and Neisseria gonorrhoea 
(Swanson et al, 1987) have developed such switching systems. Variants are likely to 
be enriched when the host immune system targets the predominant antigenic state. 
Soil and colleagues have examined the capacity of C albicans to modify the nature 
of some of its wall constituents. Switching produced altered antigenicity in a 
reversible fashion and also affected a number of putative virulence factors (Anderson 
et al., 1989; Soil et al, 1991; Soli, 1992). One of the first C. albicans switching 
systems examined in detail was the white-opaque transition (Slutsky et a l, 1987). An 
isolate from a bone marrow transplant patient was found to be able to switch from a 
white-smooth colony morphology to a flat-grey morphology. After subculture, a 
number of the new colonies appeared to be revertants. In addition, a number of other 
morphologies appeared.
Further work has identified a number of virulence factors that appear to be 
affected by the switching process. The transcription of the gene which codes for C. 
albicans acid proteinase, as well as the excretion of the enzyme itself, is under the 
regulation of switching in the white-opaque transition. Resistance to antifungal drugs 
may also be influenced by switching, as switch phenotypes exhibit different profiles of 
drug susceptibilities (Soil, 1992). Antigenic variability has been demonstrated for the
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white-opaque transition and involves the expression of an opaque-specific surface 
antigen (Anderson et al., 1989). In addition, cells of the white phenotype appear to 
be more resistant to the candidacidal activity of polymorphonuclear leukocytes, and 
are similarly more resistant to cell-free oxidants than are opaque cells (Kolotila and 
Diamond, 1990).
The ability of C, albicans to adhere may also be under the influence of the 
switching process. Kennedy et a l  (1988) demonstrated that cells of the white 
phenotype were more adhesive than opaque cells to buccal epithelial cells. The white 
cells were also found to be less cohesive which may have been due to increased 
hydrophobicity. However, both phenotypes adhered equally well to plastic.
7. ADHESION OF CANDIDA TO HOST SURFACES
7.1 The importance of adhesion
The adhesion of C. albicans to host tissues and implanted biomaterial is seen 
as an early step in the establishment of disease (Rotrosen et a l, 1983). Colonisation 
of certain body sites is made difficult by the rapid passage of material and bathing 
actions of fluids over mucosal surfaces. Adhered cells are constantly removed by 
sloughing of epithelial cells. Strong evidence for adhesion as a determinant of 
colonisation or pathogenesis by C albicans comes from studies showing that mutants 
with a reduced ability to adhere to a variety of surfaces are less pathogenic than the 
wild type strain (Fukayama and Calderone, 1991). Also strains isolated from active 
infections are more adherent and virulent than strains isolated from carriers 
(McCourtie and Douglas, 1984).
7.2 Mechanisms of adherence
Candida cells go through a number of steps before adhesion can occur: the 
cells must (i) approach the surface, (ii) overcome physicochemical forces at the
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hydrodynamic layer, (iii) penetrate the liquid-solid interface, (iv) adsorb to the surface 
and finally, (v) attach via specific adhesin-receptor interaction (Kennedy et al, 1992).
In general, cell surfaces have an overall negative charge. The colloid theory of 
Deijaguin and Landau (1941) and of Verwey and Overbeck (1948) (the DLVO 
theory) describes how adhesive interactions can occur between two negatively 
charged surfaces which should repel one another (Jones, 1977). The DLVO theory 
proposes that the forces of repulsion (electrostatic interaction in the overlapping 
double layers) and attraction (London-van der Waals forces) between two similarly 
charged surfaces are additive but vary independently with the distance separating the 
surfaces. This model is not sufficient to describe close range interactions that are 
regulated by adhesin-receptor binding. One role of fibrillar adhesins from C. albicans 
may be to make contact through the electrostatically charged layers. This effect may 
also be mediated by germ tubes which are known to be significantly more adherent 
than yeast cells to both epithelial cells and plastic (Kennedy et a l, 1992).
7.3 In vitro adhesion assays
In a study of adhesion, it is usually necessary to develop an experimental 
system that allows for the characterisation of both adhesin and receptor components 
by competitive inhibition. Liljemark and Gibbons (1973) first measured the 
attachment of C. albicans to rat buccal cells. A modification of their procedure was 
employed by Kimura and Pearsall (1980) and this has been adopted by a number of 
other laboratories (Douglas, 1987). Both radiolabelling protocols (King et a l, 1980) 
and visual determination (Douglas et al, 1981) of yeast adherence have been used. 
Each method has its limitations but the visual method allows monitoring of adhesion 
to individual epithelial cells as well as yeast-to-yeast coadherence (Douglas, 1987).
7.4 Factors affecting Candida adhesion
Candida species can adhere to a wide variety of cell types. These include 
buccal, gastrointestinal and vaginal epithelial cells, comeocytes, vascular endothelial
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cells, and platelet matrices. Among the synthetic materials to which Candida can 
adhere are PVC, acrylic and Teflon (Douglas, 1985).
7.4,1 Yeast Factors
The ability of different species of Candida to adhere to epithelial cells has
been shown to parallel closely differences in pathogenicity (King et al., 1980). C.
albicans and C tropicalis demonstrated significant adhesion to epithelial cells, while
C. parapsilosis adhered only to a slight degree. C. guilliermondi, C. krusei and
C.kefyr failed to interact with epithelial cells.
Temperature of growth is known to affect the adhesion of Candida. Yeasts
.harvested from cultures grown at 25-28°C have been shown to bind to epithelial cells
in greater numbers than those isolated from cultures grown at 37®C (Segal et ah, 
1982a).
Medium composition affects cell-surface composition and hence influences yeast 
adhesion. The adhesion of some strains of C. albicans is significantly increased after 
growth in defined media containing high concentrations of sugars (notably galactose) 
as the carbon source (Douglas et al. 1981; McCourtie and Douglas, 1984). Enhanced 
adhesion seems to be a result of the production of an additional fibrillar-floccular 
layer on the yeast cell surface.
Yeast cell-surface hydrophobicity may play an important role in regulating the 
adhesion to cells and plastics (Hazen, 1990). C tropicalis is more hydrophobic than 
C. albicans and has been shown to adhere better to PVC, acrylic and Teflon 
(Rotrosen et a i, 1983; Minagi et al, 1985). C. albicans can become more 
hydrophobic depending on growth conditions (Hazen and Hazen, 1988); for example 
growth at room temperature as compared with 37^C enhances its hydrophobicity.
Germ-tube formation has been demonstrated to increase the adherence of C. 
albicans to BEC. Kimura and Pearsall (1980) and King et a/.(1980) demonstrated 
that hyphal forms of the yeast were more adherent to epithelial cells than yeast forms.
a:
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7.4.2 Environmental factors
The optimal pH value for adherence of yeasts is reported to be in the range of 5-8 
(King et a l, 1980; Sobel et al, 1981; Samaranayake and MacFarlane, 1981; Persi et 
al, 1985). The optimum appears to be cell-type specific. For example, the adhesion 
of C. albicans to vaginal epithelial cells was shown to be greatest when yeasts were 
incubated with the cells at pH 5 in ambient air supplemented with 10% CO2 (Persi et 
a l, 1985).
7.4.3 Epithelial cell factors
A wide range of cell types have been employed in the study of Candida adhesion. 
These include buccal, gastrointestinal and vaginal epithelial cells, comeocytes, J
vascular endothelial cells, and platelet matrices. Athough some surface molecules are 
similar in all cell types, there are distinct differences in the expression of certain 
components between cells from different tissues, which is of relevance to tissue 
tropism of infections. It is also widely recognised that the cells from different 
individuals vary in receptor expression (Karlsson, 1989).
7.5 Adherence of C albicans to buccal epithelial cells
A number of investigators have studied the adherence of C  albicans to buccal 
epithelial cells (BEC) (King et al, 1980; Macura et al, 1983; Douglas et a l, 1981; 
Brassait et a l, 1991). C. albicans was found to be most adherent species with G 
tropicalis moderately adherent and C parapsilosis only slightly adherent to BEC. 
There seems to be a clear relationship between ability to adhere to epithelial cells and 
capacity for colonisation and infection of mucosal surfaces. BEC are readily 
obtainable from human volunteers by gentle swabbing or scraping, for use in adhesion 
assays.
.
â7.6 Adhesion of C albicans to vaginal epithelial cells
Adhesion of C. albicans to vaginal epithelial cells (VEC) has also been frequently
'studied (King et a l, 1980; Lee and King, 1983; Sobel et al, 1981; Segal et al,
1982a). King et al (1980) found that pH was not a factor in adhesion of C  albicans 
to VEC. Salt or divalent cations did not seem to influence adhesion either. In a later 
study (Lee and King, 1983), it was reported that C. albicans cell-wall fragments 
contained an adherence factor and that integrity of the yeast wall mannoprotein was 
important in adhesion.
The pH value of the vagina varies, being highest in the upper part and during 
menstruation, with an average of pH 4.5 (Tindall, 1987). The effect of pH on the 
adhesion of C. albicans to VEC in vitro has been examined. King et al (1980) found 
much less adherence of C. albicans yeast cells at pH 4 than at pH 7.3. Similarly,
Sobel et a l, (1981) reported that at pH 6, adhesion of C  albicans to VEC was 
enhanced when compared with pH 3-4.
Hormonal changes may also be an important factor in relation to Candida 
infections during pregnancy (Mathur et al, 1978). Segal et al, (1984) demonstrated 
that VEC from pregnant women were more receptive to C. albicans than VEC from
women on oral contraceptives.
7.7 Adherence to endothelium and fibrin-platelet matrices
Lesions such as endophthalmitis, nephritis, and endocarditis arise as a result 
of adherence of C. albicans to endothelium or exposed subendothelial surfaces 
(Klotz, 1987). Fibrils on the yeast cell surface have been shown to be responsible for 
adhesion of C. albicans to renal endothelium (Barnes et al, 1983). The mechanism 
of adherence to endothelium appears to differ from that for adherence to epithelium f
(Odds, 1988). Proteolytic treatment of fungi fail to reduce their attachment to
endothelium whereas similar treatment is known to inhibit adhesion of C. albicans to
VEC and BEC (Lee and King, 1983). Maisch and Calderone (1980) demonstrated
.that yeast surface mannan is an important determinant in the adhesion of C. albicans
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to fibrin-platelet matrices formed in vitro. They also showed that other species of 
Candida did not adhere to the matrices to the same extent.
7.8 Adherence of C. albicans to acrylic and plastics
C. albicans adheres well to a variety of materials used in catheters such as 
polyvinyl chloride and also to denture acrylic. Urinary catheters, prosthetic heart 
valves, silicone voice prostheses, endotracheal tubes, and cerebrospinal fluid shunts 
are all strongly associated with Candida infections (Odds, 1988). The adhesion of 
Candida to denture acrylic has been studied by a number of groups (Samaranayake et 
al, 1980 ; McCourtie and Douglas, 1981; Critchley and Douglas, 1985; Minagi et 
al, 1985). Cell-surface hydrophobicity may be a key factor in this interaction. C 
tropicalis is more hydrophobic than C. albicans and has been shown to adhere better 
to PVC, acrylic and Teflon (Rotrosen et al, 1983; Minagi et al, 1985). C. albicans 
can become more hydrophobic depending on growth conditions (Hazen and Hazen,
1988); for example, growth at room temperature as compared with 37°C enhances its 
hydrophobicity. The use of detergents in adhesion assays has confirmed the 
importance of hydrophobicity in yeast adhesion to plastics (Kennedy et a l, 1989). 
Candida species treated with saliva prior to adhesion assays with acrylic showed 
markedly lower adherence (McCourtie and Douglas, 1981; McCourtie et a l, 1986). 
This finding is reflected in patients with Sjogrens syndrome whose saliva flow is 
absent or minimal and who often succumb to chronic oral candidal infection 
(MacFarlane and Mason, 1974). In contrast, a recent study found that coating 
denture acrylic with whole saliva enhanced C. albicans adhesion (Vasilas et al,
1992). C. albicans surface mannoproteins are likely to be involved in adherence to 
acrylic. Yeasts grown in 500mM galactose (the conditions under which the fibrillar 
surface material is most pronounced) adhere better than yeasts grown in 50mM 
glucose (McCourtie and Douglas, 1981,1985).
Tronchin et al (1988) demonstrated that germ-tube specific components 
were involved in attachment of C albicans to plastic surfaces. The components were
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identified as mannoproteins with values of 60 kDa and 68 kDa with two 
additional proteins with Mj- > 200 kDa.
In a more recent study, Hawser and Douglas (1994) examined the ability of a 
number of Candida isolates to form biofilms on various catheter materials. They 
found that the non-albicans isolates were less able to produce biofilms than C 
albicans. They were also able to demonstrate differences in the ability of C. albicans 
to form biofilms on the different catheter materials. Biofilm formation was slightly 
increased on latex or silicone elastomer, compared with polyvinyl chloride, but 
substantially decreased on polyurethane or 100% silicone.
7.9 Effects of commensal bacteria on adherence
Endogenous bacteria on mucosal surfaces can inhibit candidal adherence 
(Samaranayake and MacFarlane, 1982) or assist the fungus in its binding (Makrides 
and MacFarlane, 1983; Levison and Pitsakis, 1987). The fact that E. coli expressing 
type 1 pili can enhance adhesion is not surprising due to the amount of mannan on the 
surface of C. albicans. Sobel et a l, (1981) found that a Lactobacillus isolate 
significantly inhibited yeast adhesion to VEC. Lactobacilli are common vaginal 
commensals and due to their non-pathogenic nature have been proposed as useful 
probiotic agents (Bibel, 1988). Vulvovaginal candidosis following systemic antibiotic 
treatment is thought to result from the depletion of the protective flora (McGroarty,
1993). Whether Lactobacillus and Candida compete for the same receptor molecule 
on VECs remains to be determined.
7.10 The yeast adhesin
C albicans may produce more than one adhesin (Ghannoum and Abu-Elteen, 
1991). Most of the major cell-wall components have been implicated as adhesins 
(Kennedy et a l, 1992). Proteins on the surface of C. albicans with the ability to bind 
a variety of blood proteins may act as adhesins in certain disease states (Calderone,
1993).
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Chitin has been suggested as a possible adhesion molecule (Lehrer et al., 
1983; Segal et al., 1988) as have candidal lipids (Ghannoum et al., 1986). However, 
the majority of reports describing lectin and carbohydrate blocking experiments 
indicate that the mannoprotein probably acts as the adhesion molecule (Kennedy et 
al., 1992).
Evidence for the role of mannoprotein in the adhesion of C. albicans to epithelial 
glycosides has been obtained by a variety of methods (Douglas and McCourtie, 1983; 
McCourtie and Douglas, 1985; Sandin et al, 1982). In vitro adhesion of C. albicans 
to epithelial cells was blocked by the addition of mannose to adhesion mixtures. 
Pretreatment of yeasts with mannose-specific lectin (concanavalin A) or tunicamycin 
(which inhibits mannoprotein synthesis) also inhibited adhesion. Tunicamycin was 
seen to inhibit the production of fibrillar material on the yeast cells (Douglas and 
McCourtie, 1983). Proteolytic enzymes (Sobel et al, 1981) and reducing agents (Lee 
and King, 1983) such as (3-mercaptoethanol and dithiothreitol (DTT) also caused a 
reduction in adhesion. McCourtie and Douglas (1985) and Critchley and Douglas 
(1987a) inhibited the adhesion of C. albicans to buccal epithelial cells (BEC) by 
pretreatment of the BEC with extracellular polymeric material (EP) derived from 
culture supernatants of the yeast grown in medium rich in galactose. This finding 
suggests that the EP (composed primarily of mannoprotein) contained an adhesin. 
The interaction seems to be strain-specific as EP from one strain (C. albicans GDH 
2023) failed to inhibit the adhesion of a second strain (McCourtie and Douglas, 
1985). Purification of the components of EP that inhibit adhesion has been pursued 
(Critchley and Douglas, 1987a). EP subjected to heat, chemicals, and enzymes was 
examined for blocking activity. Heat (60°C, 15min), DTT, mild acid, and the 
proteases chymotrypsin, bromelain, and pronase significantly destroyed the blocking 
ability of EP. However, periodate and a-mannosidase had no effect on this ability. 
This suggests that the protein part of the mannoprotein is important in mediating 
adherence in this mechanism. Interestingly, treatment of EP with the protease, 
papain, or dilute alkali appeared to enhance its ability to inhibit adhesion. When these
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two treatments were combined, substantially greater inhibition of adhesion was 
observed.
Adhesion inhibition tests with sugars and lectins have suggested that a 
receptor containing L-fucose is required for most strains of C  albicans to bind to 
BEC (Critchley and Douglas, 1987b). More recently, a degradation protocol was 
developed which involved the sequential treatment of EP with N-glycanase, papain 
and dilute alkali to cleave the protein and carbohydrate portions of the mannoprotein 
(Tosh and Douglas, 1992). Fucoside-binding protein fragments were recovered by 
affinity chromatography with the trisaccharide determinant of H (type 2) blood group 
antigen which terminates in an L-fucose residue. This purified adhesin was devoid of 
carbohydrate and could inhibit adhesion of C  albicans to BEC roughly 220 times 
more effectively, on a protein weight basis, than EP.
Some C albicans adhesins are only expressed on hyphae. Hyphal-form cells have 
been shown to express cell-surface components which are different from those of 
yeast-form cells. For example, hyphal forms bind fibrinogen, laminin, and C3d (C3 
complement conversion product) while the yeast form does not (Bouali et a l, 1986; 
Calderone et al, 1988; Bouchara et al, 1990). Heidenreich and Dierich (1985) 
described the binding of antibody-coated sheep erythrocytes conjugated with C3d or 
iC3b to hyphal and yeast forms of C. albicans. Both types of binding could be 
partially inhibited by D-mannose and D-glucose. Hostetter et al (1990) and Gilmore 
et al (1988) have reported that expression of C albicans iC3b receptor is enhanced 
in growth medium containing glucose.
In addition to components that mimic mammalian complement receptors, C. 
albicans posseses CR3-like proteins that can bind to fibrinogen, fibronectin and 
laminin. Calderone and others demonstrated that fibronectin adheres to C. albicans
and C. tropicalis in vitro and that less pathogenic species of Candida do not bind the 
glycoprotein to the same extent (Scheld et al, 1985; Skerl et a l, 1984). 
Experimental evidence for fibronectin as a receptor for C. albicans on epithelial cells 
was provided by Skerl et al (1984). The binding of fibrinogen has also been i
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demonstrated for C. albicans (Bouali et al, 1986, 1987; Tronchin et a l, 1987). 
Binding was found to be 12-fold higher for germ tubes than for yeast cells. Bouchara 
et al (1990) reported the presence of laminin receptors on C albicans germ tubes 
but yeast cells were found not to bind laminin. Binding was eliminated when germ 
tubes were heated or subjected to proteolysis by trypsin. Fibrinogen was also found 
to inhibit the binding of laminin by 57%. Two mannoproteins were identified as 
receptors of laminin, one of 68 kDa, the other 60-62 kDa. Similar proteins were 
found to have affinities for fibrinogen, laminin, and C3d binding protein by Tronchin 
et al (1989). The mannoprotein of 60 kDa extracted from hyphae of C. albicans 
appears to recognise ligands that contain the amino acid sequence arginine-glycine- 
aspartic acid (RGD), which is found in iC3b, fibrinogen, laminin, and fibronectin. 
This mannoprotein also seems to bind to C3d which does not contain the RGD 
sequence. RGD-containing proteins are important constituents of the extracellular 
matrix of endothelial cells. Preincubation of endothelial cells with RGD-containing 
ligands blocks the adherence of C albicans to these cells (Calderone and Braun, 
1991). Indwelling catheters are rapidly coated with proteins such as fibronectin and 
this is likely to promote the adhesion of C. albicans .
Other investigators have proposed that candidal chitin may act as an adhesin. This 
minor constituent of the cell wall is involved primarily in budding and septum 
formation. Ultrastructural studies have shown that chitin is distributed throughout the 
cell wall as well as at bud scars and septa (Tronchin et al, 1981). Degradation 
products of chitin block adherence of the organism to vaginal epithelial cells and 
protect mice from vaginal infection (Lehrer et a l, 1983; Segal et a l, 1988).
7,11 Glycosides as epithelial receptors for C. albicans
The plasma membrane of animal cells is composed of lipids and proteins both 
of which can be glycosylated. Carbohydrates on these lipids and proteins are essential 
binding sites for bacteria and viruses (Karlsson and Stromberg, 1987).
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Research involving sugar inhibition tests with C. albicans has produced a 
variety of contradictory results. L-Fucose (Sobel et al, 1981), amino sugars (Segal et 
al, 1982a) and D-mannose (Sandin et a l, 1982) have all been reported to be major 
inhibitors of C. albicans adhesion and therefore the likely receptor determinant. More 
recently, Critchley and Douglas (1987b) demonstrated that a receptor containing L- 
fucose is required for most strains of the yeast. Athough the addition of L-fucose to 
assay mixtures caused only partial inhibition of adhesion with sensitive strains, it is 
possible that the natural mucosal receptor is larger than L-fucose or that a particular 
stereochemical configuration is necessary. Brassait et al (1991) showed that C. 
albicans adhesion to BEC in vitro was inhibited by the addition of Fuc al-2Gaip- 
bearing complex carbohydrates. This structure is found on all blood group substances 
in the ABO system. Other studies also indicate a role for the Lewis^ antigen, which is 
found in the body fluids of non-secretors of blood group antigens (May et a/., 1986, 
1989; Tosh and Douglas, 1991). The Lewis antigens are adsorbed on to the surface 
of oral epithelial cells from saliva. In both studies, anti-Lewis^ antiserum had a 
significant inhibitory effect on yeast adhesion. From these results, it appears that the 
most likely candidates for C. albicans on BEC are fucose-containing glycosides such 
as the H antigen and the Lewis^ antigen (Tosh and Douglas, 1992). Support for this 
theory comes from a clinical survey, carried out by Burford-Mason et al (1988), 
which found that blood group O and non-secretion of blood group antigens were 
separate and cumulative risk factors for oral candidal carriage in healthy subjects.
In studies of the role of glycosides as receptors for bacterial adhesion, most 
workers have adopted glycosphingolipids over glycoproteins for binding analysis 
(Karlsson and Stromberg, 1987). Glycosphingolipids only carry one polysaccharide 
chain and are easily extracted from tissues. Glycoproteins, on the other hand, may 
express two or more different glycoside moieties and, as a result, make the 
identification of receptors more difficult.
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8. GLYCOSPHINGOLIPIDS
8.1 Glycosphingolipid structure and nomenclature
Glycosphingolipids are the glycosides of N-acylsphingosine, the trivial name 
for which is ceramide. There are a great number of chemically distinct 
glycosphingolipids due to structural variation in fatty acids, sphingosine and 
carbohydrate. Glycosphingolipids can be classified as neutral glycolipids, sulfatides 
(sulphate-containing) and gangliosides (sialic acid-containing) (Hakomori, 1993). 
They can also be classified according to the number of carbohydrate residues present 
(ceramide monohexose, ceramide dihexose etc.). An alternative classification depends 
on the backbone structure of the carbohydrate. Under this system, the globo series 
glycosphingolipids contain globotriaosylceramide (Gal(31-4 or 1 -3Gaip 1 -4Glc-Cer). 
The lacto series contain lactotriaosylceramide (GlcNAcp 1 -3 Galp 1 -4Glc-Cer). The 
ganglio series contain gangliotriaosyl ceramide (GlcNAcp 1 -4Galp 1 -4Glcp 1-1 Cer) 
and the gala series contain galabiosyl ceramide (Gal(31 -4Gaip 1-1 Cer) as the common 
structure. The lacto series show the most extensive substitutions with sialosyl, 
fucosyl, and a- and |3- galactosyl moieties. They can also have extensions or 
branching by repeating N-acetyllactosamine units which can result in a great number 
of distinct molecular structures. The fucosylated species include the major blood 
group antigens.
8.2 Glycosphingolipids as receptors for micro-organisms
Glycosphingolipids have been reported to be cell-surface receptors for a 
number of bacteria. For example, uropathogenic & coli specifically bind to a Galal- 
4Gal sequence on urinary tract epithelial cells (Leffler et a l, 1982). Aso 
Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis 
patients bind to glycosphingolipids containing GalNAcpl-4Gal sequences (Krivan et 
a l, 1988a).
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.Saccharomyces cerevisiae (Horvath et al., 1994; Sipos et al., 1994) and 
Candida deformans (Mineki et al., 1994) are known to contain some 
glycosphingolipid structures. Mineki et al. (1994) recently identified a 
glucocerebroside that contained a single glucose residue attached to ceramide, from 
the n-alkane-assimilating yeast Candida deformans. Ghannoum and colleagues found 
that various classes of lipid derived from Candida cell walls (including ceramide 
mono- and di-hexosides) were able to inhibit adherence of the yeast to BEC. They 
subsequently showed that total lipid extracts from BEC also blocked adherence 
(Ghannoum et al, 1987). More recently, Jimenez-Lucho et al (1990) proposed 
lactosylceramide as a receptor for C. albicans. Cryptococcus neoformans and other 
fungi. They found that ^^^I-labelled fungi bound to lactosylceramide but not to other
I
glycosphingolipids separated on TLC plates. Lipids expressing L-fucosyl residues 
were not used in this investigation. In a preliminary study, Yu et a l (1993) found that 
C  albicans bound to gangliosides GMi and asialo-GMi. ;sl
p
9. BLOOD GROUP ANTIGENS AND SECRETOR STATUS
Blood group antigens may be defined as molecules formed by sequential addition
•of saccharides to the carbohydrate side chains of lipids and proteins on erythrocytes 
and certain epithelial cells (Kabat, 1973). The direct gene products of each of these 
blood group systems are the glycosyl transferases which catalyse the addition of 
specific sugar residues thus conferring specific blood group activity to the glycoHpid 
or glycoprotein molecule (Green, 1989). The term "blood group secretor" refers to 
the ability of the secretory cells of an individual to produce blood group substance in 
their body fluids (Green, 1989). The A and B blood group antigens are major 
histocompatibility antigens and can cause graft and transplant rejections including 
heart, skin, and cornea (Joysey et al, 1977; Herksho et a l, 1980). Substances very 
similar in structure to the ABH antigens are also widely distributed in Nature, being 
found in many species of animals, plants, and bacteria (Springer, 1956, 1965). In
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man, various receptor properties including specific interactions with antibodies, 
viruses, toxins and pharmacological agents have been attributed to the ABH 
determinants (Green, 1989).
The type of polysaccharide chain to which the ABH specific sugars are added are 
of two main classes: type 1 chains have a terminal Gal(31-3GlcNAc sequence and 
type 2 chains have a terminal Gaipi-4GlcNAc (Rege et a l, 1963). The structures of 
the type 1 and 2 chains are shown in Fig. 1.
On the red blood cells, all the ABH active structures are synthesised on type 2 
chains with up to 80% bound to protein and 20% existing as glycolipid (Green,
1989). Synthesis of the ABH structures is controlled by genes at three different loci
i.e. ABO, H and Se loci. A total of four different glycosyltransferases are coded for 
by these genes. The H gene specifies a fucosyltransferase which adds fiicose to 
galactose in an a  1-2 linkage.
The A gene specifies an N-acetylgalactosaminyltransferase that attaches N- 
acetylgalactosamine in an a  1-3 linkage (Morgan and Watkins, 1969). The B gene 
product is a galactosyltransferase which attaches galactose in an a  1-3 linkage to the 
type 1 and type 2 precursor chains. The structures of the A and B chains are shown 
on Fig. 1. Both the A- and B- specific transferases can only add their respective 
sugars when the terminal galactose is substituted with fucose in the 2- position i.e. a 
type 1 or 2 H-active structure.
The genetics of the ABO blood groups are subject to Mendelian inheritance. One 
allele is passed by each parent with A and B co-dominant with each other and both 
being dominant over O. The O allele is recessive and must be in the homozygous 
form to be expressed in the phenotype. In rare hh individuals (Bombay phenotype), H 
active structures are not formed from the precursor so no fucose is added to the 
terminal galactose. This means that these individuals are unable to catalyse the 
addition of A-and B-specific sugars, although the appropriate gene specified 
transferase is present, because the H-active structure is required for enzyme activity 
(Green, 1989).
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Control of the secretion of blood group antigens is under the influence of the 
Se gene. The exact mechanism by which the Se gene acts is not fijlly understood. Se 
and H genes are two distinct but closely related structural genes, each of which codes 
for a distinct a-2-L-fucosyl transferase. One enzyme reacts preferentially with type 1 
chains, the other with type 2 chains. Se is dominant to se hence SeSe and Sese 
individuals are secretors of blood group antigens while sese individuals are non 
secretors.
The Lewis blood group antigens are present in plasma and body secretions 
such as saliva. Those Lewis antigens in plasma consist of polysaccharide chains 
bound through D-glucose to glycosphingolipids (Marcus and Cass, 1969; Tilley et 
ai, 1975). In saliva, the Lewis antigens are identical to those of plasma but are bound 
via N-acetylglucosamine to peptides (Watkins and Morgan, 1959). Plasma Lewis 
antigens are inserted into red cell, platelet, and lymphocyte membranes via the lipid 
component. Non-secretors of ABH blood group antigens are Le^ and secretors are 
Leb.
The Le gene produces another fucosyltransferase enzyme which adds another 
fucose residue to the type 1 H chain. When the H/Se gene product and the Le gene 
product add flicosyl residues, this will confer Le^ activity on to the type 1 chain. If an 
individual lacks the secretor gene, Le^ is the only product. The structures of Lewis 
antigens are shown in Fig. 1.
9.1 Blood group antigens in the oral mucosa
The expression of blood group antigens is related to cellular maturation. Blood 
group antigens A and B and their precursors are all expressed in different layers of 
the oral epithelium (Dabelsteen et al, 1982). In blood group A or B individuals the H 
antigen is expressed in the deeper epithelial layers and the A or B antigen is expressed 
on the more superficial cells. The palatal epithelium appears to be less differentiated 
than the buccal epithelium and, as a consequence, the A or B antigens are present in 
higher amounts on buccal epithelium than on palatal epithelium. Conversely, H
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Fig. 1. The A, B, H, and Lewis blood group structures.
Type 1 pre-cursor chain
GlcNAc-R 
Gaipi-3GlcNAcpi-3Gaipi“3 or
Glc—R
Type 2 pre-cursor chain
Type 1+2 H antigen
Type 1+2 A antigen
Typel+2 B antigen
Type 1 chain Le  ^antigen
GlcNAc—R 
Gaipi-4GicNAcpi-3Gaipi~3 or
Glc—R
1-3
Gaip or GlcNAcPi-sGaipi-sGalNAc—R
a i-2 1-4
Fuc
1-3
GalNAca i-sGalp or GIcNAcp i-sGaip i-3GalNAc—R 
a  1-2 I 1-4 
Fuc
1-3
Gala i-3Gaip or GIcNAcp i-sGalp i-sGalNAc—R
a i -2 1-4
Fuc
GalNAc—R 
Gaip i-3GlcNAcp i-sGaip 1 -3  or *
a  1 -4 Glc-R
Fuc
Type 1 chain Le  ^antigen
GalNAc-R 
Gaip i-3GlcNAcP i-sGaip 1 -3  or *
a  1-2 ai - 2  
Fuc Fuc
Glc-R
GalNAc = N-acetyl-D-galactosamine, Gal = D-Galactose, Fuc = L-Fucose, 
GlcNAc = N-acetyl-D-glucosamine, Glc = D-Glucose,
*Glc when R is sphingolipid and GalNac when R is protein.
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antigens are at a higher concentrations on palatal cells than buccal epithelium 
(Vedtofte etal,  1984).
-t
I
65
%
OBJECT OF RESEARCH
The search for host cell receptors for C albicans has, until recently, been 
limited to blocking studies using monosaccharides and/or lectins in adhesion- 
inhibition assays. A more recent investigation showed that C. albicans adhesion to 
BEC in vitro was significantly inhibited by the addition of Fucal-2Galp-bearing 
complex carbohydrates. This structure is found on all blood group substances in the 
ABO system. Blood group antigens are expressed on the carbohydrate side-chains 
of lipids and proteins on erythrocytes and certain epithelial cells. Two recent studies 
provided evidence for the role of lipids as receptors for C. albicans. One of the 
studies showed that C. albicans and other fongi bound specifically to 
lactosylceramide (a glycosphingolipid commonly found on epithelial cells), by 
employing a chromatogram overlay assay previously used in the characterisation of 
bacterial adhesion mechanisms. The other study employed a similar overlay system 
and demonstrated that C. albicans fimbriae bound to asialo-GMi and asialo-GM2, 
but failed to bind to lactosylceramide.
A complete purification scheme for the yeast adhesin was recently devised 
which made use of the findings from earlier investigations of adhesion mechanisms. 
The purification protocol involved stepwise treatment of EP with N-glycanase, 
papain, and dilute alkali followed by affinity adsorption with the trisaccharide 
determinant of the H (type 2) blood group antigen. Adhesin purified in this way is 
devoid of carbohydrate, can inhibit adhesion of yeasts to BEC by up to 80%, and 
consists of one major component as determined by reverse-phase fast protein liquid 
chromatography (FPLC). The aims of this study were:
(i) to characterise further the purified adhesin isolated previously
(ii) to isolate and identify buccal epithelial cell glycolipid receptors for C
albicans using the chromatogram overlay assay system.
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A more complete understanding of the molecules involved in the adhesion 
of C. albicans to epithelial cells may lead to the development of novel drug therapies 
and/or vaccines for this opportunistic pathogen.
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MATERIALS AND METHODS
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1. ORGANISMS
Six strains of C albicans were used in this study. Four of the strains were 
isolated in Glasgow and are now deposited with the National Collection of Yeast 
Cultures (NCYC), Food Research Institute, Norwich, UK. C. albicans GDH 2346 
(NCYC 1467) and GDH 2023 (NCYC 1468) were isolated at Glasgow Dental Hospital 
from patients with denture stomatitis; strains GRI 681 (NCYC 1472) and GRI 682 
(NCYC 1473) were obtained from routine cervical smears taken from asymptomatic 
women at Glasgow Royal Infirmary. C  albicans MRL 3153 was from the Mycological 
Reference Laboratory at the London School of Hygiene and Tropical Medicine, London, 
UK. C albicans "outbreak strain" was isolated from a patient at the London Hospital 
Medical College, London, UK, and was kindly supplied by Dr. J.P. Burnie. The 
organisms were maintained on slopes of Sabouraud dextrose agar (Difco) and 
subcultured monthly. Every two months, cultures were replaced by new ones freshly 
grown from freeze-dried stocks..
2. GROWTH CONDITIONS
2.1 For freeze-drying
For freeze-drying, yeasts were grown in yeast nitrogen base (Difco; 
YNB) containing 500mM sucrose. Batches of medium (50ml, in 250ml Erlenmeyer 
flasks) were inoculated with overnight yeast cultures (5ml) and incubated at 37®C in an 
orbital shaker operating at 150 rpm. Cells were harvested after 24h (MSE bench 
centrifuge: 5min, 1200g) and washed in sterile 0.15M phosphate-buffered saline (pH 7.2; 
PBS). Yeast cells were suspended in a small volume of 2% (w/v) sterile skimmed milk 
and a drop of suspension was added to a sterile glass ampoule. Ampoules were frozen 
before being dried in a centrifugal freeze-dryer (Edwards High Vacuum Ltd., Sussex).
2.2 For adherence assays
Batches of medium (50ml, in 250ml Erlenmeyer flasks) containing YNB 
supplemented with 500mM galactose were inoculated from stock yeast cultures and
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incubated overnight at 37^C in an orbital shaker operating at 150 rpm. Fresh medium 
(50ml) was inoculated with the overnight culture (5ml) and incubated at 37®C in an 
orbital shaker operating at 150 rpm for 24h to allow the yeast cells to reach stationary 
phase. Cells were harvested by centrifugation (MSE bench centrifuge: 5 min, 1200g) and 
washed twice in 0.15M PBS (pH 7.2).
2.3 For isolation of extracellular polymeric material.
Yeasts were grown in YNB medium containing 500mM galactose. Batches of 
medium (500ml, in 21 Erlenmeyer flasks) were inoculated with 50ml of an overnight 
culture and incubated at 37^C in an orbital shaker operating at 150 rpm for 5 d.
3. ADHERENCE TO HUMAN BUCCAL EPITHELIAL CELLS
3.1 The yeast adherence assay
3.1.1 Collection and preparation of buccal epithelial cells
Buccal epithelial cells were collected from a single donor by gently swabbing 
the inside of the cheeks with a sterile swab. The swab was agitated in PBS (10ml) in a 
universal bottle. Epithelial cells were harvested by centrifugation (MSE bench centrifiige: 
5 min, 1200g) and washed twice in PBS to remove loosely-bound microorganisms. After 
the second wash, epithelial cells were standardised using an improved Neubauer 
haemocytometer to a concentration of 1x10  ^cells ml'  ^ in PBS. Buccal cells were always 
collected between 8.30 am and 10.30 am to reduce variability.
3.1.2 Preparation of yeast cells
After the second wash of the yeasts in PBS, yeast suspensions were 
standardised in PBS using an improved Neubaur haemocytometer to the stated 
concentration for each experiment.
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3.1.3 Adherence assay
The method used was similar to that described by Douglas et al (1981). 
Epithelial and yeast cell suspensions were vortexed using a whirlimixer before being used 
in adherence assays. Standardised suspensions of buccal cells (1x10^ cells ml’  ^ in PBS; 
0 .1ml) and yeasts (0 .1ml, at the concentration stated for each experiment) were mixed in 
small screw-capped bottles and incubated at 37®C, with gentle shaking, for 45min. After 
incubation, 3ml of PBS was added to each bottle to stop any further attachment. The 
epithelial cells were collected on polycarbonate filters (12pm pore size; 25mm diameter; 
Nuclepore Corp., Pleasanton, CA) and washed with PBS (25ml) to remove unattached 
yeasts. The washed filters were placed on labelled slides and air-dried. Epithelial cells on 
the filters were fixed with absolute alcohol-acetone (1:1) for 5 sec and stained using the 
Gram procedure. After drying, filters were mounted under coverslips using DPX (BDH 
Chemicals Ltd.). The numbers of adherent yeasts on each of 100 epithelial cells were 
counted on every filter. Triplicate filters were prepared for each assay. Al adherence 
values quoted represent mean figures from 3 independent assays.
3.2 Use of inhibitors to block in vitro adherence
3.2.1 Extracellular polymeric material (EP)
Epithelial cell suspensions (1ml, containing 1x10  ^cells ml"^ ) were centrifuged in 
an MSE bench centrifijge at 1200g for 5 min and the supernatants were discarded. Crude 
EP samples (usually lOmgml'^; 1ml unless stated otherwise) were added to the cell 
pellets and the cells were mixed using a whirlimixer. Epithelial cells were incubated with 
the EP solution for 30 min at 37®C. After this treatment, epithelial cells were recovered 
by centrifugation, resuspended in PBS (1ml) and used in adherence assays.
3.2.2 RGD peptide
Yeast cell suspensions (1ml, containing 1x10  ^cells ml"^ ) were centrifuged in an 
MSE bench centrifijge at 1200g for 5 min and the supernatants were discarded. RGD 
(arginine-glycine-aspartic acid) peptide solutions (either 0.5mgml"  ^ in PBS or 0.5mg ml"^
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in 50 mM Tris-HCI pH 7.3 containing 0.02% CaCi and 0.02% MgCi) were added to the 
ceil pellets. The yeast cells were resuspended and incubated with the RGD solutions for 
30 min at 37°C in an orbital shaker operating at 150 rpm. After this treatment, yeast cells 
were recovered by centrifugation, resuspended in PBS (1ml) and used in adherence 
assays.
4. ISOLATION AND PURIFICATION OF THE YEAST ADHESIN
4.1 Preparation of extracellular polymeric material (EP)
4.1.1 Isolation of EP from culture supernatants of Candida albicans
EP from strains GDH 2346 and GDH 2023 was prepared by freeze-drying 
dialysed culture supernatants using a minor modification of a method previously 
described (Tosh and Douglas, 1992). Batches of medium (500ml in 21 Erlenmeyer flasks) 
containing yeast nitrogen base (Difco) and 500mM galactose were inoculated with 
overnight yeast cultures (50ml) and incubated at 37^C for 5 d in an orbital shaker 
operating at 150 rpm. Yeasts were removed by centrifugation and the culture 
supernatant fluid was ultrafiltered in an Amicon DC2 Hollow Fibre Concentration 
System using a 3.5K filter and then dialysed at 4^C for 3d against 5 changes (51 each) of 
distilled water. The retentate (crude EP) was then freeze-dried.
4.1.2 Biochemical analysis of EP
Carbohydrate was estimated by the method of Dubois et al (1956) using 
mannose as a standard (see Appendix LA). Protein was determined using the method of 
Lowry et a l (1951) with bovine serum albumin as a standard (see Appendix I B ).
4.2 Isolation of purified adhesin
EP (lOOmg) was dissolved in 1ml of 0.55M Na2HP04 (pH 8 .6). N-Glycanase 
(Genzyme; 250 Units ml'i; 0.096ml) was added and the mixture was incubated for 24h at 
37^C. The reaction was terminated by the addition of Sodium citrate buffer (O.IM, 
0.04ml, pH 4.4). Potassium phosphate buffer (0.0IM, pH6.2) was used to adjust the EP
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concentration to 50 mgml"\ Papain (0.1 mgml" ;^ 0.16ml) was added and the solution was 
incubated for 30 min at 25^C. The protease inhibitor a 2-Macroglobulin (2 mgml"\ 
0.5ml) was employed to terminate the reaction. NaOH (0.366M; 1ml) was added and the 
mixture was incubated for 24h at 30^C. 1 ml of HCl was used to neutralise the NaOH.
4.3 Extraction of purified adhesin by affinity chromatography
Synsorbs (Chembiomed Ltd., Edmonton, Alberta, Canada) are specific affinity 
adsorbents for the isolation and purification or removal of biologically important 
molecules. They are composed of synthetic carbohydrate structures of known specific 
composition covalently linked to an inert, insoluble matrix. Adsorbed material can be 
removed in a highly purified form and the adsorbent regenerated by elution with high or 
low pH buffers.
Synsorb H-2 (0.5g) was washed twice in PBS (2ml) and allowed to settle. The 
buffer was removed to just above the surface of the synsorb bed and EP digest was 
applied. The digest and the Synsorb were gently rotated for 3h at 4®C. Unbound material 
was eluted with 5ml aliquots of PBS until the A28O returned to 0.0. Bound material was 
then eluted by the addition of 2 ml aliquots of 1.5% NH4OH in sterile saline for 15 min 
at 4®C until the A28O returned to 0.0. Bound samples were freeze-dried and desalted on 
a Sephadex G-25 (5ml) desalting column. The adsorbent was regenerated with PBS and 
then stored at 4®C in PBS containing 0 .02% NaNs as a bacteriostat.
4.4 Adhesion inhibition activity of the purified adhesin
Epithelial cell suspensions (10$ cells ml'i in PBS; 1ml) were centrifuged in a bench 
centrifuge at 5,000 x g for 5 min, and the pellets were resuspended in PBS or purified 
adhesin solution (6.375 gg protein ml'^). After incubation at 37®C for 30 min with gentle 
shaking, the buccal cells were recovered by centrifugation and resuspended in PBS (1ml) 
for use in the adhesion assay, performed as described above (3.1.3). All adhesion- 
inhibition values quoted represent mean figures derived from three independent assays, 
each carried out in triplicate. Epithelial cells were obtained from the buccal mucosa of a
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single, healthy, male, blood group A donor and were collected at the same time of day to 
reduce variability
4.5 Adhesion inhibition index
The adhesion inhibition index (All) is a measure of the relative efficiency with 
which PA inhibits yeast adhesion compared with crude EP, on a protein weight basis. 
Preparations of crude EP, at a concentration of 10 mg ml‘  ^ routinely inhibit adhesion by 
45 to 50%. The All = W ep /W pa where W ep is the weight of EP protein required to 
produce 50% inhibition of adhesion and WpA is the weight of PA required to inhibit 
adhesion by 50%.
4.6 High Performance Liquid Chromatography of EP and purified adhesin
High Performance Liquid Chromatography (HPLC) was performed using an 
LKB Bromma HPLC machine with a TosoHaas CIS TSK-Gel reversed phase column. 
Samples (EP, EP digests and purified adhesin) were prepared in 0.1% trifluoroacetic acid 
(TFA). Details are given in the text and figure legends for individual experiments. 
Samples were filtered through a 0 .2 |am filter prior to loading and 200pl of sample was 
loaded at a time. The machine was run with a flow rate of 30 mlh-i using an acetonitrile 
gradient of 0-100% in 0.1% TFA. Absorbance was read at 208nm and was recorded on a 
chart feeder.
4.7 Amino acid analysis of purified adhesin
Amino acid analysis was kindly performed by Drs. Gordon Curry and Maggie 
Cusack from the Department of Geology and Applied Geology, University of Glasgow, 
using Applied Biosystems 420-H amino acid analyser with an automatic hydrolysis head. 
Purified material (Ipg dissolved in 50^1 of 0.1% TFA) was loaded.
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4.8 Amino acid sequencing of purified adhesin
Amino acid sequencing was kindly performed by Sandra Miller in the Department 
of Geology and Applied Geology, University of Glasgow. Purified adhesin was run on a 
polyacrylamide gel using the procedure of Schagger and Von Jagow (1987) and then 
transferred onto ProBlott (Applied Biosystems). The ProBlott was cut to include the 
band of the adhesin The position of the band was estimated using an autoradiograph of a 
gel blot of biotinylated adhesin from the same purified batch. The material on the 
ProBlott was then sequenced in an Applied Biosystems 477A Protein Sequencer.
5. LABELLING OF C ALBICANS WHOLE CELLS, EP, AND PURIFIED
ADHESIN
5.1 lodination of EP and yeasts
lodogen (Pierce; Img) was dissolved in 25ml of chloroform and 1ml aliquots 
were dispensed into clean glass universals. The chloroform was allowed to evaporate to 
dryness at R.T. under nitrogen to leave an lodogen coated universal. The coated 
universal was rinsed with PBS prior to reaction to remove unbound flakes of lodogen. 
EP (100 mg) was dissolved in 1 ml of PBS and then added to the universal. Na^^^I 
(ImCi) was added, followed by Nal (final concentration 0.25mM) to act as a carrier for 
safe handling. The universal was then placed in a lead container for the duration of the 
lodination. The reaction was allowed to proceed for 15 min with occasional shaking. The 
solution was then transferred to narrow bore dialysis tubing and dialysed for 24 h against 
PBS.
Yeast cells were iodinated using a modification of the method of Jimenez-Lucho et 
al. (1990). Washed yeast cells were adjusted to a concentration of 2x10  ^ cells m f\ To 
one of the lodogen coated universals was added 0.5 ml of fungal suspension. Na^^^I 
(ImCi) was added, followed by Nal (final concentration 0.25mM) to act as a carrier for 
safe handling. The universal was then placed in a lead container for the duration of the 
iodination. The reaction was allowed to proceed for 15 min with occasional shaking.
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After incubation, unreacted Na^^^I was removed by three centrifugal washes (MSE 
bench centrifuge: 5min, 1200g) in 0,15M phosphate-buffered saline (pH 7.2; PBS). The 
final pellet was resuspended in 10 ml of Tris-BSA buffer (0.05M Tris-hydrochloride 
[pH7.8] containing 0.15M sodium chloride and 1% BSA), and then used in TLC overlay 
analysis.
5.2 Biotinylation of yeasts, EP, and purified adhesin.
Yeasts were biotinylated by a modification of the method of Casanova et al. 
(1992) using a biotinylation kit from Amersham, UK. Washed cells were adjusted to 
2x10^ organisms ml"l in 0.05M sodium borate buffer, pH8 .6 . Biotinylation reagent 
(40p,l) was added to 1 ml of cell suspension and incubated for Ih at room temperature 
with constant agitation. The cells were washed twice in 0.05 M Tris-hydrochloride (pH 
7.8) containing 0.15 M sodium chloride and 1% BSA (Tris-BSA) and adjusted to 10  ^
cells ml"i in Tris-BSA. EP and purified adhesin were biotinylated using the Amersham 
biotinylation kit according to the manufacturer’s protocol. EP (lOmg) or adhesin 
(200pg) was dissolved in 1ml of 0.05M sodium borate buffer, pH8 .6 . Biotinylation 
reagent (40p,l) was added and the mixture was incubated for Ih at room temperature 
with constant agitation. Unreacted biotinylation reagent was removed by desalting on a 
Sephadex G-25 (5ml) desalting column and the EP and adhesin were freeze-dried.
6. SDS POLYACRYLAMIDE GEL ELECTROPHORESIS
6,1 Gel Preparation
Two SDS-PAGE systems were employed in this study: the procedures of 
Laemmli (1970) and of Schagger and Von Jagow (1987).
Plates were prepared by first washing them in detergent to remove dirt and 
grease; they were then wiped clean with paper tissue dipped in absolute alcohol. Plastic 
spacers (1.5mm) were placed between the plates which were taped together along three 
sides and baked for 30 min at 80^0 to seal the tape.
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Gels for the Laemmli procedure were prepared as follows. The separating gel 
solution containing 12.5% acrylamide, 1.5% Tris-HCl (pH 8.9), 0.4% SDS, 0.025% 
Temed and 0.8% ammonium persulphate, was mixed thoroughly and poured into the gel 
plates to about 4cm from the top (1cm for small plates). Absolute alcohol was used to 
overlay the separating gel, which was left for 20 min to polymerise. The absolute alcohol 
was then poured off and the gel was washed with distilled water. Stacking gel solution 
containing 4.5% acrylamide, 0.5M Tris-HCl (pH 6 .8), 0.4% SDS, 0.025% Temed, and 
0.08% ammonium persulphate was poured on top of the stacking gel. A sample comb 
was inserted into the stacking gel solution and any remaining spaces were filled. After 
polymerisation the comb was removed and the gel plate was dipped in running buffer to 
prevent drying out. Tris-glycine running buffer (pH 8.3) containing 0.1% SDS was used 
to fill the lower electrode tank. The sealing tape was removed from the bottom of the gel 
plates, and the plates were inserted into the top electrode tank. The upper tank was filled 
with running buffer. Sample buffer was prepared by combining 20% SDS (w/v; 4ml), 
glycerol (2.4 ml), 2-mercaptoethanol (0.4 ml). Brilliant Blue G (2.0 ml; Sigma) and tris- 
HCl (IM; pH 6 .8; 1 ml) and water (10.2 ml). Proteins or biotinylated proteins were 
treated with solubilising buffer and then carefully pipetted into the sample wells. Gels 
were run at a constant current (20 mA per gel) for approximately 3.5h. When the 
tracking dye reached the end of the gel the power was switched off.
Gels for the procedure of Schagger and Von Jagow (1987) were prepared as 
follows. The separating gel solution contained 16.5% acrylamide, 12.1% Tris-HCl (pH 
8.45), 0.1% SDS, 0.033% Temed, and 0.033% ammonium persulphate. The stacking gel 
solution contained 4% acrylamide, 9.01% Tris-HCl (pH 8.45), 0.1% SDS, 0.033% 
Temed, and 0,033% and 0.033% ammonium persulphate. The cathode buffer (pH 8.2) 
was prepared by combining tris (12.11 g), tricine (17.92 g), SDS (1.0 g) and 1 L of 
water. The anode buffer (pH 8.9) was prepared by combining tris (121.1 g) with water to 
a final volume of 5 L. Sample buffer was prepared by combining 20% SDS (w/v; 4ml), 
glycerol (2.4 ml), 2-mercaptoethanol (0.4 ml), Brilliant Blue G (2.0 ml) and tris-HCl 
(IM; pH 6 .8; 1 ml) and water (10.2 ml). Samples and markers were treated with
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solubilising buffer. Gels were run at 20 mA to allow samples to completely enter the 
stacking gel then the current was increased to 30mA until the marker dye was 1cm from 
the bottom of the gel plate.
6.2 SDS-PAGE and Western blot analysis of the C albicans adhesin.
SDS-PAGE was performed in a minigel apparatus built by University of 
Glasgow Workshop based on the Bio-Rad Mini-Protean II electrophoresis system. The 
procedure of Schagger and Von Jagow (1987) was employed as described in section 6.1 
(above). Samples (biotinylated PA) and molecular weight markers (MW-SDS-17S, 
Sigma) were electrophoresed for 3-4 hours at a constant current of 100 V. The gel was 
cut using a clean plastic ruler and the markers were stained with Brilliant Blue G 
(Sigma). The biotinylated PA lanes were transferred onto nitrocellulose (Hybond C, 
Amersham) for Western blot analysis which was performed according to the method of 
Towbin and Gordan (1984) in a Trans-Blot Electophoretic Transfer apparatus (Bio- 
Rad). The transfer was performed at 0.13A (50V) for Ih, 0.08A (30V) for 18h then 
0.13A (50V) for Ih. The nitrocellulose was transferred to a plastic box with lid and 
immersed in blocking solution (3% (w/v) skimmed milk containing 0.2% Tween 20 in 
PBS) overnight at 4°C. This solution was poured off and replaced with 10 ml of fresh 
blocking solution to which 5gCi of ^^^I-streptavidin (Amersham) was added. The box 
was then closed and incubated with gentle shaking for 2h. The nitrocellulose was 
removed from the box, washed extensively in distilled water to remove unbound i 5^j_ 
streptavidin, allowed to air-dry, then exposed for 2-5 days to blue sensitive X-ray film 
(Genetic Research Instrumentation Ltd. Dunmow, Essex, UK) with intensifying screens.
6.3 Staining of gels
6.3.1 Coontassie blue stain (Weber and Osborne, 1969)
Destaining solution was prepared by combining methanol (50 ml), glacial acetic 
acid (75 ml) and made up to a final volume of 1 L with water. Staining solution was 
prepared by combining Brilliant Blue R (125 mg; Sigma) with 500 ml of destaining
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solution. The staining solution was filtered before use. Gels were carefully removed from 
the plates and immersed in staining solution for 30 min. Gels were destained by several 
changes of destain solution then washed several times in distilled water for 30 min. The 
gels were then sealed in vacuum bags.
6.3.2 Silver staining (Oakley et a l, 1980)
Gels were carefully removed from the plates then pre-fixed for 30 min in 10% 
acetic acid, 30% methanol. Gluteraldehyde (10%) was used was used as a fixative for a 
further 30 min. After fixation, gels were rinsed overnight in a large volume of distilled 
water. Gels were then given a final rinse in distilled water for 30 min then placed in 
dithiothreitol (5mgml"^) for 30 min. This solution was poured off and 0.1% silver nitrate 
(freshly prepared) was added, without rinsing, for a further 30 min. Gels were rinsed 
twice in distilled water and then twice in developer containing 37% formaldehyde (50ml) 
in 100ml of 3% NazCOg, before being lefl; in a third volume of developer until the 
desired level of staining was reached. Development was stopped by the addition of 2.3M 
citric acid (5ml) and the gels were rinsed for 10 min in distilled water. The gels were then 
sealed in vacuum bags.
6.3.3 Western blotting
Western blotting was performed according to the method of Towbin and 
Gordan (1984) in a Bio-rad 'Transblot' transfer apparatus. The procedure was used for 
the visualisation of biotinylated proteins. The electroblotting transfer buffer was made up 
as follows. Tris (7.2g) and glycine (33.4g) were dissolved in 3 litres of 20% methanol in 
distilled water (pH8). Hybond C (Amersham) was cut to the size of the gel and two 
sheets of Whatman filter paper were cut to the size of the gel cassette. The gel, the 
Highbond C, the filter paper and two Scotch brite pads were soaked in transfer buffer for 
2 min. A Scotch brite pad was placed on one leaf of the gel cassette. One of the filter 
papers was placed on top followed by the gel. The Highbond C was carefully placed on 
the gel and air bubbles removed by gently rubbing the Highbond C with a clean glass rod.
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The second filter paper sheet was laid on top followed by the second Scotch brite pad. 
The cassette was closed and secured then inserted into the Bio-rad blot apparatus so that 
the Highbond C was on the anode side of the tank. The tank was filled with transfer 
buffer and the transfer was run at 0.13A (50V) for Ih, 0.08A (30V) for 18h then 0.13A 
(50V) for Ih. The Highbond C was removed from the cassette, placed in a shallow 
plastic container and immersed in blocking solution (3% (w/v) skimmed milk containing 
0.2% Tween 20 in PBS) to reduce the non-specific attachment of protein. This solution 
was poured off and replaced with 10ml of fresh blocking solution. 5|iCi of 
Streptavidin (Amersham) was added to the container which was then sealed and 
incubated with shaking for 2h. The Highbond C was removed from the box and washed 
in distilled water to remove unbound ^^^I-Streptavidin, allowed to air-dry, then exposed 
for 2-5 days to blue sensitive X-ray film (Genetic Research Instrumentation Ltd. 
Dunmow, Essex, UK) with intensifying screens.
7. THIN-LAYER-CHROMATOGRAM OVERLAY ASSAY
7.1 Preparation of Glycosphingolipids.
Neutral glycolipid TLC standards were purchased from Calbiochem. These 
glycolipids comprised galactosylceramide (CMH), lactosylceramide (CDH), 
trihexosylceramide (CTH), globoside (GL4), and Forssman antigen (FORS). Human 
buccal epithelial cells (BEG) were obtained by gently rubbing the inside cheek area of a 
healthy, male, blood group A donor with sterile cotton swabs. The cells were washed 
three times in PBS then stored frozen until required. A total lipid extract of BEG was 
obtained by an adaptation of the methods of Magnani et al (1980) and Esselman et al 
(1972). Cells collected over 10 days were thawed, washed in PBS, pooled and then 
weighed. The wet weight of cells ranged from 307-574 mg. The cells were resuspended 
methanol (7 ml) and homogenised with a pestle and mortar. Chloroform (14 ml) was 
added and the mixture homogenised again. The material was filtered with a Buchner 
funnel using an aspirator and a coarse-grade solvent-washed filter paper. The residue
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was re-extracted with 10 ml of chloroform-methanol (2:1). The combined filtrates were 
evaporated to dryness and weighed. The yield of lipid extracted in this way ranged from 
4.0-9.3 mg. This material contained the total lipid extract from BEC. Sheep red blood 
cell (sRBC) glycolipids were a gift from Chris Brotherston (University of Glasgow) and 
were prepared by a similar procedure.
7.2 Chromatogram overlay assay.
The chromatogram overlay assay was performed by a modification of the 
methods of Jimenez-Lucho et al. (1990) and Magnani et al. (1980). Glycolipids were 
chromatographed on aluminium-backed silica gel thin-layer plates (E. Merck AG, 
Darmstadt, Germany) and developed with chloroform-methanol-water (65:25:4) unless 
otherwise stated. The plates were dipped in a solution of polyisobutylmethacrylate 
(0.1%) in hexane, air dried, soaked for Ih in Tris-BSA buffer (0.05M Tris-hydrochloride 
[pH7.8] containing 0.15M sodium chloride and 1% BSA), and overlaid for 2h at room 
temperature with labelled ligand. Among the labelled ligands used were ^^^I-EP, 
yeast cells, biotin labelled yeasts, biotin-EP, biotin-adhesin or biotin-labelled lectins. The 
concentration of each ligand and details of the blocking procedures employed are given 
in the text and figure legends for the individual experiments. The plates were gently 
washed in distilled water to remove unbound material, soaked for Ih in Tris-BSA then 
overlaid with 5jiCi ^^^I-streptavidin (Amersham) when a biotinylated ligand was to be 
detected. When a radioiodinated ligand was used, the plates were just dried and 
autoradiographed. The ^^^I-streptavidin plates were then washed, dried, and exposed for 
2-5 days to blue sensitive X-ray film (Genetic Research Instrumentation Ltd. Dunmow, 
Essex, UK) with intensifying screens.
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7.3 Lectins
The following lectins were used in this study :
Lectin *Suear Specificitv Source
Bauhinia purpurea Gal(pl-3)GalNAc, GalNAc and Gal Camel’s foot tree
Griffonia simplicifolia II GlcNAc Bandeiraea
Helix pomatia GalNAc Edible snail
Triticum vulgaris GlcNAc Wheat germ
Ulex europaeus I Fuc Gorse
Vicia villosa GalNAc Hairy vetch
*Fuc =L-Fucose 
Gal = D-Galactose
GalNAc = N-acetyl-D-galactosamine 
Glc = D-Glucose
GlcNAc = N-acetyl-D“glucosamine
All lectins were purchased from Sigma, Poole, UK, with the exception of 
biotinylated Griffonia simplicifolia lectin II was purchased from Vector Laboratories, 
Peterborough, UK.
8. STATISTICAL ANALYSIS
Student's t test was used to detect significant differences between adherence 
values and the results are presented as p-values. Standard errors of the mean are quoted 
for all adherence assay results.
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RESULTS
83
1. ADHESION OF CANDIDA ALBICANS TO EPITHELIAL CELLS
1.1 Effect of EP on yeast adhesion in vitro
The adhesion of some strains of C. albicans to buccal epithelial cells 
(BEC) is substantially increased after growth in defined media containing certain sugars 
(notably galactose) as the carbon source. This increase in adhesive ability seems to be a 
result of the production of an additional fibrillar-ftoccular layer on the yeast cell surface 
(Douglas, 1987). These surface fibrils have been seen to mediate attachment of C. 
albicans to epithelial cells in vivo (Lee and King, 1983). Prolonged incubation of C. 
albicans in medium containing galactose causes release of surface fibrils, and 
extracellular polymeric material (EP) can be isolated from culture supernatants. This EP 
appears to contain the yeast adhesin as it can inhibit the in-vitro adhesion of C. 
albicans to epithelial cells. McCourtie and Douglas (1985) isolated EP by acetone 
precipitation, Critchley and Douglas (1987a) used prolonged dialysis and Tosh (1991) 
employed dialysis followed by ultrafiltration. Throughout this study, EP was produced 
by a method very similar to that of Tosh (1991). The molecular weight exclusion limit 
of the ultrafiltration membrane employed in this study was 3.5K in place of the 5K filter 
used by Tosh. The compositional results are shown in Table 1.1 alongside results 
obtained in previous studies (McCourtie and Douglas, 1985; Critchley and Douglas, 
1987a; Tosh, 1991). The protein content of EP from strain GDH 2346 prepared in this 
study was 8.3% and the carbohydrate content was 80.9%. These values are similar to 
those obtained by Tosh, 1991 (7.2% and 79.2% for protein and carbohydrate, 
respectively). However, the protein content of EP from a different strain (GDH 2023) 
prepared in this study was 5.5% and the carbohydrate content was 84.4% which differ 
slightly from the values obtained by Tosh (10.5% and 72.4% for protein and 
carbohydrate respectively). The different protein and carbohydrate compositions for EP 
produced in each study are most likely due to the different methods of preparation. In 
the following adhesion-inhibition experiments, yeasts were grown to stationary phase at
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Table 1.1 Composition of EP produced in this and previous studies
Strain Component Percentage composition of EP in study of:
BJC  ^ FDT^ lAC + LJD  ^ JMcC+UD"^
GDH 2346 protein 8.3 ±0.6 7.2 ±0.3 10.0 ±0 .7 6.9 ±0.2
carbohydrate 80.9 + 2.2 79.2 ±1.7 70.0 ±2.6 78.8 ±2.6
GDH 2023 protein 5.5 ±0.4 10.5 ±0.3 N.D. N.D.
carbohydrate 84.4 ±1.8 72.4 ±0.8 N.D. N.D.
 ^This study (mean ± SEM)
 ^Tosh, 1991 (mean ± SEM)
 ^Critchley and Douglas, 1987a (mean ± SEM) 
McCourtie and Douglas, 1985 (mean ± SD)
In each study, C. albicans was grown for 5 days in yeast nitrogen base medium 
containing galactose (500mM) as the carbon source. EP was isolated from culture 
supernatants in each study by a different method. McCourtie and Douglas (1985) 
used acetone precipitation, Critchley and Douglas (1987a) used prolonged dialysis 
and Tosh (1991) employed dialysis followed by ultrafiltration. Throughout this 
study, EP was produced by a method very similar to that of Tosh (1991). The 
molecular weight exclusion limit of the ultrafiltration membrane employed in this 
study was 3.5K in place of the 5K filter used by Tosh. In all studies, carbohydrate 
was estimated by the method of Dubois et al. (1956) using mannose as a standard 
and protein was determined using the method of Lowry et al. (1951) with bovine 
serum albumin as a standard. The results in this study represent the means of three 
independent assays performed in triplicate.
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37*^ C with shaking in yeast nitrogen base (Difco) containing 500mM galactose as a 
carbon source. C. albicans grows exclusively in the yeast phase under these conditions.
1.1.1 Effect of EP concentration on yeast adhesion
EP from two C. albicans strains (GDH 2346 and GDH 2023) was 
prepared and used to pretreat buccal epithelial cells (BEC) prior to adhesion assays 
with cells from the homologous strains. The concentrations of yeast cells used were 
5x10^ and 1x10  ^ cells ml  ^ for strains GDH 2346 and GDH 2023 respectively. BEC 
were collected on the day of the experiment and after washing in PBS, were adjusted to 
a concentration of 1x10  ^ cells ml \  Pre-incubation of BEC with increasing 
concentrations (2-20 mg ml )^ of EP from strain GDH 2346 inhibited yeasts from the 
homologous strain by nearly 60% (Fig. 1.1). This result is consistent with the findings of 
Critchley and Douglas (1987a). In a recent study by Brassart et al. (1991) similar 
results were obtained. They found that EP could inhibit the adhesion of C. albicans 
cells of the homologous strain by 50%. Pre-incubation of BEC with increasing 
concentrations (2-20 mg ml *) of EP from GDH 2023 inhibited yeasts from the 
homologous strain by just over 40% (Fig. 1.1), Jenq et al. (1994) isolated EP with 
adhesion-inhibition activity of 42%. This level of inhibition is similar to that for the EP 
from GDH 2023 prepared in this study. Relatively high values for yeast adhesion were 
seen in these adhesion assays. The average number of adherent yeasts on untreated 
BEC was 19.82 and 24.85 for strains GDH 2346 and 2023 respectively. The different 
shape of the curves for the two strains in Fig. 1.1 is most likely due to the different 
yeast : BEC ratio employed.
1.1.2 Effect of yeast cell concentration on adhesion inhibition by EP
The relatively high values obtained for yeast adhesion in the previous 
experiment prompted an investigation into the effect of yeast concentration on adhesion 
inhibition. EP from strain GDH 2346 was used to pretreat BEC prior to incubation 
with cells from the homologous strain at two different concentrations (1x10^ and 5x10^
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Fig. 1.1 Effect of EP concentration on the adhesion of C albicans to BEC.
EP was isolated from culture supernatants of C. albicans strains GDH 2346 
and GDH 2023 as described in Materials and Methods. Buccal cells were pretreated 
with EP solutions (2-20mg ml-^  in PBS) at 37®C for 30 min, and were then used in 
adhesion assays with the homologous strain of yeast. The concentrations of yeast 
cells used were 5x10^ and 1x10* cells mh^  for strains GDH 2346 and GDH 2023 
respectively. The concentration of BEC was 1 xlO .^ Results shown represent the 
mean values of three assays performed in triplicate.
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yeasts ml \  The results are shown in Table 1.2. There was no significant difference 
between the adhesion-inhibition values for the two concentrations of yeasts. Yeasts at a 
concentration of 1x10  ^ cells ml  ^ were inhibited by 49.1% while yeasts at 5x10^ cells 
ml  ^ were inhibited by 48.5%, when compared to PBS treated controls. Interestingly, 
with a five-fold increase in the number of yeasts there was only a 65% increase in the
7number of adherent yeasts per 100 BEC. A yeast cell concentration of 1x10 was 
adopted for all subsequent adhesion-inhibition assays.
1.1.3 Distribution of bound yeasts among BEC
The number of yeasts attached to individual BEC can vary greatly. A large 
number of BEC appear to have no yeasts attached while some have their entire surface 
covered in yeasts. This suggests that different BEC express different numbers of yeast 
receptors. Previous work by Sandin et al. (1987) examined this phenomenon. They 
performed adhesion assays with Candida and BEC in the ratio 10:1 and found that 
41% of BEC had no yeasts attached. They also found that only 12% of BEC had 9 or 
more attached yeasts but that 52% of the total yeasts were attached to this 12%. In this 
study, a similar experiment was performed but with higher yeast : BEC ratios (Table 
1.3). When the yeast : BEC ratio was 50:1, 33.7% of BEC had no yeasts attached and 
only 13.9% of BEC had 9 or more attached yeasts. Around 46% of the total yeasts 
were attached to this 13.9%. When the yeast : BEC ratio was increased to 250:1, only 
21.1% of BEC had no yeasts attached but 32.9% of BEC had 9 or more attached 
yeasts.
1.1.4 Effect of papain degradation on EP
A number of proteases have been examined for their effects on EP. All 
proteases tested destroyed the adhesion-inhibition activity of EP except for papain 
which was shown to enhance this activity (Critchley and Douglas, 1987a). This effect 
was attributed to the possible production of peptide fragments that could more easily 
bind to BEC receptors and hence block adhesion. Papain is a cysteine protease i.e. it
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Table 1.2 Effect of yeast cell concentration on adhesion inhibition by EP.
BEC
treatment
Yeast
conc.
(cells ml' )^
Yeast:
BEC
ratio
No. of adherent 
yeasts per 100 
BEC (±SEM)
Adhesion 
inhibition (%)
EP 1x107 100:1 1016.7 ± 1 0 4 49.1
PBS 1x107 100:1 1996.0 ± 1 3 9
EP 5x107 500:1 1701.0±117 48.5
PBS 5x107 500:1 3300.0 ±  178
EP from strain GDH 2346 was used to pretreat BEC (at 37^C for 30 min) prior to 
incubation with cells from the homologous strain at two different concentrations (1x10 '^  and 
5x1 G'7 yeasts ml"i)and the concentration of BEC was 1x10  ^ cells ml" .^ Results shown 
represent the mean values of three assays performed in triplicate.
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Table 1.4 Effect of papain on the ability of EP from C albicans GDH 2346 
to inhibit adherence of the homologous yeast strain to buccal 
epithelial cells
Pretreatment of BEC Mean adherence^ % inhibition p2
Control (no EP)^ 540.9 ±34.8 - -
Papain-treated EP"* 
(non- reducing) 223.1 ±19.5 58.8% <0.001
Papain-treated EP^ 
(reducing) 546.1 ±34.6 0 .0% NS
1 Mean number of adherent yeasts per 100 epithelial cells ± standard error (SEM).
2 Probability values relative to adhesion of PBS control; NS, not significant.
 ^ BEC were incubated in PBS at 37^C for 30 min prior to being used in adhesion 
assays. The results represent the means of three independent assays performed in 
triplicate.
4 EP (20 mg) was dissolved in 1 ml of 0.01 M potassium phosphate buffer (pH
6.2). To the EP solution was added 0.016 ml of papain (0.1 mg ml  ^ in 0.01 M 
potassium phosphate buffer (pH 6.2) and the mixture was incubated at 25®C for 30 
min. The reaction was stopped by the addition of 0.05 ml of (X2-macroglobulin (2 
mg ml-^ ). BEC (1x10  ^cells) were then incubated at 37°C for 30 min in the solution 
of EP. The BEC were then washed and used in adhesion assays.
5 EP (20 mg) was dissolved in 1 ml of 0.01 M potassium phosphate buffer (pH
6.2) containing 5 mM cysteine and 2 mM EDTA. The EP solution was then treated 
exactly as in  ^above.
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has an essential cysteine residue at its active site that must be maintained in the reduced 
form for activity (Butler, 1989). However, papain was previously used to digest EP 
under non-reducing conditions (Critchley and Douglas, 1987a; Tosh and Douglas, 
1992). In this study, EP was treated with papain under both reducing and non-reducing 
conditions. EP treated with the enzyme under non-reducing conditions retained its 
ability to inhibit adhesion (58.75%) whereas EP treated with papain under reducing 
conditions was found to have lost this activity (Table 1.4). There was no significant 
difference between the adhesion values obtained for BEC pretreated with this papain- 
digested EP and untreated BEC. These results suggest that when EP is treated with 
papain under reducing conditions, its adhesion-inhibition activity is destroyed due to 
extensive damage to the protein part of the molecule.
2. HPLC ANALYSIS OF EP
Previous work by Douglas and co-workers has shown that the ability of EP 
to inhibit adhesion can be enhanced or reduced by the action of various enzymes and 
chemicals. In this study reversed-phase high performance liquid chromatography (RP- 
HPLC) was used to analyse EP and to monitor the effects of the various treatments on 
EP, RP-HPLC is commonly used to resolve and prepare products of proteolysis for 
further analysis. The columns used for this system contain a hydrophobic stationary 
phase such as octyl silica (C8) or octadecyl silica (Cl8). Proteins and peptides are 
applied under acidic conditions, usually in the presence of an ion-pairing agent such as 
trifluoroacetic acid (TFA) which also acts to maintain protein solubility throughout the 
HPLC run. The majority of peptides adsorb to the stationary phase under these 
conditions and are subsequently eluted by decreasing the polarity of the mobile phase. 
This is achieved by the slow introduction of a water-miscible organic solvent. The most 
commonly used solvent system for RP-HPLC is a gradient of acetonitrile in a weak 
aqueous solution of TFA. Eluted proteins and peptides are detected by U.V.
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absorbance. At a wavelength of 280nm, only proteins and peptides that contain 
aromatic residues will be detected. However, at wavelengths of between 200-230nm, 
the peptide bond absorbs light and this range is usually very sensitive.
The solvent gradient used was 0-100% acetonitrile and TFA was at a constant 
0.1% throughout all HPLC runs. The percentage values stated for HPLC runs (% 
acetonitrile) refer to the total solvent mixture derived from pump B i.e. the percentage 
of acetonitrile in the column at a particular time.
2.1 Blank HPLC run
A typical blank HPLC run is shown in Fig. 2.1 A. After a stable baseline 
reading was obtained the acetonitrile gradient was started. From 0-30% acetonitrile the 
baseline remained steady. At 30% acetonitrile a small peak was observed. There 
followed a slight rise in absorbance until 65% acetonitrile was reached. The absorbance 
then fell gradually with increasing acetonitrile and absorbance was stiU falling after 
100% acetonitrile was reached before returning to the original baseline level.
2.2 HPLC profile of EP from strain (GDH 2346).
A typical HPLC run of EP from strain GDH 2346 is shown in Fig. 2.1 B. 
As in the blank run, the baseline was stable until 30% acetonitrile when there was a 
peak (peak I). This peak was larger than the peak observed at the same point on the 
blank run. A second larger peak (peak II) was observed between 33-35% acetonitrile. 
The largest peak (peak III) was eluted at between 39-42% acetonitrile. A number of 
smaller and less distinct peaks were observed until at 59% acetonitrile a fine sharp peak 
(peak IV) was seen. Further peaks appeared at 68%, 75%, 98% and 100% acetonitrile. 
The remainder of the run gave a similar profile to the blank run. These results indicated 
that there are a large number of distinct proteins present in EP from strain GDH 2346, 
with varying degrees of hydrophobicity. Of particular interest was the fine sharp peak 
seen at 59% acetonitrile. This component was relatively hydrophobic and appeared to 
make up a considerable proportion of the total composition of EP.
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Fig. 2.1 A Blank HPLC run.
High Performance Liquid Chromatography (HPLC) was performed using an LKB 
Bromma HPLC machine with a TosoHaas CIS TSK-Gel reversed phase column. 
The HPLC pumps were flushed with HPLC grade water then HPLC grade 
acetonitrile (both degassed) at 5 ml mim^ . The column was attached and flushed with 
HPLC grade water then HPLC grade acetonitrile at 0.5ml min k Absorbance was 
read at 208nm and was recorded on a chart feeder. The absorbance was monitored 
while the column was primed with 0 .1% TFA-HPLC grade water, and once a stable 
baseline was achieved, a blank run was started. This consisted of loading a 200pl 
sample of HPLC grade water-TFA, to check for injection effects, and also to 
monitor the effect of the acetonitrile gradient on absorbance. After a stable baseline 
reading was obtained the acetonitrile gradient was started. The gradient used was 0- 
100% acetonitrile and TFA was at a constant 0.1% throughout all HPLC runs. The 
percentage values stated for HPLC runs (% acetonotrile) refer to the total solvent 
mixture derived from pump B, i.e. the percentage of acetonitrile in the column at a 
particular time.
Fig. 2.1 B EP (GDH 2346) HPLC profile.
After a stable baseline was achieved EP from strain GDH 2346 (20mg) was 
dissolved in 0.1% TFA (400pl) in HPLC grade water. The entire solution was then 
filtered through a 0.2 pm filter and 200 pi was loaded on to the column.
Fig. 2.1 C Insulin HPLC profile
Insulin was used as a regular check on protein detection sensitivity and column 
efficiency. Insulin was dissolved in 0.1% TFA at a final concentration of 0.1 mg ml k 
After a stable baseline was achieved, 200 pi of insulin solution was loaded on to the 
column.
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2.3 HPLC profile of Insulin
The manufacturers of the column recommended the use of insulin as a 
regular check on protein detection sensitivity and column efficiency. Insulin normally 
eluted in the region of 60% acetonitrile (Fig. 2.1 C) with the rest of the trace 
resembling the blank HPLC run.
2.4 HPLC profile of EP treated with N-glycanase
The enzyme N-glycanase cleaves the N-glycosidic linkage between N- 
acetyl-D-glucosamine and asparagine on the protein backbone of glycoproteins 
(Tarentino et a l, 1985). This reaction does not affect the protein part of the molecule. 
Previous work by Tosh and Douglas (1992) had shown that N-glycanase treatment of 
EP enhanced the adhesion inhibition activity of EP. The HPLC trace of N-glycanase 
treated EP (Fig. 2.2 A) was not greatly different from the trace of EP incubated under 
the same conditions but in the absence of N-glycanase (Fig. 2.2 B). Peak I (30% 
acetonitrile, Fig.2.2B) appeared split in two and there was a new peak at 32% 
acetonitrile. Peak II (33-35% acetonitrile) was also seen to be split with a small peak at 
34% acetonitrile and a larger peak at 36% acetonitrile. A new small fine peak was 
observed at 38% acetonitrile. Peak III (39-42% acetonitrile) and Peak IV (59% 
acetonitrile) appeared unchanged. A control HPLC run with N-glycanase alone 
produced a trace that was not visibly different from that of the blank run (Fig. 2.2 C).
2.5 HPLC profile of NaOH treated EP
Mild alkali was previously found to enhance the ability of EP to inhibit 
adhesion of C albicans to BEC (Critchley and Douglas, 1987a). The optimum 
conditions for this effect were determined by Tosh (1991). He found that O.IM NaOH 
produced the maximal inhibitory effect. Base-labile oligosaccharides linked to the 
protein through serine or threonine residues are removed by the action of NaOH 
(Ballou, 1976). NaOH treatment had a profound effect on the HPLC trace of EP when
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Fig. 2.2 HPLC analysis of EF treated with N-glycanase
A. EP (lOmg) was dissolved in 400pl of 0.55M Na2HP0^ (pH8.6). 
N-glycanase was added (2.4 units, 9.6|il) and the mixture was incubated 
for 24h at 370c.
B. EP (lOmg) was dissolved in 400pl of 0.55M Na2HP0 4  (pH8.6) and 
incubated for 24h at 37<^ C.
C N-glycanase (2.4 units, 9.6pl) was added to 400pl of Na2HP0 4
(pH8.6, 0.55M) and the mixture was incubated for 24h at 37®C.
Each reaction mixture was filtered through a 0.2pm filter and loaded on to the 
column prepared as described in the legend to Fig. 2.1 A.
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compared with a trace of EP incubated under the same conditions but with PBS in 
place of NaOH (Fig 2.3, A and B). Peak I (30% acetonitrile) appeared unchanged but 
Peaks II and III (33-35% and 39-42% acetonitrile) were largely gone, replaced with 
five small peaks at 33, 35, 37, 39, and 41% acetonitrile. After this point there was a 
large broad peak ranging from 47-70% acetonitrile with its summit at 60% acetonitrile. 
One farther peak was seen at 100% acetonitrile. These results indicate that a number of 
changes have occurred to the mannoproteins present in EP after treatment with NaOH. 
In general, there seems to be a shift fi'om a relative abundance of hydrophilic proteins 
to more hydrophobic proteins. This change in the proportion of hydrophilic 
components could be consistent with the removal of polysaccharide chains fi'om the
protein backbones of the glycoproteins. This could result in the exposure of
hydrophobic regions of the protein that were previously unavailable for interaction with 
the hydrophobic column packing. There could also be some protein degradation due to 
the action of NaOH. The effect of NaOH treatment on the component normally eluted 
at 59% acetonitrile could not be determined as the broad peak between 47-70% 
acetonitrile obscures this part of the trace.
2,6 HPLC profile of EP treated with papain
Previous work by Critchley and Douglas (1987a) showed that a number of
proteases significantly decreased the ability of EP to inhibit adhesion. However, the
protease papain enhanced this ability. This increased inhibition was attributed to the
production of peptide fragments which bound more easily to epithelial cell receptors.
The HPLC trace of papain-treated EP (Fig. 2.4 A) was considerably different from the
trace of EP incubated under the same conditions but in the absence of papain (Fig. 2.4
B). The EP mannoproteins appeared greatly fragmented with a large number (19) of
sharp peaks ranging from 30%-67% acetonitrile which supports the theory of peptide
.production. Most of the fragments produced were of relatively high hydrophobicity 
compared to the trace of EP not exposed to papain. Of particular note was the fine 
sharp peak seen at 67% acetonitrile. A control HPLC run with papain and ai- tI
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Fig. 2.3 HPLC analysis of NaOH-treated EP
A. EP (lOmg) was dissolved in 400pl of NaOH (0. IM) and the mixture was 
incubated for 24h at 30^0,
B. EP (lOmg) was dissolved in 400|il of PBS and the mixture was incubated 
for 24h at SO^C.
Each reaction mixture was filtered through a 0.2p,m filter and loaded on to the 
column prepared as described in the legend to Fig. 2,1 A.
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Fig. 2.4 HPLC analysis of papain-treated EP
A. EP (lOmg) was dissolved in 400pl potassium phosphate buffer
(0.0IM, pH6.2) containing papain (40(ig). The mixture was incubated for 
30 min at 25°C. After incubation, ot2-macroglobulin (2 mg ml“i; 0 .2ml) was 
added to terminate the reaction.
B. EP (lOmg) was dissolved in 400pl potassium phosphate buffer 
(0.0IM, pH6.2) and incubated for 30 min at 25%.
C Papain (40|ig) was incubated for 30 min at 25% in 400|il potassium
phosphate buffer (O.OIM, pH6.2). After incubation, OCz-macroglobulin 
(2 mg ml'\ 0 .2ml) was added.
Each reaction mixture was filtered through a 0.2|im filter and loaded on to the 
column prepared as described in the legend to Fig. 2.1 A.
I
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this complex due to the presence of large amounts of EP digestion products.
2.7 HPLC profile of EP treated with N-glycanase, papain, and mild alkali
A number of differences were seen between this HPLC trace (Fig. 2.5 A) 
and that of EP incubated under the same conditions but in the absence of N-glycanase, 
papain, and NaOH (Fig. 2.5 B). Peaks I and II (30% and 33-35% acetonitrile) were
I
l 'macroglobulin produced a trace that had a small peak in the region of 46-48% 
acetonitrile with the remainder of the run not visibly different from that of a blank run
(Fig. 2.4 C). The peak is likely to consist of a papain-a2-macroglobulin complex. The 
corresponding region on the EP, papain and aj-macroglobulin trace shows no sign of
::
replaced by a double peak at 32-34% acetonitrile followed by a trough between 35- 
37% acetonitrile. There then followed a sharp rise in O.D. until 43% acetonitrile. A 
large broad peak was seen at 46%. After 50%, there were a number of small less 
distinct peaks, until at 64%, a small fine peak was observed. Tosh and Douglas (1992) 
showed that the combined treatment of EP with N-glycanase, papain and mild alkali 
produced an EP digest that was able to inhibit adherence by a far greater extent than 
untreated EP. A control HPLC run with N-glycanase, papain, ai-macroglobulin and 
NaOH produced a trace that was slightly different from that of a blank run (Fig. 2.5 C). 
A small peak was seen at around 48% acetonitrile and some smaller, less defined peaks 
were eluted soon after. These peaks indicate that NaOH had an effect on the possible 
papain and a^-macroglobulin complex that had been seen in a previous experiment 
(Fig. 2.4 C). The corresponding region on the EP, N-glycanase, papain, ai- 
macroglobulin, NaOH trace shows no sign of this complex due to the presence of large 
amounts of EP digestion products.
3. THE CANDIDA ALBICANS ADHESIN
Partial purification of a C albicans adhesin from EP was described by Critchley 
and Douglas (1987a). EP, composed mainly of mannoprotein, is thought to originate
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Fig, 2.5 EP treated with N-glycanase, papain, and mild alkali
Na2HP0 4  (pH 8 .6). and the mixture was incubated for 24h at 37®C. 
Sodium citrate buffer (0. IM, 0.04ml, pH 4.4) was then added. Potassium 
phosphate buffer (O.OIM, pH6.2) containing papain (0.232 mg ml-^ ) was 
added (0.864 ml) and the solution was incubated for 30 min at 25^C, The
A. EP (lOOmg) was dissolved in 1ml of 0.55M Na2HP0 4  (pH 8 .6).
N-glycanase (250 Units ml**; 0.096ml) was added and the mixture was 
incubated for 24h at 37^C. Sodium citrate buffer (O.IM, 0.04ml, pH 4.4) 
was added to terminate the reaction. Potassium phosphate buffer 
(O.OIM, pH6.2) containing papain (0.232 mg ml *) was added (0.864 ml)
and the solution was incubated for 30 min at 25°C. (%2-macroglobulin 
(2 mg ml’*, 0.5ml) was added to terminate the reaction. NaOH (1ml) was 
added and the mixture was incubated for 24h at 30^C. The reaction 
mixture was neutralised by the addition of 1 ml of HCl (0.366M).
;
B. EP (lOOmg) was dissolved in 1ml of 0.55M Na2HP04  (pH 8 .6). PBS 
(0.096ml) was added and the mixture was incubated for 24h at 37®C.
Sodium citrate buffer (0. IM, 0.04ml, pH 4.4) was then added followed by 
0.864 ml potassium phosphate buffer (O.OIM, pH6.2). The solution was 
incubated for 30 min at 25^C and then PBS (0.5ml) was then added. An 
additional 1ml of PBS was added and the mixture was incubated for 24h at 
30^C. A final 1 ml of PBS was then added.
a
C. N-glycanase (250 Units ml**; 0.096ml) was added to 1ml of 0.55M
activity of papain was terminated by the addition of CC2-macroglobulin 
(2 mg ml *, 0.5ml). NaOH (0.366M, 1ml) was added and the mixture was 
incubated for 24h at 30^C. 1 ml of HCl (0.366M) was added to neutralise 
the NaOH.
Each reaction mixture was filtered through a 0.2pm filter and loaded on to the 
column prepared as described in the legend to Fig. 2.1 A.
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from the cell surface when yeasts are grown in medium containing a high concentration 
of galactose. The protein portion of the mannoprotein was more important than the 
carbohydrate moiety in mediating yeast attachment to buccal epithelial cells (EEC).
When lectins and sugars were included in adhesion-inhibition assays, most strains tested 
were primarily inhibited by L-fucose and the L-fucose-specific lectin from Lotus 
tetragonolohus (Critchley and Douglas, 1987b). One other strain tested was inhibited 
by N-acetylglucosamine and wheatgerm agglutinin (N-acetylglucosamine specific).
These results suggested that the protein portion of yeast cell-surface mannoproteins 
may bind in a lectin-like manner to glycosides containing L-fucose or N- 
acetylglucosamine expressed on epithelial cell-surface glycoconjugates. L-Fucose is 
found on epithelial cell surfaces in the form of blood group antigens on glycoproteins or 
glycolipids.
A complete purification scheme for the yeast adhesin was recently devised (Tosh 
and Douglas, 1992) which made use of the findings from the earlier studies on adhesion 
mechanisms. The purification protocol involves the stepwise treatment of EP with N- 
glycanase, papain, and dilute alkali followed by Synsorb H-2 affinity adsorption (Fig.
3.1). The affinity adsorbent expresses the trisaccharide determinant of the H (type 2) 
blood group antigen which terminates in an L-fucose residue. Similar affinity 
adsorbents have been used in the purification of lectins (Hosomi et aL, 1993) and anti­
blood group antibodies (Rydberg et al., 1992). Synsorbs have also been used to purify 
L-fucose-binding adhesins from Aeromonas hydrophila (Quinn et a l, 1993, 1994a) and 
Staphylococcus aureus (Saadi et a l, 1994 ). Tosh and Douglas (1992) incorporated H- 
2 affinity adsorbent as a final purification step to isolate those components from EP 
digests that have an affinity for H-2 blood group substance. The resultant protein 
fraction was able to inhibit the adhesion of yeasts from the homologous strain by up to 
80%. The material was devoid of carbohydrate but could not be visualised on 
conventional SDS-PAGE (Tosh, 1991). It was finally visualised by reverse-phase FPLC 
as a single sharp peak (Tosh and Douglas, 1992).
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Crude mannoprotein adhesin
Treat with N-glycanase to cleave N-linked 
carbohydrate chains
Incubate with papain
Treat with dilute alkali to remove 
0 -linked carbohydrate chains
Affinity adsorption on Synsorb H-2 
to recover fucoside-binding protein
Fig, 3.1 Complete protocol for the purification of yeast adhesin
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3.1 Purification of the yeast adhesin
EP was produced by a method very similar to that of Tosh (1991). The
.molecular weight exclusion limit of the ultrafiltration membrane employed in this study
was 3.5K in place of the 5K filter used by Tosh. The combined treatment of EP with N-
■glycanase, papain, and NaOH followed by the Synsorb H-2 affinity chromatography 
step is the basis of the purification protocol for the yeast adhesin developed by Tosh
and Douglas (1992) and was used throughout this study, EP digest was applied to
■
PBS-washed Synsorb H-2 (0.5g). The digest and the Synsorb were gently rotated for 
3h at 4^C. Unbound material was eluted with 5ml aliquots of PBS until the A^go 
returned to 0.0. Bound material was then eluted by the addition of 2 ml aliquots of 
1.5% NH4OH in sterile saline for 15 min at 4^C until the A280 returned to 0.0. A 
typical elution profile is shown in Fig. 3.2.1. Bound samples were fireeze-dried and 
desalted on a Sephadex G-25 (5ml) desalting column. A typical desalting profile is 
shown in Fig. 3.2.2. The adsorbent was then regenerated with PBS and stored at 4°C 
in PBS containing 0.02% NaNa as a bacteriostat. S
i jr3.2 Adhesion-inhibition activity of the purified adhesin
To ensure that the purified adhesin prepared in this study was of the same 
activity as that obtained previously, BEC were treated with the new material prior to 
adhesion assays with C. albicans GDH 2346. This material inhibited adhesion by up to 
74.8% (Table 3.1.1) and the adhesion inhibition index value (All), which is a measure 
of the ability of EP or its derivatives to block adhesion, was calculated to be 178. These 
results are comparable with those obtained by Tosh and Douglas (1992).
j
3.3 Biochemical analysis of the purified adhesin
Protein and carbohydra.te analyses were performed on the purified adhesin 
(Table 3.1.2). A value for the protein content was obtained using the procedure of 
Lowry et al. (1951). However, the adhesin was found to be devoid of carbohydrate
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Fig. 3.2,1 EP components eluted from Synsorb H-2 affinity adsorbent
Synsorb H-2 (0.5g) was washed twice in PBS (5ml) and allowed to 
settle. The buffer was removed to just above the surface of the synsorb bed. 
EP digest was applied. The mixture was gently rotated for 3h at 4°C. 
Unbound material was eluted with 5ml aliquots of PBS until the A28O 
returned to 0.0. Bound material was then eluted by the addition of 2 ml 
aliquots of 1.5% HH4OH in sterile saline for 15 min at 4^C until the A28O 
returned to 0 .0 .
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Fig. 3.2.2 Material eluted from Sephadex G-25 desalting column
Fractions containing Synsorb H-2 bound material were pooled, freeze- 
dried and then desalted on a Sephadex G-25 (5ml) desalting column. The 
fractions containing purified adhesin were pooled and freeze-dried.
I l l
Table 3.1.1 Effect of EP and purified adhesin on the adhesion of C 
albicans GDH 2346 to buccal epithelial cells
^BEC treatment ^Mean adherence % inhibition 3P 4AH
adhesin
treated 254.11 ±16.4 74.81 <0.001 178
EP treated 536.62 ±22.98 46.74 <0.001 1
not treated 
(PBS) 1008.67 ± 18.23 - ”
 ^Buccal epithelial cells were incubated at 37®C for 30 min in a 
solution of purified adhesin (6,38 pg ml'^X EP (10 mg ml-i) 
or PBS.
2 The results represent the mean number of adherent yeasts per 
100 epithelial cells + the standard error (SEM) for three 
independent assays performed in triplicate.
 ^Probability values relative to adhesion of PBS control.
 ^Adherence inhibition index (AH) calculated relative to untreated EP.
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Table 3.1.2 Biochemical composition of EP and purified 
adhesin from strain GDH 2346
Component Content of AIE Proteinxarbohydrate
protein 
(pg ml'O
carbohydrate 
(pg ml'^)
ratio
EP 830 8090 1 1:9.75
purified
adhesin
6.4 N.D. 178 1:0
 ^ Adherence inhibition index (AH) calculated relative to untreated EP. 
N.D. - Not detected
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when the procedure of Dubois et al. (1956) was employed. This is consistent with the 
findings of Tosh and Douglas (1992).
I
3.4 HPLC analysis of the purified adhesin
Tosh and Douglas (1992) obtained a single peak for the adhesin on fast 
high pressure liquid chromatography (FPLC). This indicated that the adhesin was a 
single component. Attempts to repeat this result on HPLC proved unsuccessful. The 
traces obtained for purified adhesin were not remarkably different from the HPLC blank 
runs shown in section 2.1, even when as much as 50 pg of protein was loaded.
Vt:.
3.5 Amino acid analysis of the purified adhesin
Amino acid analysis was performed on the purified adhesin by Dr. M.
Cusack in the Dept, of Geology and Applied Geology, University of Glasgow. A
sample of purified material was prepared by the normal procedure. A total of 18 pg of 
material was used for amino acid analysis. The results obtained are shown on Fig. 3.3.
A blank sample that had undergone the entire purification protocol was used to adjust
.the background on the sample run. The purified adhesin was mainly composed of the 
amino acids Thr, Pro, Ala, Ser, Val, Gly, Asx and Glx, which made up around 80% of 
the total amino acids. There was no Cys detected and very little Met, Phe and Arg. This 
composition is remarkably similar to a large number of microbial adhesins (Table 3.2).
■u
3.6 Analysis of purified adhesin by SDS-PAGE
Two SDS-PAGE systems were employed in this study; the 
procedures of Laemmli (1970) and of Schagger and Von Jagow (1987). Initial attempts 
to visualise the purified adhesin employed the Laemmli procedure, using both 
Coomassie blue staining (Weber and Osborne, 1969) and silver staining (Oakley et a/., 
1980) to visualise separated proteins after electrophoresis. As was found previously by 
Tosh (1991), purified adhesin could not be visualised in this way. The second SDS- 
PAGE system, devised by Schagger and Von Jagow (1987), was then employed in an
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attempt to visualise purified adhesin. This system is able to resolve proteins and 
peptides in the range 2.5 IcDa-17.0 kDa due to the incorporation of tricine in place of 
glycine in the running buffer. Coomassie blue staining and silver staining were again 
both employed but the purified adhesin could not be visualised.
procedure of Schagger and Von Jagow (1987). This gel system is able to resolve 
proteins and peptides in the range 2.5 kDa-17.0 kDa. The samples comprised:
I
3.5,1 Chemical and enzymic degradation of I-EP monitored by SDS- 
PAGE
125In this series of experiments, EP was labelled with I and then subjected
to the purification protocol for the yeast adhesin. Samples were removed after each 
step of the procedure to monitor the effects of the various chemicals and enzymes on
EP. Five samples were taken in total and were run together on SDS-PAGE using the
I
"••ft»:
1. Untreated EP
2. N-glycanase-treated EP
3. N-glycanase-, and papain- treated EP
4. N-glycanase-, papain-, and NaOH- treated EP
5. N-glycanase-, papain-, and NaOH- treated EP (bound to Synsorb H-2)
The lanes with molecular weight standards were cut off and stained with 
Coomassie blue. The remainder of the gel was sealed in a plastic bag and exposed to X- 
ray film. The autoradiogram is shown in Fig. 3.4. Small proteins and peptides within the 
range 2.5 kDa-17.0 kDa should appear as distinct bands but proteins of higher
molecular weight are likely to be bunched at the top of the separating gel. Untreated EP
'(Lane 1) appeared as three distinct bands. Two strong bands were seen at the very top 
of the gel, one a short way into the separating gel, the other at the junction of the 
separating gel and the stacking gel. The third band, which was less intense than the
US
kDa
17.0 —  
14.4 —  
10.6 —  
8.2 —
6.2 —
3.5 -
2.5 -
Fig. 3.4 SDS-PAGE of ^ ^^ I-EP from GDH 2346 before and after chemical 
and enzymic degradation
EP (produced as described in Materials and Methods, lOOmg) was iodinated 
and then subjected to the purification protocol for the yeast adhesin as described in 
Materials and Methods. Samples were removed after each step of the protocol to 
monitor the effects of the various chemicals and enzymes on EP. Five samples were 
taken in total and were run together on SDS-PAGE using the procedure of Schagger 
and Von Jagow (1987) as described in Sigma Technical Bulletin No. MWM-100. The 
first sample was lOOpl of iodinated EP, concentrated by freeze-drying, and 
resuspended in sample buffer. The volume of each subsequent sample was increased 
in an attempt to equalise the weight of labelled material. The entire Synsorb bound 
fraction was concentrated by freeze-drying and loaded on the gel. Bands were 
visualised by autoradiography
Lane designations
1. Untreated EP
2. N-glycanase-treated EP
3. N-glycanase- and papain-treated EP
4. N-glycanase-, papain-, and NaOH-treated EP
5. N-glycanase-, papain-, and NaOH-treated EP (bound to Synsorb H-2)
119
(Lane 3) showed only one clear band a short way into the separating gel There was
123also a difihise streak of I-labelled material visible in the region of the 2.5 kDa marker.
one band a short way into the separating gel There was also a diffuse streak of I-
125labelled material the entire length of the gel No I-labelled material was visible in the 
lane containing N-glycanase-, papain-, and NaOH-treated EP (bound to Synsorb H-2)
120
f
f
other two, was seen in the region of the 3.5 kDa marker. The N-glycanase-treated EP 
(Lane 2) appeared as only two distinct bands. The band that had been seen in Lane 1, at 
the junction of the separating gel and the stacking gel, was absent but the remainder of
■r:Lane 2 was similar to Lane 1. The lane containing N-glycanase- and papain-treated EP
The lane containing N-glycanase-, papain-, and NaOH-treated EP (Lane 4) had only
i
':S,
125(LaneS). This could have been a result of insufficient I-labelled material at this point 
in the degradation. Another possibility is that the iodination may have damaged the 
adhesin molecules and prevented their binding to the Synsorb matrix. II
3.6.2 Analysis of biotinylated EP by SDS-PAGE and western blotting
An alternative labelling approach was employed in this series of 
experiments. EP was biotinylated using a commercial kit from Amersham. Biotinylated 
EP and biotinylated molecular weight standards (SDS-6B, Sigma) were separated using 
the Laemmli procedure and a mini gel apparatus. After electrophoresis, the separated 
proteins were transferred to nitrocellulose and biotinylated material was detected by 
probing with *^^I-streptavidin followed by autoradiography (Fig. 3.5). Four bands were 
visible in the biotin-EP lanes. An intense band was visible in the region of the 97,4 kDa 
marker and a broad diffuse band was seen in the region of the 39.8 kDa marker. Two 
further bands were seen in the region between the 20.1 and 14.3 kDa markers but were 
relatively faint. Any other bands present were obscured by the streak of biotinylated 
material that ran the length of the gel.
Î
kDa
14.3 -
Fig. 3.5 SDS-PAGE and western blotting of biotinylated EP.
Biotinylation of EP (produced as described in Materials and Methods) was 
performed using a commercial kit from Amersham (following the manufacturers 
protocol). lOmg of EP was dissolved in 1ml of 0.05M sodium borate buffer, pH 8.6. 
40pl of biotinylation reagent was added and the tube was incubated for Ih at room 
temperature with constant agitation. The unreacted biotinylation reagent was removed 
by desalting on G-25 Sephadex and the EP was freeze-dried. The biotin-EP was 
resuspended in lOOpl of sample buffer and 25pl was loaded in each well. Biotinylated 
EP and biotinylated SDS molecular weight standards (SDS-6B, Sigma) were 
separated using the procedure of Laemmli (1970) and a mini gel apparatus. The 
stacking gel and the separating gel were 4.5% and 12.5% respectively. After 
electrophoresis, the separated proteins were transferred on to nitrocellulose (Hybond 
C, Amersham) according to the method of Towbin and Gordan (1984) in a Trans- 
Blot Electophoretic Transfer apparatus (Bio-Rad). Biotinylated material was detected 
by probing with ^^ I^-streptavidin (30 pCi/p,g; 5 pCi in 10ml reaction volume) 
followed by autoradiography. Lane 1, biotinylated SDS-6B , lanes 2 and 3, biotin-EP. 
Bands were visualised by autoradiography
121
3.6.3 Chemical and enzymic degradation of biotinylated EP monitored by 
SDS-PAGE
In this series of experiments, EP was biotinylated and then subjected to the
purification protocol for the yeast adhesin. Samples were removed after each step of
,the procedure to monitor the effects of the various chemicals and enzymes on EP and 
using a mini gel to monitor the degradation (Fig. 3.6),The number of samples taken 
during the degradation was reduced to three and they comprised:
1. N-glycanase- and papain-treated EP
2. N-glycanase-, papain-, and NaOH-treated EP
3. N-glycanase-, papain-, and NaOH-treated EP (bound to Synsorb H-2)
4. Biotinylated SDS-6B markers
The results obtained in this experiment were poor possibly due to insufficient 
biotinylation of the EP. This seems unlikely as the degree of biotinylation seemed 
adequate in the previous experiment (3.6.2). A more likely explanation is that the 
degradation treatments had an adverse effect on the protein-bound biotin. The biotin 
may have been cleaved from the proteins or the ability of the bound biotin to bind to
125I-streptavidin may have been affected.
3.6,4 Analysis of biotinylated purified adhesin by SDS-PAGE and western 
blotting
The previous experiment suggested the possibility that purified 
adhesin could be visualised by biotinylation prior to SDS-PAGE, western blotting and 
probing with I-streptavidin. Purified adhesin was biotinylated prior to loading on a 
tricine mini SDS-PAGE gel. Samples (biotinylated PA) and molecular weight markers 
(MW-SDS-17S, Sigma) were subjected to electrophoresis for 3-4 hours at a constant 
current of 100 V. The gel was cut and the markers were stained with Brilliant Blue G 
(Sigma). The biotinylated PA lanes were transferred onto nitrocellulose (Hybond C,
122
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Fig. 3.6 SDS-PAGE and western blotting of biotinylated £P after chemical and 
enzymic degradation.
EP (produced as described in Materials and Methods) was biotinylated using 
a commercial kit from Amersham as described in the legend to Fig. 3.5 and then 
subjected to the purification protocol for the yeast adhesin. Three samples were taken 
during the degradation. The first sample was 100|il of N-glycanase- and papain- 
treated EP, concentrated by freeze-drying, and resuspended in sample buffer. The 
volume of each subsequent sample was adjusted to account for the dilution at each 
step. The entire Synsort) bound fraction was concentrated by freeze-drying and loaded 
on the gel. Proteins were separated using the procedure of Laemmli (1970) and a mini 
gel apparatus. The stacking gel and the separating gel were 4.5% and 12.5% 
acrylamide respectively. Proteins were then transferred on to nitrocellulose (Hybond 
C, Amersham) according to the method of Towbin and Gordan (1984) in a Trans- 
Blot Electophoretic Transfer apparatus (Bio-Rad). Biotinylated protein was then 
visualised by probing with ^^ I^-streptavidin (30 |iCi/pg; 5 pCi; in 10ml reaction 
volume) followed by autoradiography.
Lane designations
1. N-glycanase and papain treated EP
2. N-glycanase, papain, and NaOH treated EP
3. N-glycanase, papain, and NaOH treated EP (bound to Synsorb H-2)
4. Biotinylated SDS-6B molecular weight markers
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Amersham) for Western blot analysis which was performed according to the method of
Towbin and Gordan (1984) in a Trans-Blot Electrophoretic Transfer apparatus (Bio-
125Rad). The protein was then visualised by probing with I-streptavidin followed by 
autoradiography. The purified adhesin was seen as a strong band with a molecular 
weight of approximately 15.7 kDa with two possible breakdown products also visible 
(Fig, 3.7). This approximate molecular weight and compositional analysis was used to 
produce an estimate of the number of amino acids in the PA molecule. The pmol value 
of each amino acid was multiplied by the molecular mass of each amino acid 
(subtracted by 18 to account for the loss of an H2O molecule at each peptide bond). 
These figures were summed and the total was divided by the total pmols detected in the 
amino acid analysis. This gave an average amino acid molecular mass for the adhesin 
molecule. When 15.7 kDa was divided by this average the number of amino acid 
residues in the PA molecule was approximately 152j This was the first time that 
purified adhesin had been seen by SDS-PAGE and allowed an estimate of molecular 
weight to be made. The successful visualisation of the purified adhesin meant that 
partial amino acid sequencing could be attempted.
3.7 Amino acid sequencing of the purified adhesin
Amino acid sequencing was performed by Sandra Miller in the Dept, of 
Geology and Applied Geology, University of Glasgow. Purified adhesin was run on a 
tricine polyacrylamide gel as described previously and then transferred onto ProBlott 
(Applied Biosystems). The ProBlott was cut to include the band of the adhesin seen in 
a blot of an identical gel of biotinylated adhesin from the same purified batch. The 
material on the ProBlott was then sequenced in an Applied Biosystems 477A Protein 
Sequencer. The amounts of each amino acid detected after each sequencing cycle is 
shown in Table 3.3. The sequence determined initially was :-
Ser Arg Asp Leu He He Gin Phe Lys Asn (Amino acid sequence 1)
124
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Fig. 3.7 SDS-PAGE and western blotting of biotinylated purified adhesin.
Biotinylation of purified adhesin was performed using a commercial kit fi*om 
Amersham (following the manufacturers protocol). 200 pg of adhesin (produced as 
described in Materials and Methods) was dissolved in 1ml of 0.05M sodium borate 
buffer, pH 8.6. 40pl of biotinylation reagent was added and the tube was incubated 
for Ih at room temperature with constant agitation. The unreacted biotinylation 
reagent was removed by desalting on G-25 Sephadex and the adhesin was fi*eeze- 
dried. The procedure of Schagger and Von Jagow (1987) was employed as described 
in Sigma Technical Bulletin No. MWM-100. The biotin-adhesin was resuspended in 
lOOpl of sample buffer and 25pl was loaded in each well of a tricine mini SDS-PAGE 
gel. Samples (biotinylated PA, lanes 1,2 and 3) and molecular weight markers (MW- 
SDS-17S, Sigma, lane 4) were subjected to electrophoresis for 3-4 hours at a 
constant current of 100 V. The gel was cut and the markers were stained with 
Brilliant Blue G (Sigma). The biotinylated PA lanes were transferred onto nitro­
cellulose (Hybond C, Amersham) according to the method of Towbin and Gordan 
(1984) in a Trans-Blot Electophoretic Transfer apparatus (Bio-Rad). The protein was 
then visualised by probing with  ^^ I^-streptavidin (30 pCi/pg; 5 pCi; in 10ml reaction 
volume) followed by autoradiography.
125
Table 3.3 Sequence analysis
AMINO ACID SEQUENCE 
1 2 3
Amino 
acid No.
Amino pMol 
acid
Amino pMol 
acid
Amino
acid
pMol
1 Ser 385.26 Ser 385.26 Phe 181.97
2 Arg 31.73 Asp 404.86 Asp 404.86
3 Asp 451.28 Asp 451.28 Tyr 38.63
4 Leu 876.52 Leu 876.52 Glu 83.25
5 He 62.11 Ser 265.73 His 21.19
6 He 88.07 Phe 683.92 Val 96.97
7 Gin 66.21 Lys 372.58 Asp 106.96
8 Phe 641.32 Phe 641.32 X N.D.*
9 Lys 423.62 Lys 423.62 Ala 117.92
10 Asn 283.79 Asn 283.79 Val 139.79
Amino acid sequencing was performed by Sandra Miller in the Dept, of Geology and 
Applied Geology, University of Glasgow. Purified adhesin was run on a tricine 
polyacrylamide gel as described in the legend of Fig. 3.7, and then transferred onto 
ProBlott (Applied Biosystems) according to the method of Towbin and Gordan (1984) 
in a Trans-Blot Electophoretic Transfer apparatus (Bio-Rad). The ProBlott was cut to 
include the band of the adhesin seen in a blot of an identical gel of biotinylated adhesin 
(as described in the legend of Fig. 3 .7) from the same purified batch. The material on 
the ProBlott was then sequenced in an Applied Biosystems 477A Protein Sequencer.
* This amino acid could not be determined with any certainty but could be narrowed
down to any one of the following:
Amino acid pMoI
Leu 108.79
Lys 115.20
Pro 108.61
Gly 95.73
Ala 95.46
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■3When this sequence was run through peptide database using the FASTA program 
developed by Pearson and Lipman (1988), the closest homology was an outer capsid 
protein VP4 haemagglutinin from human Rotavirus serotype 4. The sequence had 75% 
identity in an eight amino acid overlap (Table 3.4). However, when the sequence data 
from the run was re-examined by Dr. Phil Jackson of Applied Biosystems, he 
determined that there were two distinct sequences present. The computer system 
attached to the sequencer had miss-read the data due to a high amount of background 
in the sample. The two most prominent sequences seen after re-examination of the data 
were
Ser Asp Asp Leu Ser Phe Lys Phe Lys Asn (Amino acid sequence 2)
Phe Asp Tyr Glu His Val Asp X Ala Val (Amino acid sequence 3)
a
::The amino acid at position 8 in Ammo acid sequence 3 could not be determined 
with any certainty but could be narrowed down to any one of the following: Leu, Lys,
Pro, Gly, or Ala.
When Amino acid sequence 2 was run through the data base it had 100% 
homology with the first 10 amino acids at the N-terminus of the anti H (O) binding 
lectin from Ulex europaeus (Table 3.4). This astonishing finding prompted a careful 
examination of the experimental notes relating to the production of this particular batch
gof purified adhesin. It was found that the Synsorb H-2 affinity adsorbent used for this 
batch had been exposed to the purified U. europaeus lectin. This had occurred during :|
an experiment to examine the efficiency of elution of H antigen-binding components 
from Synsorb affinity adsorbent. None of the previous batches of purified adhesin had 
been contaminated in this way. This accidental contamination in fact provided a useful
■[i"check on sequence determination. Proteins with known sequences are often included on
!:■gels destined for sequence analysis. Also, two or three proteins can be sequenced in the 
same reaction so long as the amounts of the individual proteins are sufficiently different 
to allow for sequence discrimination (Phil Jackson, personal communication). Amino
5
.
Table 3.4 Peptide data base searches of amino acid sequence 1. and 2,
Amino acid sequence 1.
S R D L ,  I I Q F K N
1 1 * 1 1  # I I
Y R D I I I R F K F 
270 275
Human Rotavirus (serotype 4) Outer capsid protein (Haemagglutinin)
75% Identity in an eight amino acid overlap.
Amino acid sequence 2.
S D D L S F K F K N
I I I I I I I I I I
S D D L S F K F K N  
1 5 10
Ulex europaeus lectin I. 100% identity in a ten amino acid overlap.
Amino acid sequencing was performed by Sandra Miller in the Dept, of Geology 
and Applied Geology, University of Glasgow. Purified adhesin was run on a tricine 
polyacrylamide gel as described in the legend of Fig. 3.7. and then transferred onto 
ProBlott (Applied Biosystems) according to the method of Towbin and Gordan 
(1984) in a Trans-Blot Electophoretic Transfer apparatus (Bio-Rad). The ProBlott 
was cut to include the band of the adhesin seen in a blot of an identical gel of 
biotinylated adhesin (as described in the legend of Fig. 3.7) from the same purified 
batch. The material on the ProBlott was then sequenced in an Applied Biosystems 
477A Protein Sequencer. The sequences obtained were run through peptide 
database using the FASTA program developed by Pearson and Lipman (1988) and 
the closest homologies are shown above. Identical amino acid residues are linked 
with a line;- ( | ).Similar amino acid residues are indicated with a full stop:- (.).
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Table 3.5 Protein database search results
Amino acid sequence 3* from the purified adhesin was run through the peptide 
database using the FASTA program developed by Pearson and Lipman (1988). 
The resulting homologies are shown below. Identical amino acid residues are 
linked with a line:- ( | ). Similar amino acid residues are indicated with a full stop; 
(.). Legend the same as for Table 3.4.
♦fdyehvdxav
RGBYI3 regulatory protein SIR3 - yeast (Saccharomyces 71.4% identity in 7 aa overlap FDYEHVDXAV
III I . I .RGBYI3 TNADDSTKFRLVNDVMDELVTSSARKELPIFDYIHIDALELAGMDALYEKIWFAISKENL 580 590 600 610 620 630
S11428 narY protein - Escherichia coli 66.7% identity in 9 aa overlap FDYEHVDXAV
I I I I I . . .  IS11428 PRLGNKMGVITKIFANPWPQIDDYYEPFTFDYEHLHSAPEGKHÏPTARPRSLIDGKRMD 
80 90 100 110 120 130
S24599 vitellogenin - Caenorhabditis elegans 100.0% identity in 5 aa overlap FDYEHVDXAV 
I I I I IS24599 NSMKMLPFERFEEVERMNREHQELLSMPVEFDYEHGLVREIRFAENDQPWSENIKRAVIN 100 110 120 130 140 150
VIT6_CAEEL VITELLOGENIN-6 PRECURSOR (FRAGMENT).
100.0% identity in 5 aa overlap FDYEHVDXAV 
I I I I IVIT6_C NSMKMLPFERFEEVERMNREHQELLSMPVEFDYEHGLVREIRFAENDQPWSENIKRAVIN 100 110 120 130 140 150
RSPB ECOLI STARVATION SENSING PROTEIN RSPB
I I . . I I . . ! .RSPB_E SSRLNANKFPIVIDWLSKGLIKPEKLITHTFDFQHVADAISLFEQDQKHCCKVLLTFSE 290 300 310 320 330
50.0% identity in 10 aa overlap FDYEHVDXAV
-
PGH1_M0USE PROSTAGLANDIN G/H SYNTHASE 1 PRECURSOR (EC 50.0% identity in 10 aa overlap FDYEHVDXAV
I I I .  . . .  IIPGH1_M n t s m l v d y g v e a l v d a f s r q r a g r i g g g r n f d y h v l h v a v d v i k e s r e m r l q p f n e y r k r420 430 440 450 460 470
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RIR1_HSVSA RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE 40.0% identity in 10 aa overlap FDYEHVDXAV 
I I  I !RIR1_H f t s t c n l a n v c l p k c l n s s n f p y t c s n t a q f d f s k l e y a v q a a v f i i n a c i l s p s p t s s a  
410 420 430 440 450 460
VG1_SPV1R CAPSID PROTEIN.71.4% identity in 7 aa overlap FDYEHVDXAV 
I I . I II.
FIXB_AZOCA FIXB PROTEIN.
5 7 .1 %  identity in 7 aa overlap FDYEHVDXAV 
I I . . I I . .FIXERA a g i s g a i q h r v g v e g a d m i v a i n t d k n a p i f d f a h v g i v t d a i r l l p a l t e a f r a r l s p h  
310 320 330 340 350 360
VG13_BPML5 GENE 13 PROTEIN (GP13}.50.0% identity in 10 aa overlap FDYEHVDXAV 
I I . Î  IIVGl3_B GRTYKKKLKVNAS PNN PVAFDMRGQQKR FAFDCBRLE DAVLEGEVWHDGN PVLRQHVLNA 480 490 500 510 520 530
130
WMBEP6 ribonucleoside-diphosphate reductase 40.0% identity in 10 aa overlap FDYEHVDXAV 
I I . . . . . .  I IWMBEP6 FTSTCNLANVCLPKCLNSSNFPYTCSNTAQFDFSKLEYAVQAAVFIINACILSPSPTSSA 
410 420 430 440 450 460
JQ1387 NAD(P)H-dependent xylose reductase - yeast 83.3% identity in 6 aa overlap FDYEHVDXAV 
Mi l . IJQ1387 l f l i h f p v t f k f v p l e e k y p p g f y c g k g d n f d y e d v p i l e t w k a l e k l v k a g k i r s i g v s  
110 120 130 140 150 160
S08450 hypothetical protein 1 - spiroplasma virus 1 71.4% identity in 7 aa overlap FDYEHVDXAV 
I I . I II.S08450 y s v l q e n i r v q q g g s a d y e n p n k v g t k r i i f d f e t v d e l d v k n i k k a i y r m i l t v d e a n l  290 300 310 320 330 340 Ï"
v g i _ s p y s v l q e n i r v q q g g s a d y e n p n k v g t k r m i f d f e t v d e l d v k n i k k a i y r m i l t v d e a n l  290 300 310 320 330 340
A35564 prostaglandin-endoperoxide synthase 
50.0% identity in 10 aa overlap FDYEHVDXAV 
I I I .  . . .  I !A35564 n t s m l v d y g v e a l v d a f s r q r a g r i g g g r n f d y h v l h v a v d v i k e s r e m r l q p f n e y r k r  420 430 440 450 460 470
S30958 gene 13 protein - Mycobacterium phage L5 50.0% identity in 10 aa overlap FDYEHVDXAV 
I I . I  IIS30958 g r t y k k k l k v n a s p n n p v a f d m r g q q k r f a f d c e r l e d a v l e g e v w h d g n p v l r q h v l n a  
480 490 500 510 520 530
. . .
:
-
1  ____________________
S14071 fixB protein - Azorhizobium caulinodans 57.1% identity in 7 aa overlap FDYEHVDXAV 
I I " • i ! • •S14 071 AGISGAIQHRVGVEGADMIVAINTDKNAPIFDFAHVGIVTDAIRLLPALTEAFRARLSPH 
310 320 330 340 350 360
___________________________________
S12955 calcium channel protein type L ~ rabbit 50.0% identity in 6 aa overlap FDYEHVDXAV 
I I . . .  IS12955 e a e c k g n y i t y k d g e v d h p i i q p r s w e n s k f d f d n v i a a m m a l f t v s t f e g w p e l l y r s i  
70 80 90 100 110 120
YMR1_Y s y i e y n r f f n s l a h w d s r r s g d i i i y y k l p f d y s d i p a a d i240 250 260 270
S05054 calcium channel alpha-1 chain, dihydropyridine 50.0% identity in 6 aa overlap FDYEHVDXAV
TRPC_SALTY INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE 55.6% identity in 9 aa overlap FDYEHVDXAV
340 350 360 370 380 390
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A40695 alpha 1 (V) procollagen - chicken (fragment)75.0% identity in 8 aa overlap FDYEHVDXAV 
I I . I I . NA40695 d a p q s q d p n q d e y y t d g e g e g d t y y y e y p y y e d v d e a v k p e a p t t k p a p p g v a a g e r p e t  250 260 270 280 290 300
YMR1_YEAST HYPOTHETICAL PROTEIN IN MRFl 5'REGION (FRAGMENT)44.4% identity in 9 aa overlap FDYEHVDXAV
I
S05054 e a e c k g n y i t y k d g e v d h p i i q p r s w e n s k f d f d n v l a a m m a l f t v s t f e g w p e l l y r s i  
1100 1110 1120 1130 1140 1150
GWEBT indole-3-glycerol-phosphate synthase 
55.6% identity in 9 aa overlap FDYEHVDXAV 
I I . I ! i . .GWEBT q a y v n a l r e a l p k q v q i w k a l s v s d a l p a r d y h h v d k y i  f d n g q g g s g q r f d w s l l q g q p 340 350 360 370 380 390
WMBEB1 ribonucleoside-diphosphate reductase 40.0% identity in 10 aa overlap FDYEHVDXAV II IIwMBEBi t e i v h p a s k r s s g v c n l g s v n l a r c v s r q t f d f g r l r d a v q a c v l m v n i m i d s t l q p t p q  
800 810 .820 830 . 840 850
YK62__CAEEL HYPOTHETICAL 105.4 KD PROTEIN C29E4.2 75.0% identity in 8 aa overlap FDYEHVDXAV
I I . I I . I IYK62_C LLIDKALPLLKKFAENRTDREQMAYEMAKAYEDVDVAVSTLQEHVDKWHSRMEPILEEGE 770 780 790 800 810 820
I
II .  I I I .  .TRPC S QAYVNALREALPKQVQIMKALSVSDALPARDYHHVDKYIFDNGQGGSGQRE'DWSLLQGQP
A44467 voltage-dependent calcium channel complex alpha 50,0% identity in 6 aa overlap FDYEHVDXAV 
I I . . .  IA4 4 4 67 EAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSI 
1070 1080 1090 1100 1110 1120
A45290 calcium channel protein type L - human 50.0% identity in 6 aa overlap FDYEHVDXAV
1 t . . .  IA4 5 2 9 0 EAECKGNYITYKDGEVDH PIIQPRSWENSKFDFDNVLAAMM7\L FTVST FEGWPELLYRSI 1090 1100 1110 1120 1130 1140
JH0427 voltage-dependent calcium channel complex alpha 
50.0% identity in 6 aa overlap FDYEHVDXAV 
1 I . . .  !JH04 27 EAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVIAAMMALFTVSTFEGWPELLYRSI 1070 1080 1090 1100 1110 1120
C25877 hypothetical protein 1 - Crithidia fasciculate 50.0% identity in 10 aa overlap FDYEHVDXAV III . 11...C2587 7 FLRLFDMRMSILLCKQCFFVGFFVFGFVCLFDYMYVDVTIETIISLFYSLWCCILPGCSF 220 230 240 250 260 270
B43921 dlhydropyridine receptor, DHP receptor - rat 50.0% identity in 6 aa overlap FDYEHVDXAV 
■ I I . . .  IB43921 EAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSI 
30 40 50 60 70 80
CICC_RAT DIHYDROPRYRIDINE-SENSITIVE L-TYPE, CARDIAC MU 50.0% identity in 6 aa overlap FDYEHVDXAV 
I 1 . . .  ICICC_R e a e s k g n y i t y k t g e v d h p i i q p r s w e n s k f d f d n v l a a m m a l f t v s t f e g w p e l l y r s i  
1100 1110 1120 1130 1140 1150
S11339 calcium channel protein - rabbit 50.0% identity in 6 aa overlap FDYEHVDXAV 
I I . . .  IS11339 EAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSI 1100 1110 1120 1130 1140 1150
■,
805007 calcium channel alpha-1 chain, dihydropyridine 50.0% identity in 6 aa overlap FDYEHVDXAV 
I I . . .  IS05007 e a e c k g n y i t y k d g e v d h p i i q p r s w e n s k f d f d n v l a a m m a l f t v s t f e g w p e l l y r s i  
20 30 40 50 60 70
S44769 C29E4.2 protein - Caenorhabditis elegans 75.0% identity in 8 aa overlap FDYEHVDXAVl l. ll . ilS4 47 69 l l i d k a l p l l k k f a e n r t d r e q m a y e m a k a y e d v d v a v s t l q e h v d k w h s r m e p i l e e g e  
770 780 790 800 810 820
132 I
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S29994 Type V collagen, alpha 1 chain, NH2-terminal do 75.0% identity in 8 aa overlap FDYEHVDXAV
M ■ I M  IS29994 DAPQSQDPNQDEYYTDGEGEGDTYYYEYPYYEDVDEAVKPEAPTTKPAPPGVAAGERPET 
250 260 270 280 290 300
RIR1_HSV11 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE 
40.0% identity in 10 aa overlap FDYEHVDXAV II IIRIR1_H TEÏVHPASKRSSGVCNLGSVNLARCVSRQTFDFGRLRDAVQACVLMVNIMIDSTLQPTPQ 800 810 820 830 840 850
F22848 hypothetical ORF-4 protein - Sauroleishmania ta 
50.0% identity in 10 aa overlap FDYEHVDXAV 
III . I I . • .F22848 FLRLFDMRMSILLCKQCFFVGFFVFGFVCLFDYMYVDVTIETIISLFYSLWCCILPGCSF 
200 210 220 230 240 250
CICC__RABIT DIHYDROPRYRIDINE-SENSITIVE L-TYPE, CARDIAC 50.0% identity in 6 aa overlap FDYEHVDXAV 
I I . . .  ICICC_R EAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLA7\MMALFTVSTFEGWPELLYRSI 1100 1110 1120 1130 1140 1150
WMBEB7 ribonucleoside-diphosphate reductase 4 0.0% identity in 10 aa overlap FDYEHVDXAV 
I I . . .  . . I IWMBEB7 TEIVHPASKRSSGVCNLGSVNLARCVSRQTFDFGRLRDAVQACVLMVNIMIDSTLQPTPQ 800 810 820 830 840 850
S28601 hypothetical protein (MRFl 5' region) - yeast 4 4.4% identity in 9 aa overlap FDYEHVDXAVill... .XS28601 SYIEYNRFFNSLAHWDSRRSGDIIIYYKLPFDYSDIPAADI 240 250 260 270
JH04 26 voltage-dependent calcium channel complex alpha 50.0% identity in 6 aa overlap FDYEHVDXAV 
I I . . .  IJH0426 EAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSI 
1070 1080 1090 1100 1110 1120
C40049 virC-region protein yscL - Yersinia enterocolit 44.4% identity in 9 aa overlap FDYEHVDXAV
I I . . I I . . .C4004 9 e t q l q c q q f y r h v e q q m s e w l l a v r k i l n d y d q v d m t l q w r e a l a l v s n q k q v w r v n  
90 100 110 120 130 140
TRPF_KLULA N-(5*-PH0SPH0RIB0SYL)ANTHRAN1LATE i s o m e r a s e 62.5% identity in 8 aa overlap FDYEHVDXAV
m i l . . .TRPF_K IKEYRSLIPSSIPIIKRFQFPQDCELLLDLYEHVDNVLTLFDSGEGGTGEKLNWSAISSW 
100 110 120 130 140 150
I
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SLAP_BACSH SURFACE-LAYER 125 KD PROTEIN PRECURSOR.100.0% identity in 5 aa overlap FDYEHVDXAV 
I I I I ISLAP_B TIKNVKDATKLNNTMLDYTGKFTRSDKEGPDYEHVINADAKAKKWLKFDKKMDAASLAD 
640 650 660 670 680 690
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ISVKNL phosphoribosylanthranilate isomerase 62.5% identity in B aa overlap FDYEHVDXAV 
M i l l . . .ISVKNL IKEYRSLIPSSIPIIKRFQFPQDCELLLDLYEHVDNVLTLFDSGEGGTGEKLNWSAISSW 
100 110 120 130 140 150
.t
MPP1_RAT MITOCHONDRIAL PROCESSING PEPTIDASE CATALYTIC 50.0% identity in 8 aa overlap FDYEHVDXAV Ml...!.MPP1_R KPEDIKRVASKMLRGKPAVAALGDLTDLPTYEHIQAALSSRDGRLPRTYRLFR 
480 490 500 510 520
,
S29854 spectrin beta chain - dog (fragment)100.0% identity in 5 aa overlap FDYEHVDXAV HIM.S298S4 RLFQLNREVDDLEQWIAEREWAGSHELGQDYEHVTMLQERFREFARDTGNIGQERVDTV 
50 60 70 80 90 100
____________________________________________
HRPN_ERWAM HARPIN (HARPIN-EA) .44.4% identity in 9 aa overlap FDYEHVDXAV 
I I  IIHRPN_E LGGGQGGNAGTGLDGSSLGGKGLRGLSGPVDYQQLGNAVGTGIGMKAGIQALNDIGTHRH 230 240 250 260 270 280
S20477 ribulose-bisphosphate carboxylase 57.1% identity in 7 aa overlap FDYEHVDXAV
S20477 LAQEGNDILRQAGKWSPELAAACEVWKEIRFDFKPVDTLDPNDKKQRDNEDTLADKLFGD 440 450 460 470 480 490
ETSl_MOUSE C-ETS-1 PROTEIN (P54).50.0% identity in 10 aa overlap FDYEHVDXAV 
Mi l l  . I .BT81_M ESYDSCDRLTQSWSSQSSFNSLQRVPSYDSFDYEDYPAALPNHKPKGTFKDYVRDRADLN 260 270 280 290 300 310
■ÎYSCL_YEREN YSC OPERON PROTEIN L.44.4% identity in 9 aa overlap FDYEHVDXAV 
II . . II • • .YSCL_Y ETQLQCQQFYRHVEQQMSEWLLAVRKILNDYDQVDMTLQWREALALVSNQKQVWRVN 90 100 110 120 130 140
S25021 probable polyketide synthase - Bacillus subtilis 
66.7% identity in 9 aa overlap FDYEHVDXAV 
II II I . . I .S25021 ETMALAEELSAYFSTYRIFDSQELDRVSAADYEHVAGAIDLIGCGTSHEHSMGWINWLQK 3410 3420 3430 3440 3450 3460
I
:
CC10_SCHPO START CONTROL PROTEIN CDCIO.
83.3% identity in 6 aa overlap FDYEHVDXAV 
I I I . I I .CC10_S SYFNISQILRLAGTSSSENAKELDDIIESGDYENVDSKHPQIDGVWVPYDRAISIAKRYG 100 110 120 130 140 150
RBL_CUSRE RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN 
57.1% identity in 7 aa overlap FDYEHVDXAV 
I I . . .  I I .RBL_CU LAQEGNDILRQAGKWSPELAAACEVWKEIRFDFKPVDTLDPNDKKQRDNEDTLADKLFGD 440 450 460 470 480 490
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COZPCD cdclO start control protein - fission yeast 83.3% identity in 6 aa overlap FDYEHVDXAV 
I I I . I I .COZPCD SYFNISQILRLAGTSSSENAKELDDIIESGDYENVDSKHPQIDGVMVPYDRAISIAKRYG 100 110 120 130 140 150
:'T
GNNYH4 genome polyprotein - human rhinovirus 14 40.0% identity in 10 aa overlap FDYEHVDXAVIII. .  ! . . .  ■ <GNNYH4 PGVLTGSAVGCDPDVFWSVIPCLMDGHLMAFDYSNFDASLSPVWFVCLEKVLTKLGFAGS 1930 1940 1950 1960 197 0 1980
S33821 median body protein - Giardia lamblia 55.6% identity in 9 aa overlap FDYEHVDXAV 
I I I . I I . . .833821 LKENSYNFDQLLEQKQQMRSDLNALREKAADYERVDRELRLKDKELEEKNASIERLLEDR 
490 500 510 520 530 540
_____________________________________________________
A36205 mitochondrial processing peptidase 50.0% identity in 8 aa overlap FDYEHVDXAV 
I I I . . .  I .A36205 KPEDIKRVASKMLRGKPAVAALGDLTDLPTYEHIQAALSSRDGRLPRTYRLFR 480 490 500 510 520
::
-I
TRJ6_EC0LI TRAJ PROTEIN (RELAXOSOME PROTEIN).100.0% identity in 5 aa overlap FDYEHVDXAV 
I I I I ITRJ6_E AIEEKAAAAGMSLSAYLLAVGQGYKITGWDYEHVRELARINGDLGRLGGLLKLWLTDDP 
30 40 50 60 70 80
JC1378 aryldialkylphosphatase {EC 3.1.8.1) - Nocardia 62.5% identity in 8 aa overlap FDYEHVDXAV
I I . . I . I IJC1378 MSAEFVIRNAKVFDGERVYERLDVAVREGRIAQVGTDLATPADGDELDAAGQALLPGLID
20 30 40 50 60
I
S23002 traJ protein - Escherichia coli plasmid RP4 100.0% identity in 5 aa overlap FDYEHVDXAV 
I I I I IS23002 AIEEKAAAAGMSLSAYLLAVGQGYKITGWDYEHVRELARINGDLGRLGGLLKLWLTDDP 30 40 50 60 70 80
■■
A35875 transforming protein (ets-1) - mouse50.0% identity in 10 aa overlap FDYEHVDXAV 
I I I I I . I .A3587 5 ESYDSCDRLTQSWSSQSSFNSLQRVPSYDSFDYEDYPAALPNHKPKGTFKDYVRDRADLN 260 270 280 290 300 310
P0LG_HRV14 g e n o m e POLYPROTEIN (COAT PROTEINS VPl TO VP2)40.0% identity in 10 aa overlap FDYEHVDXAVIII., i . . •POLG_H PGVLTGSAVGCDPDVFWSVIPCLMDGHLMAFDYSNFDASLSPVWFVCLEKVLTKLGFAGS 
1930 1940 1950 1960 1970 1980
A33856 surface-layer 125K protein precursor - Bacillus 100.0% identity in 5 aa overlap FDYEHVDXAV 
I I I IIA33856 TIKNVKDATKLNNTMLDYTGKFTRSDKEGPDYEHVINADAKAKKWLKFDKKMDAASLAD 640 650 660 670 680 690
A44159 spectrin beta-G chain - human 100.0% identity in 5 aa overlap FDYEHVDXAV
H I M .A44159 RLFQLNREVDDLEQWIAEREWAGSHELGQDYEHVTMLQERFREFARDTGNIGQERVDTV 1700 1710 1720 1730 1740 1750
A34172 traJ protein - Escherichia coli plasmid RP4 100.0% identity in 5 aa overlap FDYEHVDXAV 
II II IA34172 AIEEKAAAAGMSLSAYLLAVGQGYKITGWDYEHVRELARINGDLGRLGGLLKLWLTDDP 30 40 50 60 70 80
QQSA4E hypothetical protein C-403 - Staphylococcus aur 80.0% identity in 5 aa overlap FDYEHVDXAVMM.QQSA4E KQELQEVKDELQKANKQLQSGIEHMRSTKPFDYENERTGLFSGREETGRKILTADEFERL 210 220 230 240 250 260
Z3BPFD coat protein A  precursor - phage fd 55.6% identity in 9 aa overlap FDYEHVDXAV 
II I I  IZ3BPFD GSEGGGSEGGGSEGGGSEGGGSGGGSGSGDFDYEKMANANKGAJHTENADENALQSDAKGK 250 260 270 280 290 300
IJCHCL E-cadherin precursor, hepatic - chicken 100.0% identity in 4 aa overlap FDYEHVDXAV
MMIJCHCL NPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYEGGGSEATSLSSLNSSASDQDQDYDYL 
810 820 830 840 850 860
ACTP_ACACA ACTOPHORIN.100.0% identity in 4 aa overlap FDYEHVDXAV 
II IIACTP_A EVWEHVGGPNATYEDFKSQLPERDCRYAIFDYEFQVDGGQRNKITFILWAPDSAPIKSK 
40 50 60 70 80 90
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B4187Û DNA-directed DNA polymerase III100.0% identity in 4 aa overlap FDYEHVDXAV 
I I I IB41870 AARSLPARPPAPVLAGLLLKAEEGQLSLSSFDYEVSARVSVEAEIEEEGTVLVSGRLLAD 
20 30 40 50 60 70
A38122 ard protein - Escherichia coli plasmid ColIb~P9 
100.0% identity in 4 aa overlap FDYEHVDXAV 
I I I IA3 812 2 GEADSEEAFAVE FAS DTGLLADVPETVALY FDYEAYARDL FLDS FT FIDGHVFRR 120 130 140 150 160
CPG1_RABIT CYTOCHROME P4 50 IIGl 80.0% identity in 5 aa overlap FDYEHVDXAV
Mi l .CPG1_R RKTKGAPIDPTFFLSRTVSNVISSWFGSRFDYEDKQFLSLLRMINESFIEMSTPWAQLY 
170 180 190 200 210 220
YBK6_YEAST HYPOTHETICAL 111.7 KD PROTEIN IN PKCl 5 'REG 
50.0% identity in 10 aa overlap FDYEHVDXAVIII.. .11YBK6_Y HDVSNQINSKFFDTKKICTYGINGRITVTTFDYTQSLLAVATTAGEIHVYGQKQIEWFT 30 40 50 60 70 80
A32470 cytochrome P450 2G13, hepatic - rat 71.4% identity in 7 aa overlap FDYEHVDXAV
Mi l .  I .A32470 KKTNGSPCDPQFIMGCAPGNVICSIILQNRFDYEDKDFLNLIEKVNEAVKIISSPGIQVF 
160 170 180 190 200 210
JT0948 maltodextrin glucosidase - Escherichia coli 83.3% identity in 6 aa overlap FDYEHVDXAV
M Ml .JT0948 KLPYLKKLGVTALYLNPVFKAPSVHKYDTEDYRHVDPQFGGDGALLRLRHNTQQLGMRLV 190 200 210 220 230 240
CPA4_M0USE c y t o c h r o m e P450 11A4 57,1% identity in 7 aa overlap FDYEHVDXAV MM. . .CPA4_M RKTNGAFIDPTFYLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSLQFTATSMGQVY 170 180 190 200 210 220
%
S
Y081_CAEEL HYPOTHETICAL 65.0 KD PROTEIN ZK1236.1 100.0% identity in 4 aa overlap FDYEHVDXAV
Mi l .Y081_C RLVILWRLPLAEVAVDFFERLKKLTSGYASFDYEPDGWQDTRLVKLTILINSKEVSEFSQ 
420 430 440 450 460 470
S30718 metR protein - Escherichia coli 100.0% identity in 4 aa overlap FDYEHVDXAVMMS30718 DPQPALQQGELDLVMTSDILPRSGLHYSPMFDYEVRLVLAPDHPLAAKTRITPEDLASET 
130 140 150 160 170 180
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IJHÜCN N-cadherin precursor, neuronal - human100.0% identity in 4 aa overlap FDYEHVDXAV 
I IIIIJHUCN HPGDIGDFINEGLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGEQDYDYL 
830 840 850 860 870 880
CPH1_CHICK CYTOCHROME P4 50 IIHl (EC 1.14.14.1) (PB15)80.0% identity in 5 aa overlap FDYEHVDXAVn i l .CPH1_C RKTHEEPFNPGKFLIHAVANIICSIVFGDRFDYEDKKFLDLIEMLEENNKYQNRIQTLLY 160 170 180 190 200 210
DEJJGC glyceraldehyde-3-phosphate dehydrogenase (EC 1.
FDYEHVDXAV II IIDEJJGC NGKLTGMSMRVPTSNVSWDLTVRIEKGATYEQIKTAVKKAADGPLKGVLAYTEDDWST 
230 240 250 260 270 280
is
VCNV87 p87 capsid protein - Orgyia pseudotsugata n u d e  80.0% identity in 5 aa overlap FDYEHVDXAV
n i l .VCNV87 LPPYSSDEEDAAPPRSPKRKESLSSSEEDEFDYEREQKRRREEDKNFLRLKALELSKYAG 
380 390 400 410 420 430
ANGR_VIBAN ANGR PROTEIN.66.7% identity in 6 aa overlap FDYEHVDXAVn i l . . .ANGR_V LPLTSNQNWQLSTQRQRTEKKSITNFTYQEFDYENISRDTLERCLTTIIKHHPIFGAKLS 20 30 40 50 60 70
A36122 cytochrome P450 2C13 - rat 71.4% identity in 7 aa overlap FDYEHVDXAV
M i l .  I.A36122 KKTNGSPCDPQFIMGCAPGNVICCIILQNRFDYEDKDFLNLIEKVNEAVKIISSPGIQVF 160 170 180 190 200 210
CHLB_EQUAR PROTOCHLOROPHYLLIDE REDUCTASE CHLB SUBUNIT 100.0% identity in 4 aa overlap FDYEHVDXAV MMCHLB_E T PMGIIDTADFIRQVQKNVNKLAPFFLNKT FDYESYIDYQTKFV 60 70 80 90 100 I
  ________________________________________
B3817 0 cytochrome d complex terminal oxidase 66.7% identity in 6 aa overlap 
FDYEHVDXAV MM. .B3817 0 MFDYETLKLVWWGLIGVLLIGLALTDGFDMGAMALMPFIAKTDNERRVAINTVAPHWDGN 20 30 40 50 60
ii
50.0% identity in 8 aa overlap
4',
B49349 possible succinoglycan transport protein ExoP - 66.7% identity in 9 aa overlap FDYEHVDXAV
Ml II . I .B49349 AGGASHQRHQSNELLASPAMANLIENARNAFDYWVDLAALAPWDAKAFAPLADGILFV 
660 670 680 690 700 710
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IJMSCN N-cadherin precursor, neuronal - mouse
100.0% identity in 4 aa overlap FDYEHVDXAV 
I I I IIJMSCN HPGDIGDFINEGLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYL 
830 840 850 860 870 880
IJMSCP P-cadherin precursor - mouse 100.0% identity in 4 aa overlap FDYEHVDXAV 
I I I IIJMSCP NPDEIGNFIIENLKAANTDPTAPPYDSLMVFDYEGSGSDAASLSSLTTSASDQDQDYNYL 750 760 770 780 790 800
DYR_PNECA DIHYDROFOLATE REDUCTASE 100.0% identity in 4 aa overlap FDYEHVDXAV 
I I I IDYR_PN WSSVWKKEKHSDLESWVGTKVPHGKINEDGFDYEFEMWTRDL 170 180 190 200
PGL2_ASPTU p o l y g a l a c t u r o n a s e  II PRECURSOR 80.0% identity in 5 aa overlap FDYEHVDXAV
MM.PGL2_A l d n i e v p a g t t l d l t g l t s g t k v i f e g t t t f d y e e w a g p l i s m s g k d i t v t g a s g h l i n c  
50 60 70 80 90 100
B33S31 cytochrome P450 2A3.2 - mouse 57.1% identity in 7 aa overlap FDYEHVDXAVMM.B33531 RKTNGAFIDPT FYLSRTVSNVISSIVFGDRFDYEDKE FLSLLRMMLGS FQFTATSMGQLY 170 180 190 200 210 220
A36066 metR protein - Escherichia coli 100.0% identity in 4 aa overlap FDYEHVDXAVMMA36066 DPQPALQQGELDLVMTSDILPRSGLHYSPMFDYEVRLVLAPDHPLAAKTRITPEDLASET 130 140 150 160 170 180
A4B340 capsid protein - peanut stripe virus (fragment)
100.0% identity in 4 aa overlap FDYEHVDXAVMMA4834 0 PYIAESALKTLYTNKRTRIEELAKYLAVLDFDYEVGCGESVHLQSGSSTTQSPVLDAGVD 
40 50 60 70 80 90
QQUTC5 NADH dehydrogenase (ubiquinone)100.0% identity in 4 aa overlap FDYEHVDXAVMMQQUTC5 FFTMIYNYFLLFFLMFVFKCFCLVDCLFLLFDYECCLVYCLISLYMCILSIFFIIDFVCI 420 430 440 450 460 470
END OF DATA
.
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acid sequence 3 was run through the peptide database and the sequences with 
similarities are shown in Table 3.5. There was no complete match found in the protein 
database but the purified adhesin sequence contains an interesting motif, FDYE, that is 
found in a wide range of proteins from a variety of sources. The proteins that contain 
this sequence have diverse functions ranging from viral coat proteins to yeast enzymes.
The partial amino acid sequence obtained for the adhesin is most probably an internal 
sequence produced as a result of enzymic cleavage by the action of papain. Yu et al, 
(1994a) attempted to sequence a fimbrial adhesin of C. albicans but were unsuccessful 
due to N-terminal blockage of the protein. Similarly, Klotz et al. (1994) partially
characterised the fibronectin adhesin of C. albicans which binds the fungus to 
subendothelial extracellular matrix and matrix proteins The N-terminus of the 60-kDa
i '
glycoprotein was blocked to Edman degradation. Proteolytic cleavage prior to 
sequencing would get round the problem of N-terminal blockage.
4. IDENTIFICATION OF THE CANDIDA ALBICANS RECEPTOR ON
BUCCAL EPITHELIAL CELLS
A number of workers have found that fibronectin, a common mammalian 
cell surface glycoprotein, adheres to C. albicans in vitro (Skerl et a l, 1984; Scheld et 
ah, 1985; Klotz, 1990). Candida have been seen to bind to fibrin-platelet matrices 
(Maisch and Calderone, 1980). Mammalian proteins thought to mediate C  albicans 
attachment include fibrinogen (Tronchin et ah, 1987), laminin (Bouchara et a l, 1990), 
types I and IV collagen (Klotz, 1990). The fibronectin-cell binding domain, which has 
the amino acid sequence Arg-Gly-Asp (RGD), has been examined for its ability to 
block adherence of C albicans. RGD-containing peptides were shown not to inhibit 
adhesion of C. albicans to BEÇ by Brassart et a l (1991). However, Ollert et al 
(1993) found that C. albicans attachment to kératinocytes was inhibited by RGD- 
containing peptides derived from laminin. Similarly, Bendel et a l (1993) reported that
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inhibited from binding to BEC by L-fucose-containing complex carbohydrates (Brassart 
et ah, 1991). Other recent studies have found that C  albicans binds to the glycolipids 
lactosylceramide (Jimenez-Lucho et ah, 1990), asialo-GMi and asialo-GM2 (Yu et ah, 
1994b, c).
4.1 RGD peptide as a receptor for C albicans on buccal epithelial cells.
adhesion of C. albicans to HeLa S3 (an epithelial cell line) was inhibited by RGD- 
containing peptides.
A number of studies have examined the role of carbohydrates in the 
adhesion of C. albicans to epithelia. This work has mainly involved the use of lectins 
and/or monosaccharides (Centeno et ah, 1983; Collms-Lech et ah, 1984; Critchley and
y:|
Douglas, 1987b). A more sophisticated study demonstrated that C. albicans can be
To examine the possible role of RGD peptide in the adhesion of C
albicans to oral epithelium, C. albicans GDH 2346 cells were pre-treated with RGD 
peptide prior to adhesion-inhibition assays with BEC. Pre-incubation with RGD peptide 
in the presence and absence of Mg 2+ and Ca was found not to inhibit adhesion of 
yeasts to BEC. There was no significant difference in the adhesion values obtained for 
treated and untreated yeasts. The results are shown in Table 4.1. These results are in 
agreement with work by Brassart et a l (1991) but contradict the work of Bendel et al 
(1993) who found that adhesion of C. albicans to HeLa S3 cells (epithelial cell line) 
was inhibited by RGD containing peptides.
4.2 The role of glycolipids in the adhesion of C albicans to epithelial cells
A number of studies have examined the role of lipids on the adhesion of C. 
albicans to epithelia. Ghannoum et ah (1986) investigated the adhesion-blocking action
V:
of lipids extracted from three Candida spp. Three more recent studies have employed a 
TLC chromatogram overlay assay, previously used in the characterisation of bacterial 
adhesion mechanisms, to examine the ability of pathogenic yeasts to bind to a variety of 
lipid types (Jimenez-Lucho et ah, 1990; Yu et ah, 1994b; Prakobphol et ah, 1994).
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Table 4.1 Effect of RGD peptide on adhesion of C albicans GDH 2346
to buccal epithelial cells.
Incubation
conditions
Mean no. ± SEM of adherent 
yeasts/ 100 epithelial cells
% inhibition P5
PBS^ 1147.22 ±54 - -
PBS+RGD^ 1149.89 ±61 -0.23 NS
Tris^ 1267.56 ±86.64 - -
Tris+RGD^ 1278.44 ±86.32 -0.85 NS
 ^ Yeast cells were pre-treated with a solution of PBS  ^at 37^C for 30 min and then 
used in adhesion assays.
 ^ Yeast cells were pre-treated with a solution of RGD peptide (0.5 mgml \  In PBS) 
at 37®C for 30 min and then used in adhesion assays.
 ^ Yeast cells were pre-treated with a solution of 50 mM Tris-HCl (pH 7.3) containing 
0.02% CaCl and 0 .02% MgCl at 37^C for 30 min. The cells were then used in 
adhesion assays.
Yeast cells were pre-treated with a solution of 50 mM Tris-HCl (pH 7.3) 
containing 0.02% CaCI, 0.02% MgCl and RGD peptide (0.5 mgml'^) at 37^C for 30 min 
and then used in adhesion assays.
5 Probability values relative to adhesion of PBS and Tris controls; NS, not significant.
142
■T
4.2.1 Isolation of BEC glycolipids and their separation on TLC plates
With a view to identifying glycolipid receptors for C  albicans in the oral 
cavity, BEC were isolated from four healthy human donors (all blood group A). Total 
glycolipids were isolated from the BEC by chloroform-methanol extraction for use in a 
glycolipid chromatogram overlay assay. This system has been used to characterise a 
number of adhesin-receptor relationships (Hansson et ah, 1985). In the following 
experiments, BEC lipids, along with control glycolipids (Calbiochem) and sheep red 
blood cell (sRBC) glycolipids (a gift from Chris Brotherston, Dept, of Microbiology, 
University of Glasgow), were separated on thin layer chromatography (TLC) plates. 
The control glycolipids comprised galactosylceramide (CMH), lactosylceramide 
(CDU), globotriaosylceramide (CTH), globoside (GL4), and Forssman glycolipid 
(FORS). The structures of these lipids are shown in Table 4.2.
Various methods of lipid visualisation were examined. Iodine vapour was found 
to stain the separated lipids quite well, but not well enough to allow for clear 
photography of the plates. Anisaldehyde reagent stained the lipids clearly (blue-green 
on a pink-red background) and provided good contrast for photography (Fig. 4.1).
II
J
■'ÿ
However, the images obtained were quite variable due to difficulty in judging the 
optimum amount of anisaldehyde to be sprayed onto the chromatogram. If too much 
was applied, then intense background staining of the plates was encountered. If too 
little was used then the lipid bands were barely visible. Resorcinol and orcinol reagent 
staining both gave satisfactory results that were easy to reproduce (Figs. 4.2 and 4.3). 
Resorcinol reagent is commonly used to stain separated gangliosides and orcinol is used 
for both neutral glycolipids and gangliosides. Orcinol reagent showed lipid spots as 
reddish purple on a white background whereas resorcinol reagent gave spots that were 
brownish yellow in colour. The contrast achieved with orcinol reagent was marginally 
better than that obtained with resorcinol and so total lipid was subsequently visualised 
by treatment with orcinol reagent.
Different solvent systems for the separation of lipids were also assessed. All those 
tested contained chloroform, methanol and water but in varying proportions. The
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Fig 4.1 Thin-layer chromatogram of neutral glycolipid standards, BEC 
glycolipids, and sRBC glycolipids
Glycolipids were separated using chloroform-methanol-water (55:45:10) and then 
visualised using anisaldehyde reagent. Line 1, 2pg each of galactosylceramide (CMH), 
lactosylceramide (GDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 200 pg BEC total lipid extract; lane 3, 600 pg 
sRBC total lipid extract.
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Fig 4.2 Thin-layer chromatogram of neutral glycolipid standards, BEC 
glycolipids, and sRBC glycolipids
Glycolipids were separated using chloroform-methanol-water (60:35:8) and then 
visualised using orcinol reagent. Lane 1, 2pg each of galactosylceramide (CMH), 
lactosylceramide (CDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 150 pg BEC total lipid extract; lane 3, 200 pg 
sRBC total lipid extract.
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Fig 4.3 Thin-layer chromatogram of neutral glycolipid standards, BEC 
glycolipids, and sRBC glycolipids
Glycolipids were separated using chloroform-methanol-water (65:25:4) and then 
visualised using resorcinol reagent. Lane 1, 2pg each of galactosylceramide (CMH), 
lactosylceramide (CDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 50 pg BEC total lipid extract; lane 3, 200pg 
sRBC total lipid extract.
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solvent systems containing chloroform, methanol and water in the ratios 55:45:10 (Fig. 
4.1) and 60:35:8 (Fig. 4.2) allowed for adequate lipid separation but a system with 
chloroform, methanol and water in a ratio of 65:25:4 was found to give the most 
reproducible separation (Fig. 4.3). The mobility of a glycolipid on TLC gives a rough 
indication of the number of sugar residues present in the lipid. This is clearly 
demonstrated by the separation of the standard glycolipid mixtures on all the 
chromatograms. Those glycolipids with the few sugar residues (e.g. CMH and CDH) 
run close to the solvent front. With each additional residue, mobility is reduced. CDH is 
often seen as a double spot (Fig 4.4) due to heterogeneity in ceramide structure. The 
amount of lipid applied to the TLC plate was found to affect the subsequent separation 
of lipid components. If too much lipid was applied then streaking of the bands was 
encountered. Also, some bands seemed to run a little slower when too much lipid was 
applied. Fig. 4.1 demonstrates the effect of overloading lipid onto TLC plates. The 
EEC lipid track shows clear signs of streaking. Fig. 4.4 demonstrates the change in 
mobility pattern of different amounts of the same lipid mixture. EEC lipids were loaded 
at 80 |Lig and 160 pg. There is a clear reduction in migration distance between the two 
lipid lanes which becomes more pronounced towards the top of the chromatogram. 
Having optimised all the parameters relating to the separation of glycolipids and their 
subsequent staining, a chromatogram like that shown in Fig. 4.5 was routinely 
produced.
1254.2.2 Binding of I-EP from strain GDH 2346 to glycolipids separated on 
TLC plates
EP from C. albicans GDH 2346 was radioiodinated using the lodogen procedure 
(Pierce). Glycolipids (from EEC, sRBC, and control lipids) were separated on TLC 
plates using chloroform-methanol-water in the ratio 65:25:4. After development, TLC 
plates to be used in the overlay analysis were air-dried and briefly dipped in 
polyisobutylmethacrylate (PIBMA) in hexane. The plates were again air-dried and then
125placed in PES-ESA blocking solution. The blocking solution was tipped off and I-EP
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Fig 4.4 Thin-layer chromatogram of neutral glycolipid standards and B£C 
glycolipids
Glycolipids were separated using chloroform-methanol-water (65:25:4) and then 
visualised using orcinol reagent. Lane 1, 2pg each of galactosylceramide (CMH), 
lactosylceramide (CDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 80 pg BEC total lipid extract; lane 3, 160pg EEC 
total lipid extract.
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Fig 4.5 Thin-layer chromatogram of neutral glycolipid standards, BEC 
glycolipids, and sRBC glycolipids
Glycolipids were separated using chloroform-methanol-water (65:25:4) and then 
visualised using orcinol reagent. Lane 1, 2pg each of galactosylceramide (CMH), 
lactosylceramide (CDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 80 pg BEC total lipid extract; lane 3, 500 pg 
sRBC total lipid extract.
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125in fresh blocking solution was added. After incubation, unbound I-EP was removed 
by washing the plates in PBS. The plates were then air dried, placed inside plastic and 
sealed, and exposed to X-ray film for 72 h . Despite the high background, the
125autoradiogram obtained (Fig. 4.6) shows that I-EP to bound to two lipid 
components from sRBC. There did not appear to be any binding to either the control 
lipids or the lipids from BEC. Some clear zones were seen through the background in 
the BEC lipid lane. Some pitting of the silica was seen on the TLC plate after the 
washing steps were complete. The pits were seen to correspond to radioactive hot 
spots on the autoradiograph. This suggests that the pitting resulted in the exposure of 
silica that was not blocked to the same extent as the surrounding silica. This may have
125allowed for non-specific binding of I-EP.
1254.2.3 Binding of I-EP from strain GDH 2023 to glycolipids separated on 
TLC plates
The protocol for this experiment was identical to that described previously except
125that I-EP from strain GDH 2023 was used. The autoradiogram obtained is shown in 
Fig. 4.7. ^^^ I-EP bound to four lipid components from sRBC. There did not appear to 
be any binding to lipids from BEC or to the control lipids. There were again clear zones 
in the BEC lipid lane. The pitting that had been seen in the previous experiment was not 
as pronounced in this experiment. There was significant loss of silica on the edge of the 
TLC plates which was probably a result of the plates being free to move inside the 
reaction tray. In all subsequent experiments, the plates were cut to the exact dimensions 
of the reaction tray to minimise this collision damage.
1254.2.4 Binding of I-labelled whole cells and EP of C albicans GDH 2346 to 
glycolipids separated on TLC plates
125The binding of I-labelled whole cells and EP from strain GDH 2346 to 
glycolipids was examined by the chromatogram overlay assay. The overlay procedure 
was similar to that used in the experiments described above, but in an attempt to reduce
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Fig 4.6 TLC overlay analysis of the binding of from C albicans GDH
2346 to separated glycolipids
EP was iodinated as described in Materials and Methods. TLC plate was prepared and 
blocked as described in Results 4.2.2 and then overlaid with ' ’^l-EP. Binding was 
detected by autoradiography. Lanes 1 and 3, 2pg each of galactosylceranude (CMH), 
lactosylceramide (CDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 80 pg BEC total lipid extract; lane 4, 500 pg 
sRBC total lipid extract.
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Fig 4.7 TLC overlay analysis of the binding of from C albicans GDH
2023 to separated glycolipids
EP was iodinated as described in Materials and Methods. The TLC plate was prepared 
and blocked as described in Results 4.2.2 and then overlaid with ^^ I^-EP. Binding was 
detected by autoradiography. Lanes 1 and 3, 2pg each of galactosylceramide (CMH), 
lactosylceramide (CDH), globotriaosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lane 2, 80 pg BEC total lipid extract; lane 4, 500 pg 
sRBC total lipid extract.
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the intense background encountered previously, an alternative blocking solution (Tris- 
BSA buffer) was employed after PIBMA treatment. This solution was also used for the 
overlay incubation steps. The autoradiographs obtained (Fig. 4.8 A and B) show that 
the background was even higher than that previously encountered. Although there did
125seem to be some binding of I-labelled material, the degree of background made 
useful interpretation impossible. The pitting seen was almost as bad as that observed 
seen in the first overlay experiment.
4.2.5 Binding of lectins to glycolipids separated on TLC plates
BEC were collected from one donor (blood group A) over a period of two 
weeks and stored at -20<^ C until required. The total glycolipids were then extracted 
from the pooled BEC. This BEC lipid preparation replaced the lipid extract used 
previously that had been isolated from the BEC of four donors (section 4.2.1). 
Biotinylated lectins from Bauhinia purpurea, Triticum vulgaris and Vicia villosa were 
purchased from Sigma. The use of lectins would allow for partial characterisation of the 
separated lipids. TLC plates were prepared as previously and PBS-BSA was used as 
the blocking and binding buffer. The lectins were diluted in blocking buffer prior to 
overlay analysis. Unbound lectin was removed by washing and biotinylated material
125was detected by probing with I-streptavidin followed by autoradiography. Bauhinia 
purpurea agglutinin has an affinity for Gal(pl-3)GalNAc, N-acetylgalactosamine 
(GalNAc) and D-galactose (Irimura and Osawa, 1972), the lectin from Triticum 
vulgaris (wheatgerm agglutinin) has an affinity for GlcNAc and Vicia villosa lectin has 
an affinity for GalNAc. The autoradiographs obtained for these experiments are shown 
in Fig. 4.9 A  Band C.
The autoradiogram of the TLC plate overlaid with Bauhinia purpurea agglutinin 
showed a number of lipid components that were able to bind to this lectin. This lectin 
will bind to a number of different carbohydrate structures. It has highest affinity for 
compounds containing the Gal(jf 1 -3)GalNAc structure. It was seen to bind to two of 
the control glycolipids (CDH and CTH) but to none of the other controls. Two lipid
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1251-EP B ^^I-whole cells
Fig 4.8 TLC overlay analysis of the binding of ^^ I^-EP and whole cells from C 
albicans GDH 2346 to separated glycolipids
EP and whole cells were iodinated as described in Materials and Methods. TLC plates 
were prepared and blocked as described in Results section 4.2.4 and then overlaid with 
^^ I^-EP and ^^ I^-whole cells. Binding was detected by autoradiography. Lanes 1, 2pg 
each of galactosylceramide (CMH), lactosylceramide (CDH), trihexosylceramide 
(CTH), globoside (GL4), and Forssman glycolipid (FORS); lanes 2, 80 pg BEC total 
lipid extract; lanes 3, 500 pg sRBC total lipid extract.
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components from the BEC lipid extract with mobility similar to CDH and CMH were 
also bound by this lectin (Fig. 4.9A). This suggests that the BEC extract contains lipid 
components that are similar to CDH and CMH both in lectin binding ability and TLC 
migration. Two additional BEC lipid components were bound by this lectin. One was 
very close to the origin (Rf 0.08) which suggests that it contained a large number of 
sugar residues, and the other was close to the solvent front (Rf 0.79). Three 
components from sRBC lipid extract were also bound by the lectin from Bauhinia 
purpurea. One component was very close to the origin with an Rf value similar to a 
component from BEC (Rf 0.08). The second component had a similar Rf value to CDH 
(Rf 0.62)and the third component (close to the solvent front) had a similar Rf value to 
another BEC lipid component (Rf 0.79).
The lectin from Triticum vulgaris (wheatgerm agglutinin) binds to molecules 
containing GlcNAc with preferential binding to dimers and trimers of GlcNAc. Not 
surprisingly, none of the lipid standards was bound by this lectin, as they lack GlcNAc. 
Similarly, not one of the BEC lipids bound the lectin (Fig. 4.9B). This was slightly 
surprising as one would expect GlcNAc to be relatively common on BEC. Four sRBC 
lipid components were seen to bind to this lectin, however. These components had Rf 
values between those of CDH and CMH. One component was intensely labelled with 
the other three relatively poorly indicated.
The lectin from Vicia villosa is specific for GalNAc-containing molecules. As 
expected, the two lipid standards with terminal GalNAc bound the lectin, but not very 
intensely. Three components from the BEC lipid extract were bound by this lectin (Fig. 
4.9C). Two very poorly labelled components were seen close to the origin (Rf 0.05 and
0.08). Above them was a large and intensely stained component which migrated to a 
region that covered the area that FORS and GL4 migrated to in the control lipid lane 
(Rf 0.12-0.26). This could indicate that components similar to both FORS and GL4 are 
present in BEC. Two lipid components from sRBC bound to this lectin. One was close 
to the origin (Rf 0.05), the other had an Rf value similar to GL4 (Rf 0.24).
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Fig. 4.9 Binding of lectins to glycolipids separated on thin-layer chromatograms.
TLC plates were prepared and blocked as described in Results 4.2.5 and then overlaid 
with biotinylated lectins from Bauhinia purpurea, Triticum vulgaris and Vicia 
villosa. Each lectin was used at a concentration of 10 pgml"^ (10 ml reaction volume). 
Plates were then overlaid with ^^^I-streptavidin (30 pCi/pg; 5 pCi in 10ml reaction 
volume) and binding detected by autoradiography. Lanes 1, 2pg each of 
galactosylceramide (CMH), lactosylceramide (CDH), trihexosylceramide (CTH), 
globoside (GL4), and Forssman glycosphingolipid (FORS); lanes 2, 80 pg BEC total 
lipid extract; lanes 3, 500 pg sRBC total lipid extract.
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There was less background on these autoradiographs than had been encountered
125previously. This may have been due to the use of I-streptavidin. However, there was 
clearly some deterioration of the TLC plates. Pitting was again visible on the surface of 
the plates which corresponded to "hot spots" on the autoradiograph. The pitting is
probably due to silica loss during the extensive incubation and washing stages. Non-
125specific binding of biotinylated lectin and/or I-streptavidin to these pits is likely as the 
blocking activity of the PIBMA coating will have been lost at these places.
4.2.6 Binding of biotinylated EP from C albicans GDH 2346 and GDH 
2023 to glycolipids separated on TLC plates
EP preparations from strains GDH 2346 and 2023 were first biotinylated and 
then subjected to TLC-overlay analysis. The protocol was similar to that used 
previously (section 4.2.5) but with minor modifications intended to reduce background 
and TLC plate deterioration. The TLC plates were loaded with lipid and run as before. 
After air drying, the plates were subjected to an enhanced PIBMA treatment as follows. 
Each plate was submerged in the PIBMA solution for 1 min, removed and allowed to 
air-dry. This was repeated a further two times and then the plates were blocked as 
previously and overlaid with biotinylated EP. The autoradiographs obtained are shown 
in Fig. 4.10 A and B. The binding of biotinylated EP from strain GDH 2346 to some 
separated lipids on the TLC plate was clearly visible. Binding was seen to two lipid 
components from the sRBC and one lipid component fi*om BEC. Less intense binding 
to one fiirther component from BEC was also observed. There was no binding to any 
of the neutral glycolipid controls. The background seen in this experiment was the 
lowest yet encountered and the pitting observed previously was virtually abolished.
125This may have been due to the use of I-streptavidin to detect biotinylated proteins in 
place of the direct protein iodination system that had been used previously. The 
enhanced PIBMA treatment may have also contributed to the reduction in background. 
Biotinylated EP from strain GDH 2023 did appear to bind some lipid components from 
sRBC but only very poorly (Fig. 4.10B), In a previous experiment (section 4.2.3), there
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Fig. 4.10 Binding of biotinylated EP from C albicans GDH 2346 and 2023 to 
glycolipids separated on thin-layer chromatograms.
EP was biotinylated as described in Materials and Methods. TLC plates were prepared 
and blocked as described in Results section 4.2.6, and overlaid with biotinylated EP. 
Plates were then overlaid with ^^^I-streptavidin (30 pCi/pg; 5 pCi in 10ml reaction 
volume) and binding detected by autoradiography. Lanes 1, 2pg each of 
galactosylceramide (CMH), lactosylceramide (CDH), trihexosylceramide (CTH), 
globoside (GL4), and Forssman glycolipid (FORS); lanes 2, 80 pg BEC total lipid 
extract; lanes 3, 500 pg sRBC total lipid extract.
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125was binding of I-EP from GDH 2023 to four lipid components from sRBC. The 
weak binding seen in this experiment may have been due to poor biotinylation or 
damage to EP as a result of biotinylation, or it may have been a consequence of the 
enhanced PIBMA treatment.
4.2.7 Binding of biotinylated whole cells of different C albicans strains to 
glycolipids on TLC plates.
The binding of biotinylated whole cells from five C. albicans strains (GDH 2346, 
GRI 681, GRI 682, MRL 3153 and "outbreak") to glycolipids from BEC, sRBC and a 
number of neutral glycolipid standards (CMH, CDH, CTH, GL4, FORS), was 
examined by the chromatogram overlay assay. Bound cells were visualised by the
125addition of I-streptavidin followed by autoradiography. The autoradiographs from 
these experiments are shown in Fig. 4.11. All five strains were found to have similar 
binding patterns. By comparison with an identical chromatogram overlaid with 
biotinylated Ulex europaeus lectin (UE) it appeared that the cells were able to bind to 
two glycolipids with mobilities similar to those of lipids expressing H-blood group 
antigen. The cells also bound to an additional lipid from BEC, which was not bound by 
UE, and which had a mobility (Rf 0.04) similar to that of a lipid bound by the GalNAc- 
specific lectin from Helixpomatia (Fig. 4.11). However, GalNAc alone is unlikely to be 
the receptor as the yeast cells did not bind to the GalNAc containing neutral glycolipid 
standards, GL4 and FORS, both of which were detected by Helix pomatia lectin. None 
of the strains tested bound to lactosylceramide, recently proposed as a receptor for C. 
albicans (Jimenez-Lucho et ah, 1990). These results are consistent with previous 
experiments involving sugars and lectins (Critchley and Douglas, 1987b) which 
suggested that strains GDH 2346, GRI 681, GRI 682, and MRL 3153 all share a 
common adhesion mechanism involving fucose-containing receptors.
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4.2.8 Binding of biotinylated EP and purified adhesin from C albicans 
GDH 2346 to glycolipids on TLC plates.
The binding of EP and PA from strain GDH 2346 to glycolipids was examined by
125the chromatogram overlay assay. Bound material was visualised by the addition of I- 
streptavidin followed by autoradiography. The autoradiographs from these experiments 
are shown in Fig. 4.12. The binding patterns observed for EP and PA were remarkably 
similar. Both bound to glycolipids from BEC and sRBC but not to any of the neutral 
glycolipid standards (including lactosylceramide). By comparison with a chromatogram 
overlaid with biotinylated Ulex europaeus lectin (UE) it appeared that the EP and PA 
were able to bind to two glycolipids with a similar Rf value to lipids expressing H-blood 
group antigen. Interestingly, in the previous experiment (section 4.2.7), whole cells 
from strain GDH 2346 (and four other strains) were found to bind three lipid 
components from BEC - two with mobilities similar to those of lipids expressing H- 
blood group antigen, and a third with a mobility similar to that of a GalNAc-containing 
lipid. The component on the C. albicans cell surface that binds the GalNAc- containing 
lipid may not be released as part of EP, or the ability of EP to bind to this component 
may be lost during thé purification procedure.
4.2.9 Binding of biotinylated whole cells and EP from strain GDH 2023 to 
glycolipids on TLC plates.
The binding of whole cells and EP (both biotinylated) from strain GDH 2023 to 
glycolipids was examined by the chromatogram overlay assay. Biotin-labelled material
125was visualised by the addition of I-streptavidin followed by autoradiography. The 
autoradiographs from these experiments are shown in Fig. 4.13. Whole cells and EP 
from strain GDH 2023 were found to bind to four glycolipids from both BEC and 
sRBC (not bound to by whole cells and EP from strain GDH 2346); By comparison 
with an identical chromatogram overlaid with biotinylated Griffonia simplicifolia lectin 
II (GlcNAc specific) it appeared that the cells were able to bind to glycolipids with 
similar Rf values to lipids expressing GlcNAc from BEC and sRBC. This strain did not
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Fig 4.12 Binding of C albicans GDH 2346 EP, and PA to glycolipids separated 
on thin-layer chromatograms.
Glycolipids were obtained and separated as described in Materials and Methods. 
Glycolipids were overlaid with biotinylated EP and PA and the biotinylated lectin from 
Ulex europaeus (UE). After washing, the plates were overlaid with ^^ I^-streptavidin 
and binding was detected by autoradiography. Lanes 1, 2pg each of galactosylceramide 
(CMH), lactosylceramide (CDH), trihexosylceramide (CTH), globoside (GL4), and 
Forssman glycolipid (FORS); lanes 2, 80 pg BEC total lipid extract; lanes 3, 500 pg 
sRBC total lipid extract.
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bind to any of the neutral glycolipid standards (including lactosylceramide). These 
results are consistent with previous experiments involving sugars and lectins (Critchley 
and Douglas, 1987b) which suggested that strain GDH 2023 has an adhesion 
mechanism involving GlcNAc containing receptors.
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Fig 4.13 Binding of C albicans GDH 2023 (whole cells and EP) and Griffonia 
simplicifolia lectin H (GS H) to glycolipids separated on thin-layer 
chromatograms.
Glycolipids were obtained and separated as described in Materials and Methods. 
Glycolipids were overlaid with biotinylated C. albicans GDH 2023 whole cells, EP and 
biotinylated GS II. Plates were then overlaid with  ^^ I^-streptavidin and binding detected 
by autoradiography. Lanes 1, 2pg each of galactosylceramide (CMH), 
lactosylceramide (CDH), trihexosylceramide (CTH), globoside (GL4), and Forssman 
glycolipid (FORS); lanes 2, 80 pg BEC total lipid extract; lanes 3, 500 pg sRBC total 
lipid extract.
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DISCUSSION
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1. ADHESION OF C. ALBICANS IN  VITRO
Adhesion plays an important part in the pathogenesis of many microbial 
infections. Candida species have been shown to bind to a variety of surfaces, including 
neutrophils (Diamond et a l, 1978), vascular endothelium (Klotz et al., 1983), and inert 
materials such as denture acrylic (Samaranayake, and MacFarlane, 1980; McCourtie and 
Douglas, 1981). A number of investigators have studied the adherence of C. albicans to 
buccal epithelial cells (BEC) (King et al., 1980; Macura et al., 1983; Critchley and 
Douglas, 1985; Brassart et al., 1991). C. albicans has been found to be the most adherent 
Candida species with C. tropicalis moderately adherent and C. parapsilosis only slightly 
adherent to BEC.
There seems to be a clear relationship between ability to adhere to epithelial cells 
and the capacity for colonisation and infection of mucosal surfaces. Liijemark and Gibbons 
(1973) measured the attachment of C. albicans to rat buccal cells employing a method 
that had been previously developed for quantitating bacterial adherence. A modification of 
this procedure was used by Kimura and Pearsall (1980) which has been adopted by a 
number of other laboratories (Douglas, 1987). Radiolabelling (King et al., 1980) and 
visual determination (Douglas et al., 1981) of yeast adherence to epithelial cells have been 
used. The visual method employed in this study involves the incubation of standardised 
suspensions of yeasts and BEC. After incubation, the cell suspensions are passed through 
transparent polycarbonate filters that have a pore size of 12pm. This pore size is sufficient 
to let unbound yeasts pass through but prevents the passage of BEC and attached yeasts. 
The cells on the filters are fixed, stained, and the number of adherent yeasts can be 
determined by microscopy. This method has been used extensively in previous studies 
(Douglas et al., 1981; McCourtie and Douglas, 1984; Critchley and Douglas, 1987a, b; 
Tosh, 1991) and it permits the examination of a number of factors affecting the adhesion 
process.
The adhesion of Candida can also be measured by the use of radiometric assays 
(King et al., 1980). These assays involve growing yeasts in medium containing ^^ *C- 
glucose prior to incubation with epithelial cells. This approach is less laborious and time
167
consuming than the visual technique described above, but does not permit monitoring of 
adhesion to individual epithelial cells or yeast to yeast coadherence (Douglas, 1987; 
Ghannoum and Abu-Elteen, 1991).
Odds (1988) criticised the filtration method of separating non-adherent yeasts fi’om 
epithelial cel\~Candida mixtures. He suggested that shear forces from currents in the 
washing fluids may remove adherent yeasts and impact non-adherent yeasts on to 
epithelia. However, it is possible that the shear forces described by Odds would only 
remove loosely associated yeasts, leaving those yeasts that are firmly attached. Also, the 
impacted non-adherent yeasts on the epithelial cells are likely to be removed by the 
washing steps that normally follow the filtration procedure. Another possible criticism of 
the in-vitro adhesion assay is the variation encountered, both from donor to donor, and 
even from day to day with the same donor. In this study, a number of steps were taken to 
minimise this variation. The same BEC donor was used throughout the study, and cells 
were collected at the same time of day for each experiment. The assays were performed 
three times in triplicate with at least a 48-hour gap between assays to allow for buccal 
epithelial cell regeneration in the donor. Counting bias was minimised by coding the assay 
filters and reading them ‘blind’. For every sample, 100 epithelial cells were examined and 
the number of adherent yeasts counted. Control filters were always included to check for 
the presence of endogenous yeast flora.
1,1 Effect of EP on yeast adhesion in vitro
Previous work in this laboratory has shown that the adhesion of some strains of 
C. albicans to BEC is substantially increased after growth in defined media containing 
certain sugars (notably galactose) as the carbon source (Douglas et al., 1981; McCourtie 
and Douglas, 1984; Critchley and Douglas, 1987a). This increase in adhesive ability seems 
to be a result of the production of an additional fibrillar-fioccular layer on the yeast cell 
surface (Douglas, 1987). Prolonged incubation of C. albicans in medium containing 
galactose causes release of surface fibrils, and EP can be isolated from culture 
supernatants. Pretreatment of BEC with EP has been shown to inhibit adhesion of C.
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albicans. The interaction seems to be strain specific as EP from one strain, GDH 2023, 
failed to inhibit the adhesion of a second strain, GDH 2346 (Critchley and 
Douglas, 1987a). Pretreatment of EP with heat, dithiothreitol, and proteolytic enzymes 
(except papain) significantly reduced the blocking ability of EP, whereas pretreatment with 
sodium periodate and a-mannosidase had no effect on this ability (Critchley and Douglas, 
1987a). These findings suggest that EP (composed primarily of mannoprotein) contains an 
adhesin, and that the protein portion of the mannoprotein is more important in the 
adhesion process than the carbohydrate portion,
A variety of methods have been employed in the preparation of EP from culture 
supernatants. McCourtie and Douglas (1985) isolated EP by acetone precipitation, 
Critchley and Douglas (1987a) used prolonged dialysis, and Tosh and Douglas (1992) 
employed dialysis followed by ultrafiltration. Throughout this study, EP was produced by 
a method very similar to that of Tosh and Douglas (1992). The exclusion limit of the 
ultrafiltration membrane employed in this study was 3.5 kDa in place of the 5 kDa filter 
used previously. EP (strain GDH 2346) prepared in this study had a protein content of 
8.04% and carbohydrate content of 82% (Table 1.1). EP from strain GDH 2023 prepared 
in this study had a protein content of 5.5% and a carbohydrate content of 84.4% The 
values for strain 2346 are similar to those obtained by Tosh (7.2% and 79.2% for protein 
and carbohydrate respectively). However, the values for strain GDH 2023 differ slightly 
from those obtained by Tosh (10.5% and 72.4% for protein and carbohydrate, 
respectively). The only difference in the method of EP preparation between the two 
studies was the ultrafiltration membrane employed. The 3.5 kDa filter used in this study 
may have retained slightly more carbohydrate-containing material than a 5 kDa filter which 
would result in a higher percentage of carbohydrate and a lower percentage of protein. 
The values obtained for EP from strain GDH 2346 are very similar to those obtained by 
Tosh. This may mean that the supernatant of this strain did not contain additional 
carbohydrate components, or that both additional protein and carbohydrate components 
were retained resulting in a compositional analysis similar to that previously obtained by 
Tosh.
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1.1.1 Effect of EP concentration on yeast adhesion
For adhesion-inhibition experiments with EP, yeasts were grown to stationary 
phase at 3TC  with shaking in yeast nitrogen base (Difco) containing 500mM galactose as 
a carbon source. Under these conditions, C albicans grows exclusively in the yeast 
phase. EP from two strains (GDH 2346 and GDH 2023) was prepared and used to pre- 
treat BEC prior to adhesion assays with yeast cells from the homologous strains. The 
concentrations of yeast cells used were 5x10  ^and 1x10® cells ml"^  for strains GDH 2346 
and GDH 2023 respectively. Pre-incubation of BEC with increasing concentrations (2-20 
mg ml'*) of EP from GDH 2346 inhibited yeasts from the homologous strain by almost 
60% (Fig. 1.1). This result is consistent with the findings of Critchley and Douglas 
(1987a). In a similar experiment involving strain GDH 2023, yeast adhesion was inhibited 
by just over 40% (Fig. 1.1). Tosh (1991) performed two adhesion-inhibition assays using 
EP derived from GDH 2023 to block the adherence of the homologous strain. Adhesion 
was inhibited by 52.8 and 47.8%. These values are higher than the maximum value 
obtained for this strain in the present study (40.9%). As mentioned previously, EP from 
strain GDH 2023 prepared in this study had a lower protein content (5.5%) and higher 
carbohydrate content (84.4%) than that prepared by Tosh (10,5% and 72.4% for protein 
and carbohydrate respectively). The lower adhesion-inhibition activity may have been due 
to the lower protein content of the EP prepared in this study. However, the graph of the 
effect of EP concentration on yeast adhesion suggests that maximum inhibition had been 
reached at around 40%. The most likely explanation for the differences between the two 
studies is the difference in BEC donor.
Two other groups have demonstrated the ability of EP from C. albicans to inhibit 
adhesion of yeasts to BEC. Brassart et al (1991) found that EP could inhibit the adhesion 
of C. albicans cells of the homologous strain by up to 52%. They prepared EP using the 
method of Critchley and Douglas (1987a). More recently, Jenq et a l  (1994) isolated EP 
with adhesion-inhibition activity of 42%. This level of inhibition is similar to that for the 
EP from GDH 2023 prepared in this study.
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1.1,2 Effect of yeast cell concentration on adhesion-inhibition values
It has previously been reported that the attachment of yeasts to epithelial cells 
gradually increases as the ratio of yeasts to epithelial cells increases in assay mixtures 
(Kimura and Pearsal, 1980; King et al, 1980). BEC were pretreated with EP from strain
I
GDH 2346 prior to incubation with yeast cells from the homologous strain at two 
different concentrations; 1x10  ^and 5x10  ^yeasts ml *. The results are shown in Table 1.2. 
Inhibition of adhesion for the two concentrations of yeasts was not significantly different. 
Yeasts at a concentration of 1x10  ^ ml'* were inhibited by 49.1% while yeasts at 5x10  ^
yeasts ml * were inhibited by 48.5%, when compared to PBS-treated controls. The 
counting of attached yeasts was more difficult and time consuming when the higher yeast 
concentration was used, as some BEC had as many as 130 bound yeasts. A yeast 
concentration of 1x10  ^was adopted for all subsequent adhesion-inhibition assays.
Data from King et al. (1980) indicates that the relationship between ratio of yeast cell 
to epithelial cell in adhesion assays is not linear. They found that yeast-yeast co-adherence 
was more common when higher yeast : epithelial cell ratios were employed. This was 
apparently due to the attachment of unbound yeasts to those already bound to the 
epithelial cells, and not a result of yeast aggregation in solution. Yeast-yeast co-adherence 
could inflate the adhesion values obtained for the assay. High numbers of attached yeasts
are difficult to count and could result in an underestimate of yeast numbers.
1.1.3 Distribution of bound yeasts among BEC
The number of yeasts attached to individual BEC can vary greatly in in-vitro 
adhesion-inhibition assays. A large number of BEC appear to have no yeasts attached 
while some have their entire surface covered in yeasts. Sandin et ah (1987) performed 
adhesion assays with Candida and BEC in the ratio of 10:1 and found that 41% of BEC 
had no yeasts attached. They also observed that only 12% of BEC had 9 or more attached 
yeasts and that 52% of the total yeasts were attached to this 12% of cells. In the present 
study, a similar experiment was performed which examined the distribution of bound yeast
■'ion BEC at two different yeast-BEC ratios. At a yeast-BEC ratio of 50:1, 33.7% of BEC
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had no yeasts attached and only 13.9% of BEC had 9 or more attached yeasts. However, 
46% of the total yeasts were attached to this 13.9%. These results are comparable to the 
results of Sandin et al. (1987) and are shown in Table 1.3. When the yeast-BEC ratio was 
increased to 250:1, only 21.1% of BEC had no yeasts attached and 32.9% of BEC had 9 
or more attached yeasts. Sandin et al. took their study a stage further by examining the 
size of BEC cells and assessing the number of yeasts bound to four size subgroups. The 
subgroups had size ranges 0-35, 36-70, 71-105, and > 106pm. The most abundant size of 
BEC was 36-70 pm, making up 73% of the total population. The 71-105 pm group 
represented 24% and the 0-35 and > 106pm groups made up < 3 and < 1 % respectively. 
The 36-70 pm group had the highest average number of attached yeasts per BEC at 3, 
Both the 0-35 and 71-105 pm groups had an average of 2.7 attached yeasts. The >106 
pm averaged only 2.1 yeasts per BEC. They suggested that the differences between sub­
populations could be attributed to different levels of receptor expression and/or the 
presence of endogenous bacteria.
Oral thrush and acute atrophic candidiasis are associated with oral antibiotic therapy, 
suggesting that endogenous bacteria normally inhibit the attachment of pathogenic yeasts 
to the oral mucosa. Cox (1983) studied the adherence of C. albicans to BEC in children 
undergoing antibiotic therapy. Adherence was tested daily in 15 initially noncolonised, 
previously healthy children receiving antibiotics. The number of adherent background 
bacteria decreased significantly on the first day of narrow- or broad-spectrum antibiotic 
therapy. C. albicans adherence increased significantly on the second day and oral 
colonisation with C. albicans occurred on the third day of therapy.
The buccal mucosa is composed of stratified squamous epithelium. BEC are 
initially plump cuboidal cells with rounded upper ends. Above this basal layer are 
additional layers of irregularly polyhedral cells. BEC migrate towards the fi-ee surface of 
the mucosa as new cells are formed beneath them (Fawcett, 1986). As they migrate, the 
cells become more differentiated and cell surface receptors, such as blood group antigens, 
undergo chemical changes brought about by glycosylation enzymes (Vedtofte et al., 
1984). They also become more flattened and appear larger due to this shape change. They
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are eventually colonised by endogenous bacteria when access is made possible by the 
sloughing off of the cells immediately above them. They undergo further flattening before 
they themselved are sloughed off. This neatly explains the results obtained by Sandin et al. 
(1987). The smallest cells, that probably originated from the deepest epithelial layer 
(present only in small numbers and not fully differentiated), had quite a few yeasts 
attached. These cells are unlikely to have been colonised by bacteria. However, because 
they were less mature, they will have had few receptors. The larger cells (most abundant 
and hilly developed) had the most attached yeasts. Only very few bacteria will have been 
able to colonise these cells, and so a large number of receptors would be available. The 
closer the cells get to the surface of the mucosa, the larger (flatter) they become, and the 
greater the chance of bacterial colonisation. Bacteria are difficult to remove from EEC 
prior to adhesion assays and so the larger, more superficial cells exhibited relatively low 
yeast adhesion.
1.1.4 Effect of papain degradation on the adhesion-inhibition activity of EP
McCourtie and Douglas (1985) and Critchley and Douglas (1987a) were able to 
inhibit the adhesion of C. albicans to EEC by pretreatment of the EEC with EP derived 
from culture supernatants of the yeast grown in medium rich in galactose. This finding 
suggested that the EP (composed primarily of mannoprotein) contained an adhesin. EP 
subjected to heat, chemicals, and enzymes was examined for blocking activity. Critchley 
and Douglas, 1987a). Heat (60°C, 15min), dithiothreitol (DTT), mild acid, and the 
proteases chymotrypsin, bromelain, and pronase significantly destroyed the blocking ability 
of EP. However, periodate and a-mannosidase had no effect on this ability. This suggests 
that the protein part of the mannoprotein is important in mediating adherence.
Earlier work had demonstrated that treatment of whole cells with proteolytic 
enzymes (Sobel et al, 1981) and reducing agents (Lee and King, 1983) such as (3- 
mercaptoethanol and DTT caused a reduction in yeast adhesion. Interestingly, Critchley 
and Douglas (1987a) demonstrated that papain treatment of EP appeared to enhance its 
ability to inhibit adhesion. This effect was attributed to the possible production of peptide
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fragments that could more easily bind to BEC receptors and hence block adhesion. Papain 
is a cysteine protease i.e. it has an essential cysteine residue at its active site that must be 
maintained in the reduced form for activity (Butler, 1989). However, papain was 
previously used to digest EP under non-reducing conditions (Critchley and Douglas, 
1987a; Tosh and Douglas, 1992).
In this study, EP was treated with papain under both reducing and non-reducing 
conditions (Table 1.4). EP treated with the enzyme under non-reducing conditions 
retained its ability to inhibit adhesion whereas EP treated with papain under reducing 
conditions was found to have lost this activity. It appears that the use of papain to degrade 
EP under non-optimal conditions in previous studies resulted in the production of EP 
fragments (possibly peptides) that were capable of binding to epithelial cell receptors more 
efficiently than untreated EP. When papain is used under reducing conditions, the 
adhesion-inhibition activity of EP is abolished, presumably, because of extensive damage 
to the protein portion of the molecule. This result confirms the importance of the protein 
portion of the candidal mannoprotein in the adhesion process.
2. HPLC ANALYSIS OF EP
Previous work in this laboratory has examined the biochemical properties of EP. 
The search for the component(s) in EP that is responsible for adhesion-inhibition has 
involved the use of a number of chemical and enzymic treatments. In this study, EP was 
subjected to some of the treatments previously found to have an effect on its adhesion- 
inhibition activity, prior to analysis by reverse-phase high performance liquid 
chromatography (RP-HPLC). This HPLC system is commonly used to resolve and prepare 
products of proteolysis for further analysis.
The column used in this study contained a hydrophobic stationary phase octadecyl 
(C l8) silica. The solvent system employed was a gradient of acetonitrile, in a weak 
aqueous solution of trifluoroacetic acid (TFA), an ion-pairing agent which also acts to 
maintain protein solubility. The majority of proteins and peptides adsorb to the stationary 
phase under these conditions and are subsequently eluted by decreasing the polarity of the
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mobile phase. This is achieved by the slow introduction of a water miscible organic solvent 
(HPLC grade acetonitrile). Eluted proteins and peptides are detected by U.V. absorbance. 
At a wavelength of 280nm, only proteins and peptides that contain aromatic residues will 
be detected. However, at wavelengths of between 200-23Onm, the peptide bond absorbs 
light and this range is usually very sensitive. Detection sensitivity at 280 nm and 208 nm 
was examined. The absorbance values obtained for 280nm were very poor so all 
subsequent HPLC analyses were carried out at 208 nm.
On each occasion the HPLC machine was to be used, a number of steps were taken 
to prepare the column and to ensure that the solvent was of a suitable quality. The HPLC 
pumps were flushed with HPLC-grade water then HPLC-grade acetonitrile (both 
degassed). The column was attached and flushed with HPLC-grade water then HPLC- 
grade acetonitrile. The absorbance was monitored while the column was primed with 
acetonitrile-TFA and, once a stable baseline was achieved, a blank run was started. This 
consisted of loading a 200pl sample of acetonitrile-TFA, to check for injection effects, and 
also to monitor the effect of the acetonitrile gradient on absorbance. The blank run was 
followed by the sample runs. Periodically, insulin was loaded as a sample to check the 
efficiency of the column and detection system. A fine sharp peak was always observed 
(Fig.2.1 C).
EP from C. albicans strain GDH 2346 was subjected to HPLC analysis. This run 
indicated that there are a large number of distinct proteins present in EP from this strain, 
with varying degrees of hydrophobicity. Four major peaks and a number of smaller peaks 
were seen. Similar traces were obtained each time a sample of untreated EP was run.
In a recent study, Hazen and Hazen (1992) used hydrophobic interaction (HIC)- 
HPLC to examine cell wall proteins extracted from both hydrophobic and hydrophilic C 
albicans cells by (31-3 glucanase digestion. Both HIC-HPLC and RP-HPLC separate 
proteins on the basis of their surface hydrophobicity. Proteins are eluted from RP-HPLC 
columns using organic solvents whereas proteins are eluted with descending salt gradients 
from HIC-HPLC columns. The most striking difference observed observed by Hazen and 
Hazen between the surfaces of hydrophobic and hydrophilic cells was in the large amount
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of relatively hydrophilic protein derived from the surface of hydrophilic cells in comparison 
with hydrophobic cells. The amounts of hydrophobic proteins seen in the two cell types 
were similar. It was concluded that hydrophobic proteins are present on both cell types. 
However, in hydrophilic cells, hydrophobic proteins are masked by the hydrophilic 
proteins resulting in cells that are hydrophilic. C. albicans cell-surface hydrophobicity 
influences both adhesion and virulence of this organism and it was suggested that a simple 
mechanism, such as decreased glycosylation, may result in changes in cell-surface- 
hydrophobicity. Hazen and Glee (1994) took these results a stage further. They examined 
the glycosylation level of three hydrophobic cell wall proteins and one hydrophilic protein 
derived from the surface of yeast cells. They found that the hydrophobic proteins were 
glycosylated to a far lesser extent than the hydrophilic proteins and suggested that changes 
in glycosylation may determine exposure of hydrophobic protein regions at the cell 
surface. The effect of deglycosylation on the hydrophobicity of EP components was 
examined in the present study.
The enzyme N-glycanase cleaves the N-glycosidic bond between N-acetyl-D- 
glucosamine and asparagine on the protein backbone of glycoproteins, without damaging 
peptide bonds (Tarentino et aL, 1985). Previous work by Tosh and Douglas (1992) had 
shown that N-glycanase treatment of EP enhanced the adhesion inhibition activity of EP. 
This enzyme has also been used in the preparation of deglycosylated glucomannoproteins 
from Saccharomyces cerevisiae (Van Rinsum et al, 1991). Two samples of EP were 
prepared: one was treated with the enzyme, the other was treated under the same 
conditions but in the absence of the enzyme. A third sample of enzyme alone was included 
as a further control. The HPLC trace of N-glycanase-treated EP (Fig. 2.2 A) was not 
greatly different from the trace of EP incubated under the same conditions but in the 
absence of N-glycanase. The four major peaks were still visible but a number of new peaks 
could also be seen. The first two peaks appeared split in two and there followed a new 
small sharp peak. The largest peak appeared unchanged as did the final sharp peak. A 
control HPLC run with N-glycanase alone produced a trace that was not visibly different 
from that of the blank run. These results suggest that the N-glycanase does not have a
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great effect on the RP-HPLC retention of most EP components but that certain visible 
changes are apparent. Some of these changes may be associated with the production of 
more adhesive fragments that have greater adhesion-inhibition activity than the parent EP 
molecules.
The second experiment on EP degradation involved the treatment of EP with 
NaOH. Base-labile oligosaccharides linked to the protein through serine or threonine 
residues are removed by the action of NaOH (Ballou, 1976). Mild alkali was previously 
found to enhance the ability of EP to inhibit adhesion of C. albicans to BEC (Critchley 
and Douglas, 1987a). The optimum conditions for this effect were determined by Tosh
(1991). He found that 0. IM NaOH produced maximal inhibitory effect. Van Rinsum et al
(1991) performed some work on the breakdown of glycoproteins from the cell wall of 
Saccharomyces cerevisiae by enzymic and chemical means They employed both N- 
glycanase and NaOH treatments to remove all traces of carbohydrate from the protein 
backbone. In the present study, NaOH treatment was observed to have a profound effect 
on the HPLC trace of EP when compared with a trace of EP incubated under the same 
conditions but with PBS in place of NaOH. In general, there was a clear shift from a 
relative abundance of hydrophilic proteins to more hydrophobic proteins. This change in 
the proportion of hydrophilic components could be consistent with the removal of 
oligosaccharide chains from Ser and Thr residues on the protein backbones of the 
glycoproteins. This is likely to have resulted in the exposure of hydrophobic regions of the 
protein that were previously unavailable for interaction with the hydrophobic column 
packing. NaOH treatment may also produce some protein degradation. Van Rinsum et al
(1991) employed both N-glycanase and NaOH treatment on S, cerevisiae proteins and 
were able to remove all traces of carbohydrate from the protein backbone when both the 
treatments were used in conjunction. In their study, the NaOH was used at a concentration 
of 0.1 M and the reaction mixture was incubated at 20®C for 24H. They found that longer 
incubation times or higher temperatures resulted in protein damage. In the present study, 
the conditions used were similar to those employed by Van Rinsum et a l (1991); 
however, the temperature of incubation employed was 30°C. This higher temperature may
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have resulted in some protein degradation. Previous work by Tosh and Douglas (1992) 
found that this higher temperature was of use in the preparation of adhesion-blocking 
material from EP. It is probable that if protein was being damaged by the action of NaOH, 
the treatment was not damaging to those protein fragments that are able to block 
adhesion, and may even aid their production. Van Rinsum et al (1991) found that 
approximately 70% of the mannose residues on S. cerevisiae mannoproteins were O- 
glycosidically linked to the protein. They also found that the removal of O-linked 
carbohydrate chains had no effect of the ability of N-glycanase to act on N-linked chains. 
This suggests that N-glycanase is not sterically hindered by O-linked carbohydrate chains 
and can be used to treat proteins prior to P-elimination by NaOH.
The third experiment on EP degradation involved the treatment of EP with papain. 
Previous work by Critchley and Douglas (1987a) showed that a number of proteases, 
chymotrypsin, bromelain, and pronase, significantly decreased the ability of EP to inhibit 
adhesion. This suggested that the protein part of the mannoprotein is important in 
adhesion-inhibition. Interestingly, the protease papain or dilute alkali treatment of EP 
appeared to enhance its ability to inhibit adhesion. When these two treatments were 
combined, substantially greater inhibition of adhesion was observed. This increased 
inhibition was attributed to the production of peptide fragments which could bind 
epithelial cell receptors more easily than the parent molecule. An experiment was 
performed in order to examine the effect of papain treatment (under non-reducing 
conditions) on EP. The HPLC trace of papain-treated EP was considerably different from 
the trace of EP incubated under the same conditions but in the absence of papain. The EP 
mannoproteins appeared greatly fragmented with a large number (19) of sharp peaks, 
supporting the theory of peptide production. Most of the fragments produced were of 
relatively high hydrophobicity compared to the trace of EP not exposed to papain. A 
control HPLC run with papain and az-macroglobulin alone produced a trace that was not 
greatly different from that of a blank run. A small peak was observed which was most 
likely to be of papain-a2-macroglobulin complexed. The corresponding region on the EP, 
papain and az-macroglobulin trace shows no sign of this complex due to the presence of
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large amounts of EP digestion products. As was mentioned previously, papain is a cysteine 
protease i.e. it has an essential cysteine residue at its active site that must be maintained in 
the reduced form for activity (Butler, 1989). However, papain was previously used to 
digest EP under non-reducing conditions (Critchley and Douglas, 1987a; Tosh and 
Douglas, 1992). It appears that the use of papain to degrade EP under non-optimal 
conditions, as in previous studies, results in the production of EP fragments (possibly 
peptides) that are capable of binding to epithelial cell receptors more efficiently than 
untreated EP. When papain was used to degrade EP under reducing conditions, the 
adhesion-inhibition activity of EP was abolished, presumably because of extensive damage 
to the protein portion of the molecule.
The above mentioned treatments have been used as the basis of a purification 
protocol for the yeast adhesin. The first stage of the protocol involves the sequential 
treatment of EP with N-glycanase, papain and dilute alkali to cleave the protein and 
carbohydrate portions of the mannoprotein (Tosh and Douglas, 1992). The combined 
effect of the above treatments on EP were examined. A number of differences were seen 
between this HPLC trace (Fig. 2.5 A) and that of EP incubated under the same conditions 
but in the absence of N-glycanase, papain, and NaOH (Fig. 2.5B). Tosh and Douglas
(1992) showed that the combined treatment of EP with N-glycanase, papain and mild 
alkali produced an EP digest that was able to inhibit adherence by a far greater extent than 
untreated EP. A control HPLC run with N-glycanase, papain, a 2-macroglobulin and 
NaOH produced a trace that was slightly different from that of a blank run (Fig. 2.5 C). A 
small peak was seen and some smaller, less defined peaks were eluted soon after. These 
peaks indicate that NaOH had an effect on the papain and aa-macroglobulin complex that 
had been seen in Fig. 2.4C. The corresponding region on the EP, N-glycanase, papain, a 2- 
macroglobulin, NaOH trace shows no sign of this complex due to the presence of large 
amounts of EP digestion products. Clearly the combined treatment of EP with the above 
reagents results in the production of a number of fragments.
The full purification protocol for the yeast adhesin described by Tosh and Douglas
(1992) has, as its final step, an affinity adsorption with H-2 blood group substance
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immobilised on a silica matrix. Tosh and Douglas (1992) obtained a single peak for the 
adhesin on fast high pressure liquid chromatography (FPLC). This indicated that the 
adhesin was a single component. Attempts in the present study to repeat this result on 
HPLC proved unsuccessful.
3. THE CANDIDA ALBICANS ADHESIN
3,1 The search for adhesive components in C albicans mannoprotein
Most of the major cell wall components of C. albicans, including chitin (Lehrer et 
aL, 1983) and lipids (Ghannoum etal,  1986) have been implicated as adhesins. However, 
the majority of reports indicate that surface mannoprotein acts as the adhesion molecule 
(Calderone and Braun, 1991). As mentioned previously, the adhesion of C. albicans to 
buccal epithelial cells (BEC) has been shown to be inhibited by pretreatment of the BEC 
with extracellular polymeric material (EP) derived from culture supernatants of the yeast 
grown in medium rich in galactose (McCourtie and Douglas, 1984; Critchley and Douglas, 
1987a). These finding suggest that EP (composed primarily of mannoprotein) contains an 
adhesin for epithelia.
A considerable amount of evidence suggests that the protein part of the 
mannoprotein is important in mediating adherence. As mentioned earlier, pretreatment of 
EP with heat, DTT, and proteolytic enzymes (except papain) significantly reduced the 
blocking ability of EP, whereas pretreatment with sodium periodate and a-mannosidase 
had no effect on this ability (Critchley and Douglas, 1987a). Interestingly, the protease 
papain or dilute alkali treatment appeared to enhance the ability of EP to inhibit adhesion 
and when these two treatments were combined, substantially greater inhibition of adhesion 
was observed. In a related study, possible receptor molecules were identified (Critchley 
and Douglas, 1987b). By the incorporation of lectins and sugars in adhesion-inhibition 
assays, it was found that most strains tested were primarily inhibited by L-fucose and 
Lotus tetragonolobus lectin (L-fucose specific). One other strain tested was found to be 
inhibited by N-acetylglucosamine and wheat germ agglutinin. These results suggested that 
the protein portion of yeast cell-surface mannoproteins may bind in a lectin-like manner to
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glycosides containing L-fucose or N-acetylglucosamine expressed on epithelial cell-surface 
glycoconjugates.
L-Fucose is found on epithelial cell surfaces as a component of blood group 
antigens on glycoproteins or glycolipids. The interaction between C. albicans and host cell 
L-fiicose residues may be of great benefit to the organism in the colonisation of epithelial 
surfaces, but at other body sites, this interaction may be to the organism’s detriment. 
Sawyer et al, (1992) examined the effect of lectins on hepatic clearance and killing of C 
albicans by the isolated perfused mouse liver. When Ulex europeaus lectin (binding 
specificity for L-fucose) was included in preperfusion buffers, hepatic trapping of C. 
albicans was decreased by 37%. The lectin also eluted trapped C. albicans from the liver 
when added to postperfiision buffer. By comparison, treatment of C. albicans with U. 
europeaus lectin before infiision had no effect on the trapping or killing of yeast cells. 
These results suggest that a fucose-containing receptor on the surface of either sinusoidal 
endothelial cells or Kupffer cells is involved in the trapping of C  albicans by the perfused 
mouse liver.
3.2 Purification of the yeast adhesin
A purification scheme for the isolation of the fucoside-binding adhesin of C 
albicans was described by Tosh and Douglas (1992). The method made use of the findings 
of the above mentioned experiments on adhesion-inhibition activity of EP treated with 
various enzymes and chemicals (Critchley and Douglas, 1987a), combined with a 
knowledge of receptor specificity derived from work on lectin and sugar blocking studies 
(Critchley and Douglas, 1987b). The purification protocol involves the stepwise treatment 
of EP with N-glycanase, papain, and dilute alkali followed by affinity adsorption with the 
trisaccharide determinant of the H (type 2) blood group antigen on Synsorb silica beads 
(Fig. 3.1). Adhesin purified in this way is devoid of carbohydrate, can inhibit adhesion of 
yeasts to BEC by up to 80%, and consists of one major component as determined by 
reverse-phase fast protein liquid chromatography (FPLC).
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Synsorb affinity matrices have also been used to purify L-fucose-binding adhesins 
from other microbes. Quinn et al. (1993) described the isolation of possible L-fucose- 
binding adhesins from Aeromonas hydrophila using affinity matrices similar to those used 
in this, and previous, studies on C. albicans adhesins. They purified carbohydrate-reactive 
outer membrane proteins (CRGMPs) by affinity chromatography on two different affinity 
matrices composed of trisaccharides resembling H type 1 and 2 antigens. Reactive proteins 
were successfully eluted under alkaline conditions (pH 11.0) and in the presence of soluble 
H substance prepared from group O secretor saliva, but not by 60 mM a-L-fucose or 
under acid conditions (pH 3.0). The eluate contained at least three components (of 
molecular mass 43, 40, and <14 kDa) as detected by immunoblot analysis. In this study, 
the bound proteins were eluted from the H-2 affinity adsorbent under alkaline conditions.
Synsorbs have also been used to purify L-fricose-binding adhesins from 
Staphylococcus aureus (Saadi et aL, 1994). Tosh (1991) examined the ability of EP from 
three C. albicans strains to bind to four different oligosaccharide affinity matrices. The 
adsorbents used were H-1, H-2, Lewis^ and Lewis' .^ It was found that EP from GDH 2346 
was bound to a similar degree by H-2, Lewis^ and Lewis^ adsorbents but relatively poorly 
by H-1. However, the material eluted from H-12 adsorbent was found to have the highest 
adhesion-inhibition activity and so the H-2 adsorbent was incorporated into the adhesin 
purification protocol.
The purification protocol for the yeast adhesin developed by Tosh and Douglas
(1992) was used throughout this study. One modification to the procedure was the use of 
a 3.5 kDa Amicon ultrafiltration filter in place of the 5 kDa filter employed previously. 
When protein and carbohydrate analyses were performed on the purified adhesin, it was 
found to be devoid of carbohydrate. This is consitent with the findings of Tosh and 
Douglas (1992). To ensure that the purified adhesin prepared in this study was of the same 
activity as that obtained previously, BEC were treated with the new material prior to 
adhesion assays with C. albicans GDH 2346. This material inhibited adhesion by up to 
74.81% and the adhesion inhibition index value (All), which is a measure of the ability of 
EP or its derivatives to block adhesion, was calculated to be 178 (Table 3.1). These results
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are comparable with those obtained by Tosh and Douglas (1992). The lower adhesion- 
inhibition values of this study is most likely due to different BEC donor. In the previous 
study, the purified adhesin produced one major peak when subjected to fast high pressure 
liquid chromatography (FPLC). This indicated that the adhesin was a single component. 
Attempts to repeat this result on HPLC proved unsuccessful
The protease inhibitor, human plasma a 2-macroglobulin (Sigma), is normally used 
to inactivate papain after incubation of EP with papain. It is a 772 kDa protein that 
contains four near identical disulphide linked polypeptide chains and inhibits proteases by 
entrapment in a cleft called the bait region. The protease is then covalently anchored by 
transacylation (Neurath, 1989). There are two possible problems associated with the use 
of oc2-macroglobulin. One problem is that a 2-macroglobulin may not completely inhibit the 
activity of papain (Salvesen and Nagase, 1989). The binding of proteases to a 2- 
macroglobulin is irreversible but the complexed enzyme retains full activity against small 
substrates such as peptides. It is inactive against substrates greater than 30 kDa but the 
purified adhesin has an estimated molecular weight of 15.7 kDa which is theoretically 
susceptible to further proteolytic degradation. Another problem relating to the production 
of purified adhesin has recently come to light. Matsui et al. (1993) identified ABO(H) 
blood group structures on human plasma a 2-macroglobulin. They employed blood group- 
specific monoclonal antibodies and Ulex enropaeus lectin I in Western blotting and 
sandwich enzyme-linked immunosorbent assays. Direct sequence analysis of one of the 
blood group antigen-containing proteins identified it as a 2-macroglobulin. This was 
confirmed by the use of anti-a2-macroglobuUn. The presence of a protein that contains 
blood group antigens may cause problems when trying to isolate H-2 blood group antigen- 
binding components from the degradation mixture of EP.
3.3 Amino acid composition of the yeast adhesin
Amino acid analysis was performed on the purified adhesin by Dr. M. Cusack in the 
Dept, of Geology and Applied Geology, University of Glasgow. A sample of purified 
adhesin was prepared by the normal procedure. A total of 18 pg of material was used for
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amino acid analysis. A buffer blank sample that had undergone the entire purification 
protocol was used to adjust the background on the sample run. The results obtained are 
shown in Fig. 3.3. The purified adhesin was found to be mainly composed of the amino 
acids Thr, Pro, Ala, Ser, Val, Gly, Asx and Glx, which made up around 80% of the total 
amino acids. No Cys was detected and very little Met, Phe or Arg was present. Tliis 
composition is remarkably similar to a large number of microbial adhesins (see below) and 
lectins, including the tucose binding lectins (reviewed in Goldstein and Poretz, 1986). This 
would appear to indicate a relationship between the amino acid composition of lectins and 
lectin-like proteins and their fijnction as carbohydrate binding molecules. The composition 
is also consistent with the adhesin being a glycoprotein that would have carbohydrate 
chains linked to the protein backbone via serine, threonine and asparagine residues.
In a recent study by Yu et al. (1994a), a fimbrial adhesin of C. albicans was 
partially characterised. Its composition differed from the adhesin described in this study in 
that it contained approximately 15% protein (the remainder being D-mannose) and had a 
molecular mass of around 66 kDa. The molecular mass of the protein portion was 
assumed to be about 8.6 kDa. Amino acid analysis of the fimbrial adhesin indicated that 
the most abundant amino acids were Val, Asx, Glx, Ser, Thr, Gly, and Ala, all of which 
are in abundance in PA. Another similarity was the veiy small amount of Met in both 
analyses. The most striking difference between the two compositions was in the amount of 
Pro. This was only a minor constituent in the fimbrial adhesin but was the second most 
abundant amino acid in PA. Amino acid sequence comparison is required to determine if 
the two adhesins are in any way related.
In a further study, Yu et al. (1994b) investigated the mechanism of adherence of 
Pseudomonas aeruginosa and C. albicans to asialo-GMi. Their results suggest that 
common cell surface receptors are recognised by the P. aeruginosa and C. albicans 
adhesins because of a conserved receptor-binding domain on their adhesins. By using 
monoclonal antibodies (MAb) against purified pili of P. aeruginosa and monospecific anti­
peptide antibodies against the PAK pilin peptides (anti-PAK 128-144 and anti-PAK 134- 
140), they demonstrated that the antibodies agglutinated C. albicans whole cells and
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cross-reacted with C. albicans fimbriae in immunoblots. A control antibody, PKLl, and 
anti-PAK 75-84 peptide antibodies failed to agglutinate C. albicans whole cells or cross- 
react with the fimbrial proteins. Conversely, the anti-C. albicans fimbrial MAb Em 16 
agglutinated P. aeruginosa whole cells. P. aeruginosa and C. albicans are evolutionarily 
distant organisms but they appear to share a portion of adhesin molecule. Again, 
sequencing of the C. albicans adhesin is required to confirm the similarity at the molecular 
level.
Some bacterial adhesins have amino acid compositions that have similarities with the 
purified adhesin described in this study. Kist et a l (1990) described the purification and 
characterisation of some fibrillar hemagglutinins expressed by two uropathogenic 
Escherichia coli strains. The haemagglutinins were mechanically sheared from whole cells 
and then purified by anion-exchange high-pressure liquid chromatography. The amino acid 
compositions of the two haemagglutinins were highly similar to each other and had a 
number of similarities with the C albicans adhesin described in this study (Table 3.2). 
Sajjan and Forstner (1992) identified a Pseudomonas cepacia fimbrial mucin-binding 
adhesin. The strains tested were isolated from patients with cystic fibrosis. The amino acid 
composition of the 22-kDa protein was similar to the C. albicans adhesin. Compositional 
similarities with the C albicans adhesin are not limited to microbial proteins. Allen et al. 
(1991) isolated and characterised galaptin, a p-galactoside-binding lectin from human 
peripheral leukocytes, by affinity chromatography. The galaptin showed the presence of a 
single polypeptide when subjected to RP-HPLC. The subunit molecular mass was 14.5 
kDa and its amino acid composition was again similar to that of the C. albicans adhesin.
Not all carbohydrate binding proteins share the compositional similarities outlined 
above. There are a number of lectins and lectin-like proteins, of both plant and microbial 
origin, that are rich in cysteine. Wright et al. (1991) studied a family of GlcNAc binding 
proteins containing the disulfide-rich domain of wheat germ agglutinin. This 43-residue 
domain includes eight disulphide-linked cysteines and has been implicated in the binding of 
GlcNAc and its polymers.
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Tannich et al. (1991) examined the interaction of a galactose-binding surface lectin 
from the pathogenic amoeba Entamoeba histolytica with colonic mucins and host cells. 
The extracellular portion of the lectin was found to contain a cysteine-rich domain which 
shows a degree of sequence homology to wheat germ agglutinin. Gillin and Diamond 
(1981) suggested that the cysteine-rich surface proteins may be important for survival in 
the harsh environment of the gut. Saukkonen et al. (1992) examined pertussis toxin (PT) 
carbohydrate recognition domains. Bordetella pertussis binds to glycoconjugates on 
human cilia and macrophages by multiple adhesins, including PT. Comparison of the 
peptide sequences of the carbohydrate binding regions of PT to those of plant and animal 
lectins revealed that regions essential for function of the prokaryotic lectins are strongly 
related to a subset of eukaryotic carbohydrate recognition domains. Of particular interest 
was the effect of amino acid substitutions on receptor specificity of the PT. Substitution of 
certain residues resulted in a shift of carbohydrate recognition from lactosylceramide to 
gangliosides. Mutational exchange of amino acid residues between two domains 
interchanged their carbohydrate and target cell specificity. This gives an indication of a 
possible mechanism by which organisms can alter their tissue specificity by means of a 
mutation at an adhesin’s carbohydrate binding site.
3.4 Analysis of EP and purified adhesin by SDS-PAGE
Previous attempts in this laboratory to visualise EP and purified adhesin by SDS- 
PAGE have met with mixed success. Critchley (1986), was unable to visualise EP after 
SDS-PAGE using either Coomassie blue R250 or silver staining. However, Tosh (1991) 
visualised EP components using both staining procedures. Indeed, when EP prepared in 
earlier studies was subjected to SDS-PAGE along side EP that Tosh had prepared, similar 
protein components were seen. This suggests that the SDS-PAGE procedure used by 
Critchley was in some way flawed.
Tosh (1991) made a number of unsuccessful attempts to visualise purified adhesin by 
SDS-PAGE, using both Coomassie blue R250 and silver staining. A number of factors
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may have contributed to this failure. The adhesin may have been lost from the gel during 
the staining procedures. The acid-alcohol solutions used in Coomassie blue staining do not 
completely fix proteins in the gel which can result in the loss of some low molecular 
weight proteins (Garfin, 1990). This, however, does not explain the failure of silver 
staining. A more likely explanation is that the Laemmli gel system employed by Tosh 
(1991) is not ideally suited to the separation of small proteins and peptides. The stacking 
limit for large proteins in the Laemmli system lies far beyond 100 kDa, but proteins below 
20 kDa are only partly or not at all separated from the bulk of SDS (Schagger and Von 
Jagow, 1987). This property causes streaking of small proteins and so proteins present in 
small amounts are less likely to stain well. Moreover, the amino acid composition of the 
adhesin may be a contributing factor in the failure of conventional protein stains. Certain 
types of synthetic peptides are undetectable with both Coomassie blue R250 and silver 
staining (Wallace and Saluz, 1992). The peptides that exhibit this property are rich in Asp, 
Ala, and Pro and are relatively poor in Cys, Met, and aromatic amino acids. (Andrew 
Wallace, personal communication). The amino acid composition of the purified adhesin fits 
the above description of a peptide likely to stain poorly by conventional means.
Two SDS-PAGE systems were employed in this study; the procedures of Laemmli 
(1970) and of Schagger and Von Jagow (1987). Initial attempts to visualise the purified 
adhesin used the Laemmli procedure. Coomassie blue staining (Weber and Osborne, 1969) 
and silver staining (Oakley et ah, 1980) were then used to visualise separated proteins 
after electrophoresis. As was found previously by Tosh (1991), purified adhesin could not 
be visualised in this way.
The second SDS-PAGE system, described by Schagger and Von Jagow (1987), was 
then employed in an attempt to visualise purified adhesin. This system is able to resolve 
proteins and peptides in the range 2.5 kDa-17.0 kDa, and because of the incorporation of 
tricine in place of glycine in the running buffer, there is no possibility of glycine 
contamination in subsequent sequencing analysis. A number of attempts were made to 
visualise the purified adhesin using both Coomassie blue staining and silver staining but 
without success. An alternative approach to protein visualisation was required.
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In a previous study, Sweet and Douglas (1991) examined the cell-surface 
composition of radio-iodinated whole cells from strain GDH 2346 grown in different 
concentrations of iron. The isolated cell wall mannoproteins were subjected to SDS-PAGE 
and then visualised by autoradiography. A number of protein components were resolved by 
this procedure.
In this study, an experiment was performed in which EP was first labelled with I 
using the lodogen procedure (Fraker and Speck, 1978) and then subjected to the 
purification protocol for the yeast adhesin. Samples were removed after each step of the 
procedure to monitor the effects of the various chemicals and enzymes on EP. Five 
samples were taken in total and were run together on SDS-PAGE using the procedure of 
Schagger and Von Jagow (1987). The lanes with molecular weight standards were cut off 
and stained with Coomassie blue. With this gel system, small proteins and peptides within 
the range 2.5 kDa-17.0 kDa should appear as distinct bands but proteins of higher 
molecular weight are likely to be bunched towards the top of the separating gel. The 
autoradiograph is shown in Fig. 3.4. Untreated EP appeared as three distinct bands. Two 
strong bands were seen at the very top of the gel, one a short way into the separating gel, 
the other at the junction of the separating gel and the stacking gel. The third band which 
was less intense than the other two, was seen in the region of the 3.5 kDa marker. The lane 
containing N-glycanase treated EP was not remarkably different from the untreated EP 
lane except for a noticeable reduction in the intensity of the band at the junction of the 
separating gel, and the stacking gel. The lane containing N-glycanase- and papain-treated 
EP showed only one clear band a short way into the separating gel. There was also a
125diffuse streak of I-labelled material visible in the region of the 2.5 kDa marker. The lane 
containing N-glycanase-, papain-, and NaOH-treated EP had only one band a short way 
into the separating gel. There was also a diffuse streak of I-labelled material running the
125entire length of the gel. No I-labelled material was visible in the lane that should contain 
purified adhesin (the N-glycanase-, papain-, NaOH-treated EP and bound to Synsorb H- 
2). This could have been a result of insufficient I-labelled material at this point in the 
degradation. Another possibility is that iodination may have damaged the adhesin
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molecules and prevented binding to the Synsorb matrix. Between pH 7 and 8 , the ortho 
position in the aromatic ring of tyrosine in peptides and proteins is activated for 
electrophilic attack, due to the electron-donating effect of the neighbouring hydroxyl 
group. Similarly, at pH 9, the the two nitrogen atoms in the imidazole ring of histidine 
have an electron donating effect on their neighbouring carbon atom (Bolton, 1977). So, 
iodine (^^ ^U) acts as the electrophilic agent to produce the radiolabelled protein. Direct 
radiolabelling with iodine is a very sensitive method, but it can change the physical and 
biological properties of proteins (Wallace and Saluz, 1992).
Although iodination of protein is a relatively simple procudure, the use of ^ ^ I^-labelled 
proteins was problematic. The handling of labelled material, and the subsequent steps 
involving SDS-PAGE, produced large amounts of contaminated waste and equipment. 
Also, the ionination procedure may adversely affect the integrity of the proteins and is 
relatively inefficient. An alternative labelling procedure, biotinylation, was used in 
subsequent experiments. Biotinylation has been used by Casanova et al. (1992) to label cell 
wall proteins from yeast and mycelial cells of C. albicans. They demonstrated that the 
labelling of intact, living C. albicans cells with biotin allows characterisation of cell surface 
proteins and glycoproteins following SDS-PAGE and Western blot analyses. Casanova et 
al. (1992) detected proteins on nitrocellulose by incubation with Extravidin-peroxidase 
conjugate (Sigma). In this study, ^^^I-streptavidin was used in an attempt to maximise the 
sensitivity of the procedure. Biotinylation allows for the safe handling of proteins right up 
to the point of detection with ^^^I-streptavidin. As this is the final step prior to 
autoradiography, the amount of radioactive waste produced is far less. Also, the total 
activity of the material required is greatly reduced.
In the first experiment of this type, EP was biotinylated using a commercial kit from 
Amersham. Biotinylated EP and biotinylated SDS molecular weight standards (SDS-6B, 
Sigma) were separated using the Laemmli procedure on a mini gel apparatus. After 
electrophoresis, the separated proteins were transferred on to nitrocellulose and 
biotinylated material was detected by probing with I-streptavidin followed by 
autoradiography (Fig. 3.5). Four bands were visible in the biotin-EP lanes. An intense
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band was visible in the region of the 97.4 kDa marker and a broad diffuse band was seen in 
the region of the 39.8 kDa marker. Two additional bands were seen in the region between 
the 20.1 and 14.3 kDa markers but these were relatively faint. Any other bands present 
were obscured by the streak of biotinylated material that ran the length of the gel. Sweet
125and Douglas (1991) examined I-proteins released from the surface of GDH 2346 cells 
grown in medium with varying iron concentrations, by boiling the cells in the presence of 
SDS and DTT, prior to SDS-PAGE. It is not possible to directly compare the result shown 
in Fig. 3.5 with the result of Sweet and Douglas (1991) due to the different growth 
conditions and method of purification of the cell surface proteins. However, some proteins 
visualised in both studies appear similar. Sweet and Douglas (1991) identified five main 
protein components in cells grown under reduced iron conditions ( 16, 26, 39, 47, and 85 
kDa). By contrast, six components appeared in increased amounts in organisms grown in 
high iron medium (18, 19, 35, 49, 51, and 64 kDa). In this study, four components were 
most dominant with approximate molecular weights of 100, 40, 18, and 16 kDa. More 
accurate estimation of the weights was not possible due to the intense background in the 
sample tracks.
EP was labelled with biotin and then subjected to the purification protocol for the 
yeast adhesin. Samples were removed after each step of the procedure. Three samples 
were taken in total, to monitor the effects of the various chemicals and enzymes on EP and 
were run together on SDS-PAGE using a mini gel and the Laemmli procedure (Fig. 3.6). 
The results obtained in this experiment were poor possibly due to insufficient biotinylation 
of the EP although the degree of biotinylation seemed adequate in the previous experiment 
(Fig. 3.5). A more likely explanation is that the degradation treatments had an adverse 
effect on the protein-bound biotin. The biotin may have been cleaved from the proteins or 
the ability of the bound biotin to bind to I-streptavidin may have been affected.
Overall, the results of these SDS-PAGE experiments were rather disappointing, with 
poor band resolution a major problem. However, the experiments were valuable in 
demonstrating that biotin-labelling could be used as an alternative to direct radiolabelling 
of EP components, prior to SDS-PAGE and Western blot analyses.
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Purified adhesin was biotinylated prior to SDS-PAGE on a mini-gel, using the 
procedure of Schagger and Von Jagow (1987). After electrophoresis, the gel was cut and 
the markers were stained with Brilliant Blue G (Sigma).The biotinylated purified adhesin 
lanes were transferred onto nitrocellulose for Western blot analysis. The protein was then
125visualised by probing with I-streptavidin followed by autoradiography. The purified 
adhesin was seen as a strong band with a molecular mass of approximately 15.7 kDa with 
two possible breakdown products also visible (Fig. 3.7). This was the first time that 
purified adhesin had been seen by SDS-PAGE. The successful visualisation of the purified 
adhesin meant that partial amino acid sequencing could be attempted. In a recent study by 
Yu et al. (1994a), a fimbrial adhesin was partially characterised. Its composition differed 
from the adhesin described in this study in that it contained approximately 15% protein 
(the remainder being D-mannose) and had a molecular mass of around 66 kDa. The 
molecular mass of the protein portion was assumed to be around 8.6 kDa.
3.5 Amino acid sequencing of the purified adhesin
Purified adhesin was subjected to sequencing on an Applied Biosystems 477A Protein 
Sequencer. The sequence determined initially was
Ser-Arg-Asp-Leu-Ile-Ile-Gln-Phe-Lys-Asn (Amino acid sequence 1).
When this sequence was run through the FASTA program developed by Pearson and 
Lipman (1988), the closest homology was found to be an outer capsid protein (VP4 
haemagglutinin) from human Rotavirus serotype 4 with 75% identity in an eight amino 
acid overlap. However, when the sequence data from the run was re-examined by Dr. Phil 
Jackson of Applied Biosystems, he determined that there were two distinct sequences 
present. The computer system attached to the sequencer had miss-read the data due to a 
high amount of background in the sample. The most prominent sequence seen after re­
examination of the data was :-
Ser-Asp-Asp-Leu-Ser-Phe-Lys-Phe-Lys-Asn (Amino acid sequence 2), 
and the second sequence was :-
Phe-Asp-Tyr-Glu-His-Val-Asp-X-Ala-Val (Amino acid sequence 3).
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The amino acid at position 8 in Amino acid sequence 3 could not be determined with any 
certainty.
When Amino acid sequence 2 was run through the data base it had 100% homology 
with the first 10 amino acids at the N-terminus of the anti H (O) binding lectin from Ulex 
enropaeus. As mentioned in the Results section, the experimental notes relating to the 
production of this particular batch of purified adhesin were carefully examined. It was 
found that the Synsorb H-2 affinity adsorbent used had been exposed to the purified U. 
enropaeus I lectin. This had occurred during an experiment to examine the efficiency of 
removal of H antigen binding components from Synsorb affinity adsorbent. This suggests 
that the removal of Synsorb bound material in by no means complete even afl;er prolonged 
NH4OH treatment.
Amino acid sequence 3 was run through the peptide database. Although no complete 
matches were found for the peptide sequence there was a predominance of microbial 
protein homologies including quite a few yeast proteins (Fig.3.5). Among the closest 
matches for the peptide was the Saccharomyces cerevisiae regulatory protein SIR 3 
(Silent information regulator) with 71.4 % identity in a 7 amino acid overlap. The partial 
amino acid sequence obtained is most probably an internal sequence produced as a result 
of enzymic cleavage by the action of papain.
Recent studies have sought to characterise and sequence adhesins isolated from C. 
albicans. Yu al. (1994a) attempted to sequence a fimbrial adhesin of C. albicans but 
were unsuccessful due to N-terminal blockage of the protein. However, in a later study 
(Yu et al. 1994b), the same workers were able to demonstrate that the fimbrial adhesin 
was antigenically similar to a P. aeruginosa adhesin. Klotz et al. (1994) partially 
characterised the fibronectin adhesin of C. albicans which binds the fungus to 
subendothelial extracellular matrix and matrix proteins. The adhesin was found to be 
composed of 75 to 80% carbohydrate and approximately 20 to 25% protein by weight. 
HPLC of material eluted from a fibronectin-agarose affinity column demonstrated the 
presence of three components, all of which migrated as one protein of approximately 60 
kDa on SDS-PAGE. Molecular weight sizing column chromatography demonstrated that
192
the adhesin eluted with an apparent molecular mass of 42 kDa. The N-terminus of the 60- 
kDa glycoprotein was blocked to Edman degradation.
A considerable amount of work remains to be done on all the reported C. albicans 
adhesins. Extensive sequence analysis should provide valuable information on the 
relationships between carbohydrate-binding adhesins and fibronectin-binding adhesins. 
Proteolytic cleavage prior to sequencing would circumvent the problem of N-terminal 
blockage encountered by the groups mentioned above. The cleavage can be performed 
prior to SDS-PAGE or HPLC. Alternatively, the in situ enzymic cleavage of proteins on 
nitrocellulose followed by RP-HPLC, would produce fragments suitable for gas-phase 
microsequencing (Aebersold etal,  1987).
The next stage in the characterisation of the C albicans adhesin described in this 
study should involve the identification of the receptor-binding domain. The molecular 
details of how glycoconjugate-binding proteins interact with their ligands have been 
revealed by a variety of techniques, as reviewed by Holt (1991). For example, proteases, 
chemical-modifying reagents and antibodies have been useful probes for locating lectin 
binding domains. Protein crystallography has shown how lectins are structured, and 
identified which amino acids in these proteins are positioned appropriately for bond 
formation with glycoconjugates. Studies of lectin mutants produced by site-directed 
mutagenesis, and characterisation and sequencing of naturally occurring, non-functional 
lectin variants have demonstrated the importance of particular amino acids for 
glycoconjugate binding.
The first step in this work would require the determination of the primary structure 
of the C. albicans adhesin. This could be achieved by using methods previously employed 
in the study of lectin binding domains. Yamamoto et a l (1992b) identified carbohydrate 
binding peptides from several blood group H-binding lectins. The peptides obtained from 
the endoproteinase digestion were subjected to affinity chromatography, to isolate those 
components with an affinity for the H-antigen, then the peptides were sequenced. A 
problem with this approach is that a binding portion of the adhesin may be destroyed 
during endoproteinase digestion. Konami et a l (1991) determined the primary structures
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of two Ulex europaens lectins by endoproteinase digestion, RP-HPLC purification and 
peptide sequencing. The resultant sequences were aligned to give the complete protein 
sequence.
This approach could be adopted in the search for the C. albicans adhesin binding 
domain. Once the complete protein sequence of the C. albicans adhesin is identified, 
synthetic peptides could be used to determine the minimum binding domain of the C. 
albicans adhesin. The multipin peptide synthesis technology developed by Geysen et al.
(1984) could be used to produce a series of overlapping peptides that correspond to the 
primary structure of the adhesin. The peptides can be made a variety of lengths and could 
either be N-terminally biotinylated, for use in peptide binding studies, or left 
unbiotinylated for use in adhesion-inhibition studies. The peptide binding assay would 
involve mixing the biotinylated peptides with a suspension of the target cells e.g. exfoliated 
BEC or a cell line of interest. Unbound peptide could be removed by washing, and bound 
peptide probed for with a streptavidin-conjugate. This rational approach should pave the 
way to a better understanding of the complexity of C albicans adhesion. It may also help 
to explain the variable results that have been obtained in sugar and lectin blocking studies.
It could be the case that the basic architecture of the C. albicans adhesin is similar 
for all strains with only a few differences at the carbohydrate-binding domains, resulting in 
different glycoside specificities, Saukkonen et al. (1992) demonstrated that amino acid 
substitutions at the carbohydrate binding site of B. pertussis toxin resulted in altered 
glycoside specificity. Substitution of certain residues resulted in a shift of carbohydrate 
recognition from lactosylceramide to gangliosides. Mutational exchange of amino acid 
residues between two domains interchanged their carbohydrate and target cell specificity. 
This suggests a possible mechanism by which pathogenic organisms can alter their tissue 
specificity. Similar alterations in the carbohydrate binding domain of Bauhinia purpurea 
lectin, resulted in altered glycoside-binding specificity (Yamamoto e ta l, 1992a).
The discovery of amino acid homologies dispersed over long segments of the 
primary sequences of several lectins has suggested that many of these proteins have a 
related three-dimensional organisation. In addition, the identification of more highly
194
focused regions of sequence homology has indicated that many structures within the lectin 
glycoconjugate-binding domains themselves may be conserved (Holt, 1991). There is no 
reason to suppose that the same is not also true of microbial lectin-like proteins.
4. IDENTIFICATION OF THE C. ALBICANS RECEPTOR ON BUCCAL 
EPITHELIAL CELLS
C. albicans is a commensal yeast which can cause infections at cutaneous, 
mucocutaneous and systemic sites. The organism appears to utilise cell surface 
mannoproteins to colonise host epithelial and endothelial cells (Calderone and 
Wadsworth, 1993). Such cell-cell interactions are frequently mediated by lectin- 
carbohydrate recognitions, as already established for numerous viruses, bacteria and 
protozoa (Karlsson and Stromberg, 1987).
The mechanism of adherence of C. albicans to endothelium appears to differ from 
that for adherence to epithelium (Odds, 1988). Lesions such as endophthalmitis, nephritis, 
and endocarditis arise as a result of adherence of C. albicans to endothelium or exposed 
subendothelial surfaces (Klotz, 1987). Fibrils on the yeast cell surface have been shown to 
be responsible for adhesion of C. albicans to renal endothelium (Barnes, 1983). 
Proteolytic treatment of fungi fails to reduce their attachment to endothelium whereas 
similar treatment is known to inhibit adhesion of C. albicans to VEC and BEC (Lee and 
King, 1983).
The search for host cell receptors for C albicans has, until recently, been limited to 
blocking studies using monosaccharides and/or lectins in adhesion-inhibition assays. 
Studies involving sugar inhibition tests have produced a variety of contradictory results. L- 
Fucose (Tosh and Douglas, 1992), amino sugars (Segal et al., 1982a) and D-mannose 
(Sobel et al., 1981) have all been reported to be major inhibitors of C  albicans adhesion 
and therefore suggested as likely receptor determinants. More recent work, using both 
monosaccharides and lectins in adhesion-inhibition assays, demonstrated that a receptor 
containing L-fucose is required for most strains of the yeast (Critchley and Douglas,
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1987a). Although the addition of L-fiicose to assay mixtures caused only partial inhibition 
of adhesion with sensitive strains, it is possible that the natural mucosal receptor is larger 
than L-fucose or that a particular stereochemical configuration is necessary (Tosh and 
Douglas, 1992), Brassait et al. (1991), demonstrated that C albicans adhesion to BEC in 
vitro was significantly inhibited by the addition of Fucal-2Galp-bearing complex 
carbohydrates. This structure is found on all blood group substances in the ABO system. 
Blood group antigens are expressed on the carbohydrate side chains of lipids and proteins 
on erythrocytes and certain epithelial cells (Kabat, 1982).
A number of groups have found that C. albicans adheres to fibronectin (FN), a 
common mammalian cell surface glycoprotein, in vitro (Skerl et al,, 1984; Scheld et al., 
1985; Klotz, 1990). As mentioned earlier, Klotz et al. (1994) partially characterised the 
FN adhesin of C. albicans which binds the fungus to subendothelial extracellular matrix 
and matrix proteins. Other mammalian proteins thought to mediate C  albicans attachment 
include fibrinogen (Tronchin et al, 1987), laminin (Bouchara et a l, 1990), and types I and 
IV collagen (Klotz, 1990).
The FN-cell-binding domain, which has the amino acid sequence Arg-Gly-Asp 
(RGD), has been examined by two groups for its ability to block adherence of C. albicans. 
RGD-containing peptides were shown not to inhibit adhesion of C albicans to BEC by 
Brassait et al. (1991). However, Ollert et al (1993) found that C  albicans attachment to 
kératinocytes was inhibited by RGD containing peptides derived from laminin.
More recently Santoni et al. (1994) investigated the expression of the FN receptor 
prototype, integrin, on C. albicans and its involvement in adhesion to FN. Several 
monoclonal antibodies (mAbs) directed against human or Pi integrin subunits, or two 
different antisera to FN receptor, positively stained C. albicans yeasts and germ tubes. 
Both C. albicans yeast and germ tube forms bound to an RGD-containing 120 kDa tryptic 
fragment of FN and adhesion to FN was markedly inhibited by GRGDSP, but not 
GRGESP peptides.
Studies that have examined BEC for the presence of FN have produced contradictory 
results. Woods et ah, (1981 a, b) found measurable amounts of FN on scraped BEC from
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healthy humans. The level of FN on scraped BEC from ill individuals was found to be 
reduced. When the level of bacterial adhesion was assessed between the two groups, in an 
in vitro assay, the BEC of ill patients were found to bind more bacteria than BEC from 
healthy individuals. There appeared to be an association between reduced FN levels and 
the susceptibility of BEC to bacterial attachment. Mason et al. (1990) however, could not 
detect FN on BEC in epithelial biopsy specimens from rodents or humans. The presence of 
FN in the studies by Woods and coworkers may be due to the method of BEC collection. 
FN from lower levels of the epithelium may have been collected along with the more 
superficial BEC layers. The increased bacterial adhesion seen in the BEC from the ill 
subjects may be related to different receptor expression. This possibility will be expanded 
upon below.
4.1 The effect of RGD peptide on C. albicans adhesion to BEC
In this study, the possible role of RGD peptide in the adhesion of C. albicans to oral 
epithelium was examined. Pre-incubation of yeasts (strain GDH 2346) with RGD peptide 
in the presence and absence of Mg^+ and Ca^ '*' did not inhibit adhesion to BEC (Table 4.1 
and 4.2). There was no significant difference in the adhesion values obtained for treated 
and untreated yeasts. These results are in agreement with work by Brassart et a l (1991) 
but contradict the work of Bendel et a l (1993) who found that adhesion of C albicans to 
HeLa S3 cells (an epithelial cell line) was inhibited by RGD containing peptides. However, 
transformed cells may not express the same receptors as exfoliated epithelial cells. The 
results obtained in the present study suggest that the oral adhesion of C. albicans is not 
affected by the presence of the FN binding domain peptide, RGD.
4.2 Epithelial glycosides as receptors for C albicans
A number of studies have examined the role of carbohydrates in the adhesion of C. 
albicans to epithelia. This work has mainly involved the use of lectins and/or 
monosaccharides (Centeno et a l, 1983; Collins-Lech et a l, 1984; Critchley and Douglas, 
1987b). More recent studies on the role of glycosides in candidal adhesion have employed
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a chromatogram overlay assay previously used in the characterisation of bacterial adhesion 
mechanisms.
In studies of the role of glycosides as receptors for bacterial adhesion, most workers 
have adopted glycosphingolipids over glycoproteins for binding analysis (Karlsson and 
Stromberg, 1987). Glycosphingolipids carry only one oligosaccharide chain and are easily 
extracted from tissues. Glycoproteins, on the other hand, may express two or more 
different glycoside moieties and as a result, make the identification of receptors more 
difficult.
Glycosphingolipid structure and nomenclature was recently reviewed by Hakamori 
(1993) and is summarised in the Introduction. Briefly, glycosphingolipids can be classified 
as neutral glycolipids, sulfatides (sulphate-containing) and gangliosides (sialic acid- 
containing). They can also be classified according to the number of carbohydrate residues 
e.g. ceramide monohexose, ceramide dihexose etc. Alternative classification depends on 
the backbone structure of the carbohydrate. Under this system, the globo series 
glycosphingolipids contain globotriaosylceramide (Galpl-4 or 1 -3 Gaip 1 -4Glc-Cer). The 
lactoseries contain lactotriaosylceramide (GlcNAc(31 -3Gal|31 -4Glc-Cer). The ganglio 
series contain gangliotriaosyl ceramide (GlcNAcpl-4Galpl-4Glc|31-lCer) and the gala 
series contain galactobiosyl ceramide (Gaipi-4Galpl-lCer) as the common structure. The 
lactoseries show the most extensive substitutions with sialosyl, fucosyl, and a -  and p- 
galactosyl moieties. They can also have extensions or branching by repeating N- 
acetyllactosamine units which can result in a great number of distinct molecular structures. 
The fucosylated species include the major blood group antigens.
Glycosphingolipids have been reported to be cell-surface receptors for a number of 
bacteria. Uropathogenic E. coli specifically bind to Galal-4Gal sequence on urinary tract 
epithelial cells (Leffler et aL, 1982). Also, Haemophilus influenzae, Staphylococcus 
aureus, Streptococcus pneumoniae, Klebsiella pneumoniae. Pseudomonas aeruginosa 
and Pseudomonas cepacia, isolated from cystic fibrosis patients, bind to 
glycosphingolipids containing GalNAcpl-4Gal sequences (Krivan et a l, 1988).
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The TLC overlay assay has the advantage of combining the high-resolution separation 
of potential receptors with direct solid-phase binding (Karlsson and Stromberg, 1987). 
Glycolipids are normally separated on silica gel-coated aluminium sheets that tend to be 
more resistant to layer detachment during washing than glass plates. The aluminium plates 
are also easy to cut.
The dried chromatogram with separated glycolipids is dipped in a solvent solution of 
polyisobutylmethacrylate (PIBMA) and then allowed to air dry before being blocked with 
a buffered protein solution. The hydrophobic film produced by the PIBMA treatment may 
both optimise the protein blocking of the silica gel and induce presentation of the 
amphipathic glycolipids to resemble the situation in the natural cell membrane (Karlsson 
and Stromberg, 1987). The glycoside chains are then free to interact with the ligand while 
the hydrophobic lipid components are embedded in the plastic layer.
During the assay, the plate is rocked or shaken to reduce the volume of the sample 
solution required. After incubation, the plate is washed a number of times to remove the 
unbound ligand, and then treated depending on the ligand used. Detection can be based on 
direct autoradiography, using a labelled ligand, or a non-labelled ligand can be detected 
using antibodies (Hansson et al. 1985).
An early report on the role of lipids in yeast adhesion was published by Ghannoum et 
al. (1986). They found that various classes of lipids derived from Candida cell walls 
(including ceramide mono- and di-hexosides) were able to inhibit adherence of the yeast 
to BEC. They subsequently showed that total lipid extracts from BEC also blocked 
adherence (Ghannoum et al., 1987). Two more recent studies have suggested that C. 
albicans can bind specifically to certain glycosphingolipids. Using a chromatogram overlay 
assay, Jimenez-Lucho et al. (1990) claimed that C. albicans and other fungi bound 
specifically to lactosylceramide (a glycosphingolipid commonly found on epithelial cells. 
More recently, Y\x et al. (1994c), employed a similar overlay system to show that C. 
albicans fimbriae bound to asialo-GMi and asialo-GM2, but failed to bind to 
lactosylceramide. Lipids expressing L-fucosyl residues were not used in either study.
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The most recent investigation of this type examined the binding of C tropicalis to a 
range of lipids (Prakobphol et a l, 1994). A lipid library of potential host receptors was 
screened using the TLC-overlay system and ^^S-labelled C tropicalis cells. No interaction 
was observed with glycolipids or phospholipids. However, lysophospholipids were found 
to support adherence of C. tropicalis but not Saccharomyces cerevisiae. Binding resulted 
in rapid metabolism of the substrate, suggesting that the lipid-metabolising enzymes of the 
organism are linked to the adhesion process.
L-Fucose-containing glycoconjugates have been proposed as receptors for C. albicans 
on the basis of adhesion-inhibition assays using lectins and sugars as blocking agents 
(Critchley and Douglas, 1987b). More recently. Brassait et a l (1991), using complex 
carbohydrates derived from human milk, determined that the minimum structure required 
to inhibit C albicans attachment to BEC was Fuc(al-2)Galpl which is the terminal 
disaccharide of the H blood-group antigen. Tosh and Douglas (1992) used a Synsorb 
affinity chromatography step to purify an adhesin from C. albicans. The adsorbent had 
covalently linked H-2 blood group antigen (containing a terminal fucose residue) and the 
adhesin was able to inhibit the attachment of yeasts to BEC by up to 80%. A similar 
degree of adhesion-inhibition was achieved in this study (74.81%). These results suggest a 
role for H blood-group antigen in the adhesion of C. albicans to BEC.
With a view to identifying glycolipid receptors for C. albicans in the oral cavity, 
BEC glycolipids were prepared in this investigation and a glycolipid chromatogram overlay 
assay was employed. As mentioned above, this system has been used to characterise a 
number of adhesin-receptor relationships (Hansson et al., 1985). Glycolipids were isolated 
from BEC by chloroform-methanol extraction. In addition to BEC lipids, control 
glycolipids (Calbiochem) and sheep red blood cell (sRBC) glycolipids (a gift from Chris 
Brotherston, Dept, of Microbiology, University of Glasgow), were included in most 
assays. The control glycolipids comprised galactosylceramide (CMH), lactosylceramide 
(CDH), trihexosylceramide (CTH), globoside (GL4), and Forssman antigen (FORS) 
(Table 4.3). Various methods of lipid visualisation were investigated including iodine 
vapour, anisaldehyde (Fig. 4.1), orcinol (Fig. 4.2) and resorcinol (Fig. 4.3). Total lipid was
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subsequently visualised by treatment with orcinol reagent (Figs. 4.4 and 4.5). Different 
solvent systems for the separation of lipids were also assessed. All those tested contained 
chloroform, methanol and water but in varying proportions. The systems containing 
chloroform, methanol and water in the ratios 55:45:10 (Fig. 4.1) and 60:35:8 (Fig. 4.2) 
were found to bunch the majority of lipids. A system with chloroform, methanol and water 
in a ratio of 65:25:4 (Figs. 4.3, 4.4, and 4.5), gave good separation of lipids and was used 
in all subsequent experiments.
1254.2.1 Binding of I-EP from strains GDH 2346 and GDH 2023 to glycolipids 
separated on TLC plates
The EP from C. albicans GDH 2346 was radio-iodinated using the lodogen 
procedure as described in Materials and Methods. The TLC plate of separated glycolipids 
(BEC, sRBC, and control lipids) was air-dried and subjected to a two stage blocking step. 
Step 1 was PIBMA in hexane; step 2 was PBS-BSA blocking solution. Then the plate was 
incubated with ^^ I^-EP in fresh blocking solution. After incubation, the unbound ^^ I^-EP 
was removed by washing the TLC plate in PBS. The TLC plate was then air dried, placed 
inside a plastic bag and autoradiographed. Despite the high background, the 
autoradiograph obtained (Fig. 4.6) shows that I-EP bound to two lipid components 
from sRBC. There did not appear to be any binding to either the control lipids or the lipids 
from BEC. However, some clear zones were seen through the background in the BEC 
lipid lane. The TLC overlay system showed promise but required considerable 
optimisation.
125Binding of I-EP from strain GDH 2023 to glycolipids was also examined using the
125same procedure. The autoradiograph obtained is shown in Fig. 4.7. I-EP bound to four 
lipid components from sRBC but there did not appear to be any binding to lipids from 
BEC or to the control lipids. However, clear zones were visible in the BEC lipid lane. 
Background radioactivity on this autoradiograph was to that seen previously. One possible 
reason for the intense background could be the ability of C. albicans to bind to inert plastic 
surfaces such as denture base materials (Minagi et a l, 1985), and polyvinyl chloride
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(Rotrosen et al., 1983). The treatment of TLC plates with PIBMA results in a plastic 
coating which may promote the adhesion of C. albicans whole cells and proteins. To 
prevent the possibility of this non-specific adhesion to plastic, the TLC plates must be 
effectively blocked with an appropriate protein-buffer solution. The buffer solution that 
had been used in the above experiments may not have been appropriate and so other 
solutions were tested in subsequent experiments.
4.2.2 Binding of ^^ I^-labelled whole cells and I-EP from strain GDH 2346 to 
glycolipids separated on TLC plates
Whole cells and EP from C. albicans GDH 2346 were radio-iodinated using the 
lodogen procedure as described in Materials and Methods. The overlay procedure was 
similar to the previous experiments but in an attempt to reduce the intense background, an 
alternative blocking solution (Tris-BSA buffer) was employed after PIBMA treatment. 
This solution was also used for the overlay incubation steps. The autoradiographs obtained 
(Fig. 4.8) show that the background was even higher than that previously encountered. 
Although there did seem to be some binding of I-labelled material, the degree of 
background made useful interpretation impossible. A number of technical difficulties were 
encountered, ranging from silica damage due to the TLC plates colliding with the side of 
the reaction trays, to intense background. The procedure also produced a considerable 
amount of contaminated equipment and large volumes of radioactive waste.
4.2.3 Binding of lectins to glycolipids separated on TLC plates
The following biotinylated lectins were purchased from Sigma: Bauhinia purpurea, 
Triticum vulgaris and Vicia villosa. Bauhinia purpurea agglutinin has an affinity for 
Gal(pl-3)GalNAc, N-acetyl-galactosamine (GalNAc) and D-galactose (Irimura and 
Osawa, 1972), the lectin from Triticum vulgaris (wheat germ agglutinin) has an affinity 
for GlcNAc (Nagata and Burger, 1974) and Vicia villosa lectin has an affinity for GalNAc 
(Goldstein and Poretz, 1986). TLC plates were prepared as previously and PBS-BSA was 
used as the blocking and binding buffer. The lectins were diluted in blocking buffer prior to
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overlay analysis and the bound lectins were detected by probing with ^^^I-streptavidin. The 
autoradiographs obtained for these experiments are shown in Fig. 4.9 A, B and C. Less 
background was seen on these autoradiographs than had been encountered previously but 
there was clearly some deterioration of the TLC plates. Small pits were visible on the 
surface of the plates and they corresponded to "hot spots" on the autoradiograph. The 
pitting may have been due to silica loss during the extensive incubation and washing 
stages. Non-specific binding of biotinylated lectin and/or ^^^I-streptavidin to these pits is 
likely as the blocking activity of the PIBMA coating will have been lost. The reduced 
backgound encountered in the lectin-binding experiment may have been due to the use of 
biotinylation and ^^^I-streptavidin instead of directly radiolabelled lectins.
4.2.4 Binding of biotinylated EP from C albicans GDH 2346 and GDH 2023 to 
glycolipids separated on TLC plates
EP preparations from strains GDH 2346 and 2023 were first biotinylated and then 
subjected to TLC-overlay analysis. A minor modification was incorporated in the protocol 
in an attempt to reduce background and TLC plate deterioration. Each plate was 
submerged in PIBMA solution for 1 min, removed and allowed to air-dry. This was 
repeated a further two times and then the plates were blocked as previously and overlaid 
with biotinylated EP. The autoradiographs obtained are shown in Fig. 4.10. The 
background seen in this experiment was the lowest yet encountered and the pitting 
observed previously was virtually abolished. The binding of biotinylated EP from strain 
GDH 2346 to some separated lipids on the TLC plate was clearly visible. Binding was seen 
to two lipid components from the sRBC and one lipid component from BEC. Less intense 
binding to one further component from BEC was also observed. There was no binding to 
any of the neutral glycolipid controls. Biotinylated EP from strain GDH 2023 did not 
appear to bind any lipid components. In a previous experiment, there was found to be
125binding of I-EP from GDH 2023 to four lipid components from sRBC. The absence of 
any binding may have been due to poor biotinylation, damage to the biological activity of
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EP as a result of biotinylation, or increased blocking as a result of the enhanced PIBMA 
treatment.
4,2,5 Binding of biotinylated whole cells of different C albicans strains to 
glycolipids on TLC plates.
The binding of biotinylated whole cells from five C albicans strains (GDH 2346, GRI 
681, GRI 682, MRL 3153 and "outbreak") to glycolipids from BEC, sRBC and neutral 
glycolipid standards (CMH, CDH, CTH, GL4, FORS), was examined by the
125chromatogram overlay assay. Bound cells were visualised by the addition of I- 
streptavidin followed by autoradiography (Fig. 4.11). All five strains had similar binding 
patterns. By comparison with an identical chromatogram overlaid with biotinylated Ulex 
europaeus lectin it appeared that the cells were able to bind to four glycolipids expressing 
H-blood group antigen. The cells also bound to an additional lipid from BEC, not bound 
by Ulex europaeus lectin, with an Rf value similar to a lipid bound by the GalNAc specific 
lectin from Helix pomatia (Hammarstrom and Kabat, 1971). However, GalNAc alone is 
unlikely to be the receptor as the yeast cells were found not to bind to the GalNAc- 
expressing neutral glycolipid standards, GL4 and FORS, both of which were detected by 
Helix pomatia lectin. None of the strains tested were found to bind to lactosylceramide, 
recently proposed as a receptor for C. albicans (Jimenez-Lucho et a l, 1990). These 
results are consistent with experiments involving sugars and lectins which suggested that 
strains GDH 2346, GRI 681, GRI 682, and MRL 3153 all share a common adhesion 
mechanism involving fucose-containing receptors (Critchley and Douglas, 1987b).
4.2.6 Binding of biotinylated EP and purified adhesin from C, albicans GDH 
2346 to glycolipids on TLC plates.
To take the study of C. albicans GDH 2346 adhesion a stage further, the binding of
biotinylated EP and purified adhesin from strain GDH 2346 to glycolipids was examined
125by the chromatogram overlay assay. Bound material was visualised by the addition of I- 
streptavidin followed by autoradiography. The resulting autoradiograph is shown in Fig.
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4.12. The binding patterns observed for EP and purified adhesin were remarkably similar. 
Both bound to glycolipids from BEC and sRBC but not to any of the neutral glycolipid 
standards (including lactosylceramide). By comparison with a chromatogram overlaid with 
biotinylated Ulex europaeus lectin (UE) it appeared that the EP and purified adhesin were 
able to bind to glycolipids with Rf values similar to lipids expressing H-blood group 
antigen. Interestingly, in the previous experiment, whole cells from strain GDH 2346 (and 
four other strains) bound to three lipid components from BEC, two with Rf values similar 
to lipids expressing H-blood group antigen, and a third with an Rf value similar to a lipid 
expressing GalNAc. The problems of plate deterioration and intense background had been 
greatly reduced by adopting the modifications outlined in the above experiments.
4.2,7 Binding of biotinylated whole cells and EP from strain GDH 2023 to 
glycolipids on TLC plates.
The binding of biotinylated whole cells and EP from strain GDH 2023 to glycolipids 
was then examined by the chromatogram overlay assay. Biotinylated Griffonia 
simplicifolia lectin II (GSII) was purchased from Vector Laboratories. This lectin has an 
affinity for GlcNAc (Goldstein and Poretz, 1986). Biotin-labelled material was visualised
125by the addition of I-streptavidin followed by autoradiography (Fig. 4.13). Whole cells 
and EP from strain GDH 2023 were found to bind to four glycolipids from both BEC and 
sRBC. By comparison with an identical chromatogram overlaid with biotinylated GSII it 
appeared that the cells were able to bind to glycolipids with Rf values similar to lipids 
expressing GlcNAc from BEC and sRBC. This strain did not bind to any of the neutral 
glycolipid standards (including lactosylceramide). These results are in agreement with 
previous experiments involving sugars and lectins (Critchley and Douglas, 1987b) which 
suggested that strain GDH 2023 has an adhesion mechanism involving GlcNAc containing 
receptors.
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4.2.8 The role of glycolipids in the adhesion of C albicans to epithelial cells
Six strains in total were examined in this study for their ability to bind to separated 
glycolipids. Five strains were found to bind to glycolipids expressing H-blood group 
antigen by comparison with an identical chromatogram overlaid with biotinylated Ulex 
europaeus lectin. These strains bound to an additional lipid from BEC which appeared to 
have a terminal GalNAc, as determined by comparison with an identical chromatogram 
overlaid with GalNAc specific lectin from Helix pomatia. However, the yeast cells did not 
bind to control glycolipids with GalNAc as a terminal sugar residue (GL4 and FORS) and 
so GalNAc is unlikely to be the receptor. By comparing the relative migration of this 
Candida binding lipid with the control lipids a possible explanation is that the yeast cells 
were binding to blood-group A antigen, to which Ulex europaeus lectin cannot bind. This 
would suggest that more than one fucose-containing glycoside can act as receptor for C. 
albicans. EP and purified adhesin from GDH 2346 were biotinylated and overlaid onto
125TLC plates of separated glycolipids probed with I-streptavidin prior to autoradiography. 
EP and purified adhesin bound to H-blood group antigen by comparison with an identical 
chromatogram overlaid with biotinylated Ulex europaeus lectin. However, there was no 
binding to the additional lipid to which whole cells of the same strain bound. The 
additional lipid (possibly blood-group A antigen) appeared to have a terminal GalNAc, as 
determined by comparison with an identical chromatogram overlaid with GalNAc specific 
lectin from Helix pomatia. This lectin will bind to blood-group A antigen as it has a 
terminal GalNAc residue (Fig. 1). There are two possible explanations for this finding. The 
component on the Candida cell surface that binds to the additional component may not be 
released as part of EP or the ability of EP to bind to this receptor may be lost during the 
purification procedure.
Biotinylated whole cells and EP from a sixth strain, GDH 2023, were overlaid onto 
TLC plates of separated lipids as previously described. By comparison of the resultant 
autoradiographs with an identical chromatogram overlaid with biotinylated GSII lectin 
(specific for GlcNAc), both EP and whole cells from this strain were seen to bind to 
glycolipids containing GlcNAc.
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The findings of recent reports suggest alternative glycolipid receptors for C. albicans. 
Firstly, Jimenez-Lucho et al. (1990) provided evidence that C  albicans, Cryptococcus 
neoformans and Saccharomyces cerevisiae could bind to the glycosphingolipid, 
lactosylceramide. The strains of C  albicans tested in the present study did not share this 
ability. More recently, Yu et al. (1994c), employing a similar overlay system, showed that 
C. albicans fimbriae bound to asialo-GMj and asialo-GM^, but failed to bind to 
lactosylceramide. Neither of the above studies examined the binding of yeasts to lipids 
expressing L-fucosyl residues. The role of lactosylceramide in the adhesion of C. albicans 
to epithelium remains to be resolved. If lactosylceramide is present in epithelial cells, it 
could be the case that it is not exposed at the cell surface. Lactosylceramide has been 
shown to be localised mainly intracellularly in polymorphonuclear neutrophils (Symington 
et al., 1987) and on the human erythrocyte membrane this glycolipid is not accessible to 
galactose oxidase (Gahmberg and Hakomori, 1973). In contrast, the presence of blood 
group-expressing glycolipids is clearly demonstrated on the surface of BEC by the work of 
Vedtofte eta l (1984).
Another recent study, Prakobphol et al. (1994), examined the binding of C tropicalis 
to a range of lipids. They screened a lipid library for potential host receptors using the 
TLC-overlay system and ^^S-labelled C. tropicalis cells. They found no interaction with 
glycolipids or phospholipids. However, lysophospholipids were found to support 
adherence of C. tropicalis but not Saccharomyces cerivisiae. They additionally found that 
binding resulted in rapid metabolism of the substrate, suggesting that the lipid-metabolising 
enzymes of the organism are linked to the adhesion process. C. albicans remains to be 
tested for this ability.
One possible reason for the variability obtained in the above studies is the growth 
medium empoyed. For example, Jimenez-Lucho et al. (1990) used the same medium as 
this study (yeast nitrogen base, Difco) but the carbon source and culture conditions were 
quite different (Jimenez-Lucho et a l, 1% glucose, cultures unshaken; this study, 9% 
galactose, with shaking). In a previous investigation of the effect of different growth 
conditions on the adhesion and virulence of C. albicans (McCourtie and Douglas, 1984)
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medium containing 0.9% glucose produced cells that were less adherent to BEC and less 
virulent in mice than cells from the same strain grown in medium containing 9% galactose. 
Growth of C. albicans in high galactose medium has also been shown to result in the 
production of an outer fibrillar layer (McCourtie and Douglas, 1985). This could result in 
the masking of other adhesins present on the cell surface and lead to the enhanced 
expression of adhesins associated with the fibrillar layer. High concentrations of galactose 
may exist in the oral cavity due to the degradation of lactose by oral bacteria (Chauncey et 
al. 1954), and it is known that a carbohydrate-rich diet often contributes to the 
development and persistence of oral candidosis (Ritchie et ah, 1969; Shuttleworth and 
Gibbs, 1960).
Yu et al. (1994c) found that C albicans fimbriae (from one clinical isolate) did not 
bind to lactosylceramide (which is in agreement with this study) but bound to asialo-GM^ 
and asialo-GM2. They also reported that the synthetic disaccharide pGalNAc(l-4)pGal 
was able to inhibit the binding of fimbria to BEC. In the present study, a BEC lipid 
component that contained GalNac was bound by five strains of C. albicans. This 
component could possibly be asialo-GMi but this would require confirmation. It remains 
for future studies to examine the possibility that C  albicans can produce a number of 
different adhesins, expressed under different environmental constraints. The different 
adhesins may enable the yeast to bind a variety of glycoside structures on glycolipids and 
glycoproteins. This may explain how C. albicans can colonise so many body sites 
(epithelial and endothelial), and under certain conditions, become invasive.
The findings of this study are in agreement with the sugar inhibition assay results 
obtained by Critchley and Douglas (1987b). The findings are also supported by the work 
of Brassait et al. (1991) and Sawyer et al. (1992). Brassait et a l (1991) used complex 
carbohydrates derived from human milk and determined the minimum structure required to 
inhibit C. albicans attachment to BEC was Fuc(al-2)Galpl, which is the terminal 
disaccharide of the H blood-group antigen. In addition, the data presented by Sawyer et 
al. (1992) suggested that a fucose-containing receptor on the surface of either sinusoidal 
endothelial cells or Kupffer cells is involved in the trapping of C. albicans by the perfused
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mouse liver. The results of sugar inhibition studies can be criticised due to the possibility 
that the sugar residue involved in binding may be part of either the host cell receptor or the 
microbial cell adhesin. This study however, made use of the TLC overlay analysis system 
which can confirm the identity of receptors as glycoconjugates. It appears that the adhesin 
molecules on the yeast cell surface are binding in a lectin-like manner to the epithelial cell 
glycoconjugates containing L-fucose or GlcNAc.
Adhesion-inhibition values of 100% have not been attained in previous studies on 
yeast adhesion. Addition of L-fucose to assay mixtures caused only partial inhibition of 
adhesion with sensitive strains (Critchley and Douglas, 1987b), the addition of Fucal- 
2Gaip-bearing complex carbohydrates resulted in between 30-55% adhesion-inhibition 
(Brassart et al. 1991) and purified adhesin inhibited yeast adhesion by 80% (Tosh and 
Douglas, 1992). These results suggest that C. albicans cells may express at least two 
types of adhesin simultaneously. The occurrence of a multi-adhesin system has already 
been proposed for C. albicans (Kennedy et al., 1988). Adhesion of C. albicans to BEC 
could resemble that of Mycoplasma pneumoniae to human colon adenocarcinoma cells; 
both sialyllactose and dextran sulphate have been seen to partially inhibit adhesion to these 
cells, whereas in combination, the compounds inhibited binding by 90% (Krivan et al., 
1989; Roberts e ta l, 1989).
The H and A blood group antigens are both present on the BEC glycolipids of 
blood group A individuals; the A antigen is synthesised by the addition of a terminal 
GalNAc to a precursor substance with blood group H activity. Blood group A antigen 
tends to be on more superficial cells than blood group H and this phenomenon is believed 
to be related to cell differentiation (Vedtofte et a l, 1984). Other fucose-containing 
molecules, the Lewis antigens, have been studied as possible receptors of C albicans. 
Unlike ABO antigens, the Lewis antigens are adsorbed onto the surface of oral epithelial 
cells from the saliva of non-secretors of blood group antigens. Brassart et al. (1991) 
reported that Lewis antigens failed to act as adhesion inhibitors, but two other studies 
indicate a role for the Lewis^ antigen (May et a l, 1989; Tosh and Douglas, 1991). Taken 
together, it appears that the most likely candidates for the receptors of C  albicans on
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BEC are fucose-containing glycosides such as the H antigen and blood group A antigen 
(Tosh and Douglas, 1992). Support for this theory comes from a clinical survey, carried 
out by Burford-Mason et al. (1988), which found that blood group O and non-secretion of 
blood group antigens were separate and cumulative risk factors for oral candidal carriage 
in healthy subjects.
C. albicans infections are common among critically ill patients (Widmer, 1994). 
One reason for this may be that BEC carbohydrates are altered during critical illness. 
Weinmeister and Dal Nogare (1994) compared respiratory cell and BEC surface 
carbohydrate levels of normal subjects with those of critically ill patients. Lectins were 
used to quantitate the amount of mannose, galactose, fucose, and sialic acid on BEC and 
respiratory cells. The BEC of severely ill patients had decreased amounts of sialic acid and 
galactose. However, there was no decrease in the level of fucose on the BEC of these 
patients. No differences were found between the respiratory-cell carbohydrates of normal 
and critically ill patients. They concluded that severely ill patients have decreased amounts 
of galactose and sialic acid on their upper-airway epithelial cells, and that loss of these two 
monosaccharides may explain the high prevalence of gram-negative bacterial colonisation 
and pneumonia in the critically ill. The same may also apply to C. albicans colonisation 
and infection. Varki (1993) suggested that under normal circumstances, sialic acid and 
galactose may function to mask internal carbohydrate residues, preventing microbial 
attachment. Weinmeister and Dal Nogare (1994) proposed two possible mechanisms by 
which BEC carbohydrates are altered during illness. Firstly, oligosaccharide synthesis may 
be affected by the cytokines and hormones released during illness. Support for this comes 
from Wang et al. (1989) who demonstrated that glucocorticosteroids affect the activity of 
a sialyltransferase that normally adds sialic acid to oligosaccharide chains. The second 
proposed mechanism is that glycocompounds may be degraded externally by enzymes 
present in respiratory tract secretions. High levels of exoglycosidase activity has been seen 
in the saliva and tracheal secretions obtained from critically ill patients (Quinn et al, 
1994b). Both mechanisms would result in alterations to the carbohydrate chains expressed 
on BEC and could result in an increase in potential C. albicans receptors. The source of
2 1 0
these exoglycosidases remains to be found. Interestingly, there is evidence to suggest that 
Pseudomonas aeruginosa exoproducts modify epithelial cell surface carbohydrates 
resulting in an increase in the potential receptors for this organism (Saiman et at., 1992). 
This suggests that some pathogens may modify their epithelial habitat to enhance 
adhesion.
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APPENDIX
BIOCHEMICAL ASSAYS
A. Carbohydrate determination using the phenol-sulphuric acid method 
(Dubois et a l, 1956)
Reagents
1 Concentrated sulphuric acid (Reagent Grade)
2 5% phenol (v/v)
Procedure
Phenol reagent (0.05ml) was added to samples (2ml) containing carbohydrate 
(0-100pgml"l). Reagent grade concentrated sulphuric acid (5ml) was rapidly 
added and samples were left for 30 min at room temperature to allow colour 
development. Samples were read at 485nm in a Shimatzu PR-1 
spectrophotometer. A standard curve was produced using mannose.
B. Protein determination using the method of Lowry e ta l, 1951.
Reagents
A. 2% NaiCOs in 0. IM NaOH
B. 0.5% CUSO4.5H2O in 1% sodium tartrate (separate double strength
solutions mixed 1:1 before use).
C. Folin-Ciocalteau reagent diluted 1:1 with distilled water (to give 
total acidity of exactly 1.0 N
D. Mix 50 vol of reagent A with 1 vol of reagent B (renewed daily) 
Procedure
Reagent D (3ml) was added to each sample (0.6ml), containing 0-200pgmh^ 
of protein, mixed well and left to stand at room temperature for 10 min. Reagent C 
(0.3ml) was added rapidly with immediate mixing. Samples were left to stand for 30 
min at room temperature then read against a reagent blank in a spectrophotometer at 
750 nm. A standard curve was produced using bovine serum albumin.
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A / O  1 Attempts 10 Identify a IniegrinCl-Iikc Moleculer \ l  O  I fmmCandida albicansG.A. KÜHLER*. S.H. MIYASAKl, T.C. WHITE and N. AGABIAN University of California - San Francisco, Ca,The adherence of Candida albicans to host tissue may be mediated by interactions of fungal cell surface molecules with ligands on host cells or molecules of the extracellular matrix. Although rate grins have only been described from multi cellular eukaryotes e.g. vertebrates and invertebrates like Drosophila, immunological studies with antisera raised to chicken integrin Bl showed crossreactivity to a 95 kd protein of Candida albicans (Marcantonio. E.E. & Hynes, R.O.. 1988. J. Cell. Biol. 106. 1765- 1772). suggesting that tntegrin-Iike molecules may be involved in Candida adherence.We tested Candida albicans protein extracts with a commercial antiserum to the human fibronectin receptor (integrin n5Bl) by immunoblotting. We detected a band in the same molecular weight range in both blastospore and hyphal extracts. In hyphae. however, the corresponding protein may be more abundant. A second, direct approach to the identification of an inlegrin-like molecule was the inviiro amplification of a DNA (ragment of Candida albicans with de^ncrate primers directed to evolutionatily conserved regions of integrin B subunits. Southern hybridization analysis of genomic restriction digests with the amplified fragment as probe, revealed a single band in C, albicans DNA. We have isolated and are now sequencing the DNA fragment of Candida albicans with nucleic acid sequence similarities to integrin Q genes.
A / O ^  A67-kOa High Affinity Lam in in Receptor-likc Molecule Is O ^ T  Differentially E.sprcssed in C w id b a  iilhicam  Yea.si and 
Mycelial Cell,s. J.L. LOPEZ-RIBOT'*. P. SEPULVEDA-'. C. 
MONTEAGUDO=, M. CASANOVa:. and J.P. MARTINEZL Texas Tech University Health Sciences Center. Lubbock. Te.xax 79430. U.S.A.', and Univ. de Valencia. Valencia. Spain’.
Cell interactions with extracellular matrix, as mediated by cell surface receptors, are thought to play an essential role in the dissemination of C. alhicani cells in vivo. Cell wall extracts and 
protoplast homogenates from both fungal growth forms (yeasts and 
germinated yeasts) were analyzed by SDS-PAGE and Western 
immunoblotting using four affinity-purified rabbit antibodies (Ab) raised to synthetic peptides deduced from the cDNA sequence of the 
human 67-kDa high-affinity laminin teccptor (67LR). that recognize 
different domains of this molecule. Ab4160 recognized the 37-kDa precursor of the 67LR only in wall extracts from yeasts. This was 
confirmed by indirect immunofluorescence (the Ab labelled 
exclusively the yeast cell surface). Ab4U56 recognized the 37-kDa 
precursor in all extracts analyzed, With A64099. only a 57-70 kDa 
species was found in the protoplast lysate from mycelial but not from yeast cells. No specific bands were recognized with Ab4162. The 
differential expression of 67LR observed in C. albicans yeast and 
mycelial cells may be responsible, at least in part, for the different behaviour of both forms in infected htittian ti.ssues.
^ \ / 3 2  Analyses of Glycoproteins from Blasto­conidia and Mycelia of Candida albicans Using Lectins and Treatment with Glycosidases. ELSA WADSWORTH and RICHARD CALDERONE. Georgetown University School of Medicine, Washington, D.C.
Quantitative differences in labelling with a biotin-hydrazide reagent were observed with two major glycoproteins of approximately 50kD from blastoconidia and 60kD from mycelial cells of Candida albicans. Both proteins reactedsimilarly in Western blot with either a monospecific antiserum (CA-7) or a monoclonal antibody (CA-A) to the Q. albicans C3d-bindingprotein (complement receptor 2 or CR2).Reactivity of these two proteins with lectin- peroxidase reagents differed; also, treatment with N-glycanase and Endoglycosidase F increased the electromobility of the 60kD but not the 50kD species, while both proteins retained theirantibody reactivity following glyoosidase digestion, neuraminidase treatment abolished reactivity of only the 60kD glycoprotein to the CA-7 antibody. Our data indicate that an epitope common to both a mycelial and blastoconidial glycoprotein is associated with a structurally different oligosaccharide for each growth form.
A  / Q C  Effect ofCytoioxicDnigs on Adherence-r A /  O  V  to Murine Tissues. J.L. LOPEZ-RIBOT*. und W.L. 
CHAFFIN. Texas Tech University Health Science.s Center. Lubbock. Texas 79430, U.S.A.
The attachment of C, albicans to host cells and tissues is considered to be the initial step leading to establishment of Infection. 
In this era of cytotoxic chemotherapies (among other factors), C. albicans is gaining prevalence as an appommistic pathogen. Mice were treated with lipopolysaccharide and clinically u.scd amicanccr drugs doxorubicin, cisplatin and vincri.stine (2 different concentrations per drug. 3 mice per group). Effects on white blood cell population were 
monitored. Adherence of C. albicans 3153A blastospores to the different ti.ssues was studied using the "ex vivo" a.ssay. No differences were observed in binding of the fungal cells to liver and kidney tissues from treated or untreated animals. All drug-treated 
spleens displayed altered patterns of adhesion for C. albicans compared to the control group, with yeast cells bound not onl)' to the 
marginal zone but also to the white and red pulp. Immunostaining for macrophages showed no apparent differences between the control and 
the experimental spleens that could account for the change in adhesion 
patterns, Preliminary scanning electron microscopy images suggested 
that yeast binding to the white pulp in treated tissues is mediated 
through fibers, perhaps exposed exu acetlullar matrix components.
/ \ / 3 3  Isolation of Avirulent Clones of C a n d id a  
a l b i c a n s  with Reduced Ability to Recognize the CR2 Ligand C3D. S. FBANZKE AND R. CALDERONE, Georgetown University, Washington, D.C.Four clones of the yeast C a n d id a  a l b i c a n s  were isolated on the basis of their tolerance to clotrimazole. These clones produced germ tubes or pseudomycelia but no true hyphae in a pattern which was specific for each strain. Growth of each clone at 37*C, under conditions which favor the filamentous growth form of the organism, was equal to the parental strain (H12) , In an intravenous mouse model, none of the mice infected with the tolerant clones but all of the mice infected with H12 developed severe renal candidiasis. As a correlate, we measured the complement receptor activity (CR2 and CR3)ot each clone. We found that all tolerant clones showed reduced recognition of C3d bearing sheep erythrocytes (EAC3d) in resetting assays. in comparison, recognition of iC3b (EAiC3b) by each of the clones was similar to wt cells. DTT- extracts of clone P and H12 (wt) were compared by immunoblot. Both quantitative and quali­tative differences in immunoblot analyses of clone P were observed with antibodies specific for the C a n d id a C3d-receptor.
A  /  ^  R  Fucose-Conuûràng Glycosphingolipids as Receptors for O  vJ Candida albicans,
B.J, CAMERON* and L.J, DOUGLAS. University of Glasgow, Glasgow, Scotland.
L-Fucose inhibits the adhesion of Candida albicans GDH 2346 to buccal epithelial cells in viiro. This organism produces extracellular 
polymeric material (EP) which contains a mannoproiein adhesin with a lectin-like affinity for fucose-coniatning glycosides. To examine the 
possible role of fucose-containing glycosphingolipids as receptors forC. albicans . a chromatogram overlay assay was used.
EP was layered on thin-layer chromatograms of separated 
glycosphingolipids which had been extracted from human buccal epithelial cells and sheep red blotxl cells. Two methods for detecting 
bound EP were used. In the f irs t, EP was labelled with '^ 1  prior to 
overlay and binding was detected on the chromatograms by autoradiography. The second method involved biotin labelling of EP 
prior to overlay; binding was detected by the addition of >^ *1- streptavidin followed by autoradiography. Fucose-containing glycosphingolipids were detected similarly by the use of bio tin-labelled lectin from UUx europaeus which has an affinity for L-fucose. The results obtained showed that EP bound to the same glycosphingolipid bands as the fucose-spccific lectin suggesting that these lipids can act as receptors for C. albicans .
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